These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
13-1,
Nihonbashi
1-chome
|
|
|
(Jurisdiction of incorporation or organization)
|
(Address of principal executive offices)
|
|
Title of Each Class
|
Trading Symbol(s)
|
Name of Each Exchange On Which Registered
|
||
|
*
|
|
|
| * |
|
|
Large accelerated file
r
|
Accelerated filer ☐ |
Non-accelerated
filer ☐
|
Emerging growth company
|
|
|
International Financial Reporting Standards as issued
by the International Accounting Standards Board ☐
|
Other ☐ |
|
Page
|
||||
|
PART I
|
||||
|
Item 1.
|
2 | |||
|
Item 2.
|
2 | |||
|
Item 3.
|
2 | |||
|
Item 4.
|
21 | |||
|
Item 4A.
|
55 | |||
|
Item 5.
|
55 | |||
|
Item 6.
|
92 | |||
|
Item 7.
|
119 | |||
|
Item 8.
|
119 | |||
|
Item 9.
|
120 | |||
|
Item 10.
|
120 | |||
|
Item 11.
|
128 | |||
|
Item 12.
|
143 | |||
|
PART II
|
||||
|
Item 13.
|
145 | |||
|
Item 14.
|
145 | |||
|
Item 15.
|
145 | |||
|
Item 16A.
|
146 | |||
|
Item 16B.
|
146 | |||
|
Item 16C.
|
146 | |||
|
Item 16D.
|
147 | |||
|
Item 16E.
|
147 | |||
|
Item 16F.
|
148 | |||
|
Item 16G.
|
148 | |||
|
Item 16H.
|
150 | |||
|
Item 16I.
|
150 | |||
|
Item 16J.
|
150 | |||
|
Item 16K.
|
150 | |||
|
PART III
|
||||
|
Item 17.
|
152 | |||
|
Item 18.
|
152 | |||
|
Item 19.
|
152 | |||
|
F-1
|
||||
|
·
|
Risks Relating to the Business Environment
|
|
1
|
Our business may be materially affected by financial markets, economic conditions and market fluctuations in Japan and elsewhere around the world, including the ones caused by geopolitical events
|
| (1) |
Governmental fiscal and monetary policy changes in Japan, or in any other countries or regions where we conduct business may affect our business, financial condition and results of operations
|
| (2) |
Extended market declines and decreases in market participants can reduce liquidity and lead to material losses
|
| (3) |
Natural disaster, terrorism, military dispute and infectious disease could adversely affect our business
|
|
2
|
The financial services industry faces intense competition
|
| (1) |
Competition with other financial firms and financial services by
non-financial
companies is increasing
|
| (2) |
Increased consolidation, business alliance and cooperation in the financial services industry mean increased competition for us
|
| (3) |
Our global business continues to face intense competition and may require further revisions to its business model
|
|
3
|
Event risk, including the ones caused by geopolitical events, may cause losses in our trading and investment assets as well as market and liquidity risk
|
|
4
|
Sustainability factors including climate change and broader associated policy changes in each jurisdiction could adversely affect our business
|
|
·
|
Risks Relating to Our Businesses
|
|
5
|
Our business may incur losses due to various factors in the conduct of its operations
|
| (1) |
We may incur significant losses from our trading and investment activities
|
| (2) |
Holding large and concentrated positions of securities and other assets may expose us to significant losses
|
| (3) |
Our hedging strategies may not prevent losses
|
| (4) |
Our risk management policies and procedures may not be fully effective in managing risk
|
| (5) |
Market risk may increase other risks that we face
|
| (6) |
Our brokerage and asset management revenues may decline
|
| (7) |
Our investment banking revenues may decline
|
|
6
|
We may be exposed to losses when third parties do not perform their obligations to us
|
| (1) |
Defaults by a large financial institution could adversely affect the financial markets generally and us specifically
|
| (2) |
There can be no assurance as to the accuracy of the information about our credit risk, or the sufficiency of the collateral we use in managing it
|
| (3) |
Our clients and counterparties may be unable to perform their obligations to us as a result of political or economic conditions
|
|
7
|
We are exposed to model risk, i.e., risk of financial loss, incorrect decision making, or damage to our credibility arising from model errors or incorrect or inappropriate model application
|
|
8
|
NHI is a holding company and depends on payments from its subsidiaries
|
|
9
|
We may not be able to realize gains we expect, and may even suffer losses, on our investments in equity securities and
non-trading
debt securities
|
|
10
|
We may face an outflow of clients’ assets due to losses incurred within cash reserve funds or debt securities we offer to clients
|
|
·
|
Risks Relating to Our Financial Position
|
|
11
|
We may have to recognize impairment losses with regard to the amount of goodwill, tangible and intangible assets recognized on our consolidated balance sheets
|
|
12
|
Liquidity risk could impair our ability to fund operations and jeopardize our financial condition
|
| (1) |
We may be unable to access unsecured or secured funding
|
| (2) |
We may be unable to sell assets
|
| (3) |
Lowering of our credit ratings could impact our funding
|
|
13
|
Equity investments in affiliates and other investees accounted for under the equity method in our consolidated financial statements may decline significantly over a period of time and result in us recognizing impairment losses
|
|
·
|
Risks Relating to Legal, Compliance and Other Operational Issues
|
|
14
|
Operational risk could adversely affect our business
|
|
15
|
We identified a material weakness in our internal control over financial reporting and, despite our efforts to remediate, may identify further material weaknesses in the future
|
|
16
|
Misconduct or fraud by an employee, director or officer, or any third party, could occur, and our reputation in the market and our relationships with clients could be harmed
|
|
17
|
A failure to identify and appropriately address conflicts of interest could adversely affect our business
|
|
18
|
Our business is subject to substantial legal, regulatory and reputational risks
|
| (1) |
Legal liability related to our business may occur and could adversely affect our business, financial condition and results of operations
|
| (2) |
Extensive regulation of our businesses limits our activities and may subject us to significant penalties and losses
|
| (3) |
Tightening of regulations applicable to the financial system and financial industry could adversely affect our business, financial condition and results of operations
|
| (4) |
Deferred tax assets may be impacted due to a change in business condition or in laws and regulations, resulting in an adverse effect on our operating results and financial condition
|
| (5) |
Defects in our anti-money laundering and counter-terrorism financing measures could have serious consequences such as, administrative penalties or punitive fines
|
|
19
|
Unauthorized disclosure or misuse of personal information held by us may adversely affect our business
|
|
20
|
System failure, information leakage and cost of maintaining sufficient cybersecurity could adversely affect our business, financial condition and results of operations
|
|
21
|
Our business may be adversely affected if we are unable to hire, retain and develop qualified personnel
|
|
·
|
Risks Related to Holding or Trading of our Shares and ADSs
|
|
22
|
Because of daily price range limitations under Japanese stock exchange rules, you may not be able to sell your shares of the Company’s common stock at a particular price on any particular trading day, or at all
|
|
23
|
Under Japan’s unit share system, holders of shares of the Company’s common stock constituting less than one unit are subject to transfer, voting and other restrictions
|
|
24
|
As a holder of ADSs, you will have fewer rights than a shareholder has and you will have to act through the depositary to exercise these rights
|
|
25
|
Rights of shareholders under Japanese law may be more limited than under the laws of other jurisdictions
|
|
26
|
The Company’s shareholders of record on a record date may not receive the dividend they anticipate
|
|
27
|
It may not be possible for investors to secure personal jurisdiction within the U.S. over the Company or the Company’s directors or executive officers, or to enforce against the Company or those persons judgments obtained in U.S. courts predicated upon the civil liability provisions of the federal securities laws of the U.S.
|
|
·
|
Special Note Regarding Forward-looking Statements
|
|
·
|
Risks Relating to the Business Environment
|
|
1.
|
Our business may be materially affected by financial markets, economic conditions and market fluctuations in Japan and elsewhere around the world, including the ones caused by geopolitical events
|
|
2.
|
The financial services industry faces intense competition
|
|
3.
|
Event risk, including the ones caused by geopolitical events, may cause losses in our trading and investment assets as well as market and liquidity risk
|
| • |
sudden and significant reductions in credit ratings with regard to financial instruments held by our trading and investment businesses by major rating agencies,
|
| • |
sudden changes in trading, tax, accounting, regulatory requirements, laws and other related rules which may make our trading strategy obsolete, less competitive or no longer viable, or
|
| • |
an unexpected failure in a corporate transaction in which we participate resulting in us not receiving the consideration we should have received, as well as bankruptcy, deliberate acts of fraud, and administrative penalty with respect to the issuers of our trading and investment assets.
|
|
4.
|
Sustainability factors including climate change and broader associated policy changes in each jurisdiction could adversely affect our business
|
|
·
|
Risks Relating to Our Businesses
|
|
5.
|
Our business may incur losses due to various factors in the conduct of its operations.
|
|
6.
|
We may be exposed to losses when third parties do not perform their obligations to us
|
|
7.
|
We are exposed to model risk, i.e., risk of financial loss, incorrect decision making, or damage to our credibility arising from model errors or incorrect or inappropriate model application
|
|
8.
|
NHI is a holding company and depends on payments from its subsidiaries
|
|
9.
|
We may not be able to realize gains we expect, and may even suffer losses, on our investments in equity securities and
non-trading
debt securities
|
|
10.
|
We may face an outflow of clients’ assets due to losses incurred within cash reserve funds or debt securities we offer to clients
|
|
·
|
Risks Relating to Our Financial Position
|
|
11.
|
We may have to recognize impairment losses with regard to the amount of goodwill, tangible and intangible assets recognized on our consolidated balance sheets
|
|
12.
|
Liquidity risk could impair our ability to fund operations and jeopardize our financial condition
|
| • |
We incur large trading losses,
|
| • |
The level of our business activity decreases due to a market downturn,
|
| • |
Regulatory authorities take significant action against us, or
|
| • |
Our credit rating is downgraded.
|
|
13.
|
Equity investments in affiliates and other investees accounted for under the equity method in our consolidated financial statements may decline significantly over a period of time and result in us recognizing impairment losses
|
|
·
|
Risks Relating to Legal, Compliance and Other Operational Issues
|
|
14.
|
Operational risk could adversely affect our business
|
|
15.
|
We identified a material weakness in our internal control over financial reporting and, despite our efforts to remediate, may identify further material weaknesses in the future
|
|
16.
|
Misconduct or fraud by an employee, director or officer, or any third party, could occur, and our reputation in the market and our relationships with clients could be harmed
|
|
17.
|
A failure to identify and appropriately address conflicts of interest could adversely affect our business
|
|
18.
|
Our business is subject to substantial legal, regulatory and reputational risks
|
|
19.
|
Unauthorized disclosure or misuse of personal information held by us may adversely affect our business
|
|
20.
|
System failure, information leakage and cost of maintaining sufficient cybersecurity could adversely affect our business, financial condition and results of operations
|
|
21.
|
Our business may be adversely affected if we are unable to hire, retain and develop qualified personnel
|
|
·
|
Risks Related to Holding or Trading of our Shares and ADSs
|
|
22.
|
Because of daily price range limitations under Japanese stock exchange rules, you may not be able to sell your shares of the Company’s common stock at a particular price on any particular trading day, or at all
|
|
23.
|
Under Japan’s unit share system, holders of shares of the Company’s common stock constituting less than one unit are subject to transfer, voting and other restrictions
|
|
24.
|
As a holder of ADSs, you will have fewer rights than a shareholder has and you will have to act through the depositary to exercise these rights
|
|
25.
|
Rights of shareholders under Japanese law may be more limited than under the laws of other jurisdictions
|
|
26.
|
The Company’s shareholders of record on a record date may not receive the dividend they anticipate
|
|
27.
|
It may not be possible for investors to secure personal jurisdiction within the U.S. over the Company or the Company’s directors or executive officers, or to enforce against the Company or those persons judgments obtained in U.S. courts predicated upon the civil liability provisions of the federal securities laws of the U.S.
|
|
·
|
Special Note Regarding Forward-looking Statements
|
|
*
|
The Retail Division has been renamed the “Wealth Management Division”, effective April 1, 2024.
|
|
Purpose
We aspire to create a better world by harnessing the power of financial markets
|
| • |
the quality, range and prices of our products and services,
|
| • |
our ability to originate and develop innovative client solutions,
|
| • |
our ability to maintain and develop client relationships,
|
| • |
our ability to access and commit capital resources,
|
| • |
our ability to retain and attract qualified employees, and
|
| • |
our general reputation.
|
| • |
the monetary and fiscal policies of national governments and international economic organizations,
|
| • |
economic, political and social developments both within and between Japan, the U.S., Europe and other major industrialized and developing countries and regions, and
|
| • |
increasing digitalization beyond the traditional financial sector
|
| (i) |
significantly reduce the number of instruments in scope of full transparency by trading venues and investment firms to those instruments considered most liquid (Category 1 instruments), with only venues responsible for providing transparency on other
non-equity
instruments (Category 2 instruments) when these are traded on venue; and
|
| (ii) |
streamline
pre-trade
waivers and post-trade deferrals, as well as allowing venues to calibrate these themselves for Category 2 instruments (applying specified criteria).
|
|
•
|
Wealth Management Division
|
| • |
Investment Management Division
|
| • |
Wholesale Division
|
| • |
Risk Management and Compliance, etc.
|
| • |
Supporting the sustainability efforts of our clients and stakeholders through business activities as a leading financial institution
|
| • |
The Company’s efforts to continue being a sustainable corporate group
|
| • |
Risk that clients will not adequately respond to climate change, resulting in financial damage, decline in creditworthiness and inability to fulfil their contractual obligations
|
| • |
Risk that climate change causes market fluctuations and losses are incurred due to fluctuations in the market price of Nomura’s financial assets
|
| • |
Risk of reputational damage if Nomura and counterparties fail to respond appropriately to climate change
|
| • |
Risk of financial losses or reputational damage due to inadequate or failed internal processes and employee response to climate change
|
| • |
Risk of inadequate strategies or failed execution of strategies as compared with competitors, and risk of gap between strategies and resources
|
| (1) |
Absenteeism: The impact of absenteeism is measured by financial losses due to absence from work coursed by injury or illness, calculated by multiplying the average compensation of employees for such financial year by the number of employees and the utilization rate of sick leave.
|
| (2) |
Presenteeism: A condition in which individuals go to work despite being ill or experiencing symptoms of illness, with negative impacts on business execution and productivity. The figure is calculated based on responses to the SPQ (Single-Item Presenteeism Question, Tokyo University
1-Item
Version).
|
| (3) |
Work Engagement: A positive, fulfilling, work-related state of mind. This is measured based on deviation from the results of the national average of annual stress assessment, which is an annual mandatory workplace program in Japan to screen for mental health issues in workers.
|
|
Name
|
Country/Region
|
Ownership
Interest
|
||||
|
(%)
|
||||||
|
Nomura Holdings, Inc.
|
Japan | — | ||||
|
Nomura Securities Co., Ltd.
(1)
|
Japan | 100 | ||||
|
Nomura Asset Management Co., Ltd.
|
Japan | 100 | ||||
|
The Nomura Trust & Banking Co., Ltd.
|
Japan | 100 | ||||
|
Nomura Babcock & Brown Co., Ltd.
|
Japan | 100 | ||||
|
Nomura Capital Investment Co., Ltd.
|
Japan | 100 | ||||
|
Nomura Investor Relations Co., Ltd.
|
Japan | 100 | ||||
|
Nomura Fiduciary Research & Consulting Co., Ltd.
|
Japan | 100 | ||||
|
Nomura Research & Advisory Co., Ltd.
|
Japan | 100 | ||||
|
Nomura Business Services Co., Ltd.
|
Japan | 100 | ||||
|
Nomura Properties, Inc.
|
Japan | 100 | ||||
|
Nomura Institute of Capital Markets Research
|
Japan | 100 | ||||
|
Nomura Healthcare Co., Ltd.
(1)
|
Japan | 100 | ||||
|
Nomura Agri Planning & Advisory Co., Ltd.
(1)
|
Japan | 100 | ||||
|
Nomura Financial Products & Services, Inc.
|
Japan | 100 | ||||
|
Nomura Institute of Estate Planning
|
Japan | 100 | ||||
|
Nomura Capital Partners Co., Ltd.
|
Japan | 100 | ||||
|
Nomura Mezzanine Partners Co., Ltd.
|
Japan | 100 | ||||
|
Corporate Design Partners Co., Ltd.
|
Japan | 100 | ||||
|
Nomura Kagayaki Co., Ltd.
|
Japan | 100 | ||||
|
Nomura IM Investment LLC
|
Japan | 100 | ||||
|
Nomura Asia Pacific Holdings Co., Ltd.
|
Japan | 100 | ||||
|
Nomura International (Hong Kong) Limited
|
Hong Kong | 100 | ||||
|
Nomura Singapore Limited
|
Singapore | 100 | ||||
|
Nomura Securities Singapore Pte. Ltd.
|
Singapore | 100 | ||||
|
Nomura Australia Limited
|
Australia | 100 | ||||
|
Nomura Asia Investment (Fixed Income) Pte. Ltd.
|
Singapore | 100 | ||||
|
Name
|
Country/Region
|
Ownership
Interest
|
||||
|
(%)
|
||||||
|
Nomura Asia Investment (Singapore) Pte. Ltd.
|
Singapore | 100 | ||||
|
Nomura Financial Advisory and Securities (India) Private Limited
|
India | 100 | ||||
|
Nomura Holding America Inc.
|
U.S. | 100 | ||||
|
Nomura Securities International, Inc.
|
U.S. | 100 | ||||
|
Nomura Corporate Research and Asset Management Inc.
|
U.S. | 100 | ||||
|
Nomura America Mortgage Finance, LLC
|
U.S. | 100 | ||||
|
Nomura Global Financial Products, Inc.
|
U.S. | 100 | ||||
|
Instinet Incorporated
|
U.S. | 100 | ||||
|
Nomura Europe Holdings plc
|
U.K. | 100 | ||||
|
Nomura International plc
|
U.K. | 100 | ||||
|
Nomura Bank International plc
|
U.K. | 100 | ||||
|
Nomura Financial Products Europe GmbH
|
Germany | 100 | ||||
|
Banque Nomura France
|
France | 100 | ||||
|
Nomura Bank (Luxembourg) S.A.
|
Luxemburg | 100 | ||||
|
Nomura Bank (Switzerland) Ltd.
|
Switzerland | 100 | ||||
|
Nomura Europe Finance N.V.
|
The Netherlands | 100 | ||||
|
Nomura European Investment Limited
|
U.K. | 100 | ||||
|
Laser Digital Group Holdings AG
|
Switzerland | 100 | ||||
|
Nomura Asia Investment (India Powai) Pte. Ltd.
|
Singapore | 100 | ||||
|
Nomura Services India Private Limited
|
India | 100 | ||||
|
Nomura International Funding Pte. Ltd.
|
Singapore | 100 | ||||
|
Nomura Orient International Securities Co., Ltd.
|
China | 51 | ||||
| (1) |
Nomura Securities Co., Ltd. (“NSC”), Nomura Healthcare Co., Ltd. (“NHSA”) and Nomura Agri Planning & Advisory Co., Ltd. (“NAPA”), merged effective on May 1, 2024. NSC is a surviving entity and NHSA and NAPA are absorbed entities.
|
|
Name
|
Location
|
Segment
|
Nature of the plan
|
Estimate of the
amount of expenditures (Millions of yen) |
Amount of
expenditures already paid (Millions of yen) |
Method of
financing |
Date of start of
the activity |
Estimated
date of completion of the activity |
||||||||||||
|
NHI
|
Tokyo
|
Other
|
Nihonbashi
1-Chome
Naka Area Type 1 Urban Area Redevelopment Project
|
149,200 | 17,233 |
Own funds
|
December 2021
|
March 2026
|
||||||||||||
|
1.
|
Diluted net income attributable to NHI shareholders per share.
|
|
Year ended March 31 (Trillions of yen)
|
||||||||||||||||||||
|
2022
|
2023
|
% Change from
previous year |
2024
|
% Change from
previous year |
||||||||||||||||
|
Recurring revenue assets
|
¥ | 19.6 | ¥ | 18.7 | (4.6 | )% | ¥ | 23.0 | 23.0 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Year ended March 31 (Billions of yen)
|
||||||||||||||||||||
|
2022
|
2023
|
% Change from
previous year |
2024
|
% Change from
previous year |
||||||||||||||||
|
Net inflows of recurring revenue assets
|
¥ | 555.5 | ¥ | 333.7 | (39.9 | )% | ¥ | 317.4 | (4.9 | )% | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Year ended March 31 (Thousands)
|
||||||||||||||||||||
|
2022
|
2023
|
% Change from
previous year |
2024
|
% Change from
previous year |
||||||||||||||||
|
Flow business clients
|
1,505 | 1,446 | (3.9 | )% | 1,692 | 17.0 | % | |||||||||||||
|
Services for salaried employees
|
3,357 | 3,489 | 3.9 | % | 3,627 | 4.0 | % | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
(Trillions of yen)
|
||||||||||||||||||||
|
March 31, 2022
|
March 31, 2023
|
% Change from
previous year |
March 31, 2024
|
% Change from
previous year |
||||||||||||||||
|
The balance of assets under management
|
¥ | 67.9 | ¥ | 67.3 | (0.9 | )% | ¥ | 89.0 | 32.2% | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Year ended March 31 (Billions of yen)
|
||||||||||||||||||||
|
2022
|
2023
|
% Change from
previous year |
2024
|
% Change from
previous year |
||||||||||||||||
|
Net inflow
|
¥ | 2,066 | ¥ | (760 | ) | — | % | ¥ | 3,760 | — % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Year ended March 31
|
||||||||||||||||||||
|
2022
|
2023
|
% Change from
previous year |
2024
|
% Change from
previous year |
||||||||||||||||
|
Cost-to-income
|
89 | % | 96 | % | 7 | % | 94 | % | (2 | )% | ||||||||||
|
Revenue/modified RWA
|
7.0 | % | 6.5 | % | (0.5 | )% | 6.8 | % | 0.3 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Millions of yen, except percentages
|
||||||||||||||||||||
|
Year ended March 31
|
||||||||||||||||||||
|
2022
|
2023
|
% Change from
previous year |
2024
|
% Change from
previous year |
||||||||||||||||
|
Non-interest
revenues:
|
||||||||||||||||||||
|
Commissions
|
¥ | 332,344 | ¥ | 279,857 | (15.8 | )% | ¥ | 364,095 | 30.1 | % | ||||||||||
|
Fees from investment banking
|
149,603 | 113,208 | (24.3 | ) | 173,265 | 53.1 | ||||||||||||||
|
Asset management and portfolio service fees
|
269,985 | 271,684 | 0.6 | 310,154 | 14.2 | |||||||||||||||
|
Net gain on trading
|
368,799 | 563,269 | 52.7 | 491,611 | (12.7 | ) | ||||||||||||||
|
Gain on private equity and debt investments
|
30,768 | 14,504 | (52.9 | ) | 11,877 | (18.1 | ) | |||||||||||||
|
Gain (loss) on investments in equity securities
|
5,446 | (1,426 | ) | — | 9,612 | — | ||||||||||||||
|
Other
|
152,832 | 130,940 | (14.3 | ) | 175,824 | 34.3 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total
Non-interest
revenues
|
1,309,777 | 1,372,036 | 4.8 | 1,536,438 | 12.0 | |||||||||||||||
|
Net interest revenue
|
54,113 | (36,459 | ) | — | 25,562 | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Net revenue
|
1,363,890 | 1,335,577 | (2.1 | ) | 1,562,000 | 17.0 | ||||||||||||||
|
Non-interest
expenses
|
1,137,267 | 1,186,103 | 4.3 | 1,288,150 | 8.6 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Income before income taxes
|
226,623 | 149,474 | (34.0 | ) | 273,850 | 83.2 | ||||||||||||||
|
Income tax expense
|
80,090 | 57,798 | (27.8 | ) | 96,630 | 67.2 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Net income
|
¥ | 146,533 | ¥ | 91,676 | (37.4 | )% | ¥ | 177,220 | 93.3 | % | ||||||||||
|
Less: Net income (loss) attributable to noncontrolling interests
|
3,537 | (1,110 | ) | — | 11,357 | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Net income attributable to NHI shareholders
|
¥ | 142,996 | ¥ | 92,786 | (35.1 | )% | ¥ | 165,863 | 78.8 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Return on equity
|
5.1 | % | 3.1 | % | 5.1 | % | ||||||||||||||
|
Millions of yen
|
||||||||||||||||||||
|
Year ended March 31
|
||||||||||||||||||||
|
2022
|
2023
|
% Change from
previous year |
2024
|
% Change from
previous year |
||||||||||||||||
|
Non-interest
revenue
|
¥ | 324,642 | ¥ | 297,496 | (8.4 | )% | ¥ | 395,900 | 33.1 | % | ||||||||||
|
Net interest revenue
|
3,343 | 2,695 | (19.4 | ) | 6,461 | 139.7 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Net revenue
|
327,985 | 300,191 | (8.5 | ) | 402,361 | 34.0 | ||||||||||||||
|
Non-interest
expenses
|
268,745 | 266,695 | (0.8 | ) | 279,682 | 4.9 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Income before income taxes
|
¥ | 59,240 | ¥ | 33,496 | (43.5 | )% | ¥ | 122,679 | 266.2 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Millions of yen
|
||||||||||||||||||||
|
Year ended March 31
|
||||||||||||||||||||
|
2022
|
2023
|
% Change from
previous year |
2024
|
% Change from
previous year |
||||||||||||||||
|
Commissions
|
¥ | 138,525 | ¥ | 112,455 | (18.8 | )% | ¥ | 173,461 | 54.2 | % | ||||||||||
|
Brokerage commissions
|
67,419 | 50,901 | (24.5 | ) | 80,239 | 57.6 | ||||||||||||||
|
Commissions for distribution of investment trusts
|
43,537 | 30,183 | (30.7 | ) | 54,857 | 81.7 | ||||||||||||||
|
Other commissions
|
27,569 | 31,371 | 13.8 | 38,365 | 22.3 | |||||||||||||||
|
Net gain on trading
|
43,981 | 44,171 | 0.4 | 55,919 | 26.6 | |||||||||||||||
|
Fees from investment banking
|
19,003 | 16,184 | (14.8 | ) | 23,066 | 42.5 | ||||||||||||||
|
Asset management fees
|
109,300 | 108,085 | (1.1 | ) | 124,446 | 15.1 | ||||||||||||||
|
Others
|
13,833 | 16,601 | 20.0 | 19,008 | 14.5 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Non-interest
revenues
|
¥ | 324,642 | ¥ | 297,496 | (8.4 | )% | ¥ | 395,900 | 33.1 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Trillions of yen
|
||||||||||||||||||||
|
Year ended March 31, 2023
|
||||||||||||||||||||
|
Balance at
beginning of year
|
Gross inflows
|
Gross outflows
|
Market
appreciation /
(depreciation)
|
Balance at
end of year
|
||||||||||||||||
|
Equities
|
¥ | 77.5 | ¥ | 21.4 | ¥ | (18.6 | ) | ¥ | (2.3 | ) | ¥ | 78.0 | ||||||||
|
Debt securities
|
17.7 | 15.5 | (22.9 | ) | 8.2 | 18.5 | ||||||||||||||
|
Equity investment trusts
|
10.8 | 2.8 | (2.6 | ) | (0.8 | ) | 10.2 | |||||||||||||
|
Debt investment trusts
|
7.5 | 0.1 | (0.7 | ) | (0.1 | ) | 6.8 | |||||||||||||
|
Overseas mutual funds
|
1.3 | 0.1 | (0.1 | ) | (0.1 | ) | 1.2 | |||||||||||||
|
Others
|
7.3 | 1.0 | (0.5 | ) | (0.3 | ) | 7.5 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total
|
¥ | 122.1 | ¥ | 40.9 | ¥ | (45.4 | ) | ¥ | 4.6 | ¥ | 122.2 | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Trillions of yen
|
||||||||||||||||||||
|
Year ended March 31, 2024
|
||||||||||||||||||||
|
Balance at
beginning of year
|
Gross inflows
|
Gross outflows
|
Market
appreciation /
(depreciation)
|
Balance at
end of year
|
||||||||||||||||
|
Equities
|
¥ | 78.0 | ¥ | 31.1 | ¥ | (27.0 | ) | ¥ | 20.4 | ¥ | 102.5 | |||||||||
|
Debt securities
|
18.5 | 13.6 | (18.4 | ) | 6.4 | 20.1 | ||||||||||||||
|
Equity investment trusts
|
10.2 | 3.8 | (3.6 | ) | 2.9 | 13.3 | ||||||||||||||
|
Debt investment trusts
|
6.8 | 0.8 | (0.3 | ) | 0.0 | 7.3 | ||||||||||||||
|
Overseas mutual funds
|
1.2 | 0.5 | (0.1 | ) | 0.2 | 1.8 | ||||||||||||||
|
Others
|
7.5 | 1.8 | (0.8 | ) | 0.1 | 8.6 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total
|
¥ | 122.2 | ¥ | 51.6 | ¥ | (50.2 | ) | ¥ | 30.0 | ¥ | 153.6 | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Millions of yen
|
||||||||||||||||||||
|
Year ended March 31
|
||||||||||||||||||||
|
2022
|
2023
|
% Change from
previous year |
2024
|
% Change from
previous year |
||||||||||||||||
|
Non-interest
revenue
|
¥ | 129,848 | ¥ | 120,096 | (7.5 | )% | ¥ | 149,575 | 24.5 | % | ||||||||||
|
Net interest revenue
|
18,145 | 8,463 | (53.4 | ) | 4,568 | (46.0 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Net revenue
|
147,993 | 128,559 | (13.1 | ) | 154,143 | 19.9 | ||||||||||||||
|
Non-interest
expenses
|
76,478 | 85,064 | 11.2 | 93,945 | 10.4 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Income before income taxes
|
¥ | 71,515 | ¥ | 43,495 | (39.2 | )% | ¥ | 60,198 | 38.4 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Millions of yen
|
||||||||||||||||||||
|
Year ended March 31
|
||||||||||||||||||||
|
2022
|
2023
|
% Change from
previous year |
2024
|
% Change from
previous year |
||||||||||||||||
|
Business revenue
(1)
|
¥ | 119,920 | ¥ | 120,664 | 0.6 | % | ¥ | 137,249 | 13.7 | % | ||||||||||
|
Investment gain/ loss
(2)
|
28,073 | 7,895 | (71.9 | ) | 16,894 | 114.0 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Net revenue
|
¥ | 147,993 | ¥ | 128,559 | (13.1 | )% | ¥ | 154,143 | 19.9 | % | ||||||||||
| (1) |
Consists of divisional revenue, other than investment gain/loss, including revenue generated by our asset management business (excluding gains and losses related to our investment in American Century Investments), revenues generated by Nomura Babcock & Brown Co., Ltd.’s aircraft leasing-related businesses and management fee revenues generated from our private equity and other investment businesses
|
| (2) |
Consists of divisional revenue attributable to investments (including fair value fluctuations, funding cost and dividends), including gains and losses related to our investment in American Century Investments, our investments held in our private equity and other investment businesses.
|
|
Billions of yen
|
||||||||||||||||||||
|
Year ended March 31, 2023
|
||||||||||||||||||||
|
Balance at
beginning of year
|
Gross inflows
|
Gross outflows
|
Market
appreciation /
(depreciation)
|
Balance at
end of year
|
||||||||||||||||
|
Nomura Asset Management Co., Ltd .
|
¥ | 69,592 | ¥ | 23,168 | ¥ | (24,762 | ) | ¥ | 1,094 | ¥ | 69,092 | |||||||||
|
Nomura Corporate Research and Asset Management Inc. etc
|
3,867 | 1,040 | (1,074 | ) | 35 | 3,868 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Combined total
|
73,459 | 24,208 | (25,836 | ) | 1,129 | 72,960 | ||||||||||||||
|
Shared across group companies
|
(5,546 | ) | (1,409 | ) | 1,382 | (115 | ) | (5,688 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total
|
¥ | 67,913 | ¥ | 22,799 | ¥ | (24,454 | ) | ¥ | 1,014 | ¥ | 67,272 | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Billions of yen
|
||||||||||||||||||||
|
Year ended March 31, 2024
|
||||||||||||||||||||
|
Balance at
beginning of year
|
Gross inflows
|
Gross outflows
|
Market
appreciation /
(depreciation)
|
Balance at
end of year
|
||||||||||||||||
|
Nomura Asset Management Co., Ltd .
|
¥ | 69,092 | ¥ | 31,019 | ¥ | (28,614 | ) | ¥ | 19,514 | ¥ | 91,011 | |||||||||
|
Nomura Corporate Research and Asset Management Inc. etc
|
3,868 | 1,799 | (1,098 | ) | 1,019 | 5,588 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Combined total
|
72,960 | 32,818 | (29,712 | ) | 20,533 | 96,599 | ||||||||||||||
|
Shared across group companies
|
(5,688 | ) | (2,061 | ) | 1,680 | (1,529 | ) | (7,598 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total
|
¥ | 67,272 | ¥ | 30,757 | ¥ | (28,032 | ) | ¥ | 19,004 | ¥ | 89,001 | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
March 31
|
||||||||||||
|
2022
|
2023
|
2024
|
||||||||||
|
Total of publicly offered investment trusts
|
27 | % | 27 | % | 26 | % | ||||||
|
Equity investment trusts
|
25 | % | 25 | % | 25 | % | ||||||
|
Debt investment trusts
|
44 | % | 44 | % | 44 | % | ||||||
|
Millions of yen
|
||||||||||||||||||||
|
Year ended March 31
|
||||||||||||||||||||
|
2022
|
2023
|
% Change from
previous year |
2024
|
% Change from
previous year |
||||||||||||||||
|
Non-interest
revenue
|
¥ | 617,227 | ¥ | 809,681 | 31.2 | % | ¥ | 875,664 | 8.1 | % | ||||||||||
|
Net interest revenue
|
85,828 | (37,301 | ) | — | (9,517 | ) | — | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Net revenue
|
703,055 | 772,380 | 9.9 | 866,147 | 12.1 | |||||||||||||||
|
Non-interest
expenses
|
628,563 | 743,011 | 18.2 | 812,236 | 9.3 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Income before income taxes
|
¥ | 74,492 | ¥ | 29,369 | (60.6 | )% | ¥ | 53,911 | 83.6 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Millions of yen
|
||||||||||||||||||||
|
Year ended March 31
|
||||||||||||||||||||
|
2022
|
2023
|
% Change from
previous year |
2024
|
% Change from
previous year |
||||||||||||||||
|
Wholesale net revenue:
|
||||||||||||||||||||
|
Global Markets net revenue
|
¥ | 556,417 | ¥ | 656,298 | 18.0 | % | ¥ | 707,113 | 7.7 | % | ||||||||||
|
Investment Banking net revenue
|
146,638 | 116,082 | (20.8 | ) | 159,034 | 37.0 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Net revenue
|
¥ | 703,055 | ¥ | 772,380 | 9.9 | % | ¥ | 866,147 | 12.1 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Millions of yen, except per share data and percentages
|
||||||||||||||||||||
|
Year ended March 31
|
||||||||||||||||||||
|
2020
|
2021
|
2022
|
2023
|
2024
|
||||||||||||||||
|
Statement of income data:
|
||||||||||||||||||||
|
Revenue
|
¥ | 1,952,482 | ¥ | 1,617,235 | ¥ | 1,593,999 | ¥ | 2,486,726 | ¥ | 4,157,294 | ||||||||||
|
Interest expense
|
664,653 | 215,363 | 230,109 | 1,151,149 | 2,595,294 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Net revenue
|
1,287,829 | 1,401,872 | 1,363,890 | 1,335,577 | 1,562,000 | |||||||||||||||
|
Non-interest
expenses
|
1,039,568 | 1,171,201 | 1,137,267 | 1,186,103 | 1,288,150 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Income before income taxes
|
248,261 | 230,671 | 226,623 | 149,474 | 273,850 | |||||||||||||||
|
Income tax expense
|
28,894 | 70,274 | 80,090 | 57,798 | 96,630 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Net income
|
¥ | 219,367 | ¥ | 160,397 | ¥ | 146,533 | ¥ | 91,676 | ¥ | 177,220 | ||||||||||
|
Less: Net income (loss) attributable to noncontrolling interests
|
2,369 | 7,281 | 3,537 | (1,110 | ) | 11,357 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Net income attributable to NHI shareholders
|
¥ | 216,998 | ¥ | 153,116 | ¥ | 142,996 | ¥ | 92,786 | ¥ | 165,863 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Balance sheet data (period end):
|
||||||||||||||||||||
|
Total assets
|
¥ | 43,999,815 | ¥ | 42,516,480 | ¥ | 43,412,156 | ¥ | 47,771,802 | ¥ | 55,147,203 | ||||||||||
|
Total NHI shareholders’ equity
|
2,653,467 | 2,694,938 | 2,914,605 | 3,148,567 | 3,350,189 | |||||||||||||||
|
Total equity
|
2,731,264 | 2,756,451 | 2,972,803 | 3,224,142 | 3,448,513 | |||||||||||||||
|
Common stock
|
594,493 | 594,493 | 594,493 | 594,493 | 594,493 | |||||||||||||||
|
Per share data:
|
||||||||||||||||||||
|
Net income attributable to NHI shareholders—basic
|
¥ | 67.76 | ¥ | 50.11 | ¥ | 46.68 | ¥ | 30.86 | ¥ | 54.97 | ||||||||||
|
Net income attributable to NHI shareholders—diluted
|
66.20 | 48.63 | 45.23 | 29.74 | 52.69 | |||||||||||||||
|
Total NHI shareholders’ equity
(1)
|
873.26 | 879.79 | 965.80 | 1,048.24 | 1,127.72 | |||||||||||||||
|
Cash dividends
(1)
|
20.00 | 35.00 | 22.00 | 17.00 | 23.00 | |||||||||||||||
|
Cash dividends in USD
(2)
|
$ | 0.19 | $ | 0.32 | $ | 0.18 | $ | 0.13 | $ | 0.15 | ||||||||||
|
Weighted average number of shares outstanding (in thousands)
(3)
|
3,202,370 | 3,055,526 | 3,063,524 | 3,006,744 | 3,017,128 | |||||||||||||||
|
Return on equity
(4)
:
|
8.2 | % | 5.7 | % | 5.1 | % | 3.1 | % | 5.1 | % | ||||||||||
| (1) |
Calculated using the number of shares outstanding at year end.
|
| (2) |
Calculated using the Japanese Yen—U.S. Dollar exchange rate as of the respective fiscal year end date, the noon buying rate in New York City for cable transfers in foreign currencies as certified for customs purposes by the Federal Reserve Bank of New York.
|
| (3) |
The number shown is used to calculate basic earnings per share.
|
| (4) |
Calculated as net income attributable to NHI shareholders divided by total NHI shareholders’ equity.
|
|
Millions of yen
|
||||||||||||
|
March 31, 2024
|
||||||||||||
|
Funded
|
Unfunded
|
Total
|
||||||||||
|
Europe
|
¥ | 16,707 | ¥ | 168,259 | ¥ | 184,966 | ||||||
|
Americas
|
27,951 | 287,623 | 315,574 | |||||||||
|
Asia and Oceania
|
21,616 | 29,870 | 51,486 | |||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ | 66,274 | ¥ | 485,752 | ¥ | 552,026 | ||||||
|
|
|
|
|
|
|
|||||||
|
Millions of yen
|
||||
|
March 31, 2024
|
||||
|
Deferred tax assets
|
||||
|
Depreciation, amortization and valuation of fixed assets
|
¥ | 41,883 | ||
|
Investments in subsidiaries and affiliates
|
7,364 | |||
|
Valuation of financial instruments
|
136,834 | |||
|
Accrued pension and severance costs
|
11,837 | |||
|
Other accrued expenses and provisions
|
83,418 | |||
|
Operating losses
|
477,358 | |||
|
Lease liabilities
|
48,951 | |||
|
Other
|
20,811 | |||
|
|
|
|||
|
Gross deferred tax assets
|
828,456 | |||
|
Less—Valuation allowances
|
(595,668 | ) | ||
|
|
|
|||
|
Total deferred tax assets
|
232,788 | |||
|
|
|
|||
|
Deferred tax liabilities
|
||||
|
Investments in subsidiaries and affiliates
|
109,611 | |||
|
Valuation of financial instruments
|
111,175 | |||
|
Undistributed earnings of foreign subsidiaries
|
2,257 | |||
|
Valuation of fixed assets
|
22,945 | |||
|
Right-of-use
|
43,443 | |||
|
Other
|
4,404 | |||
|
|
|
|||
|
Total deferred tax liabilities
|
293,835 | |||
|
|
|
|||
|
Net deferred tax assets (liabilities)
|
¥ | (61,047 | ) | |
|
|
|
|||
|
Billions of yen
|
||||||||||||||||
|
Average for
year ended
March 31, 2023
|
March 31, 2023
|
Average for
year ended
March 31, 2024
|
March 31, 2024
|
|||||||||||||
|
Cash, cash equivalents and time deposits
(1)
|
¥ | 3,155.5 | ¥ | 3,229.3 | ¥ | 3,741.8 | ¥ | 3,629.9 | ||||||||
|
Government debt securities
|
4,073.8 | 3,984.0 | 4,029.4 | 4,348.6 | ||||||||||||
|
Others
(2)
|
416.9 | 441.0 | 423.4 | 439.5 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Total liquidity portfolio
|
¥ | 7,646.2 | ¥ | 7,654.3 | ¥ | 8,194.6 | ¥ | 8,418.0 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| (1) |
Cash, cash equivalents, and time deposits include nostro balances and deposits with both central banks and market counterparties that are readily available to support the liquidity position of Nomura.
|
| (2) |
Others include other liquid financial assets such as money market funds and U.S. agency securities.
|
|
Billions of yen
|
||||||||||||||||
|
Average for
year ended
March 31, 2023
|
March 31, 2023
|
Average for
year ended
March 31, 2024
|
March 31, 2024
|
|||||||||||||
|
Japanese Yen
|
¥ | 1,613.6 | ¥ | 1,852.0 | ¥ | 1,964.8 | ¥ | 1,702.3 | ||||||||
|
U.S. Dollar
|
4,326.0 | 3,953.3 | 4,341.1 | 4,601.7 | ||||||||||||
|
Euro
|
869.3 | 964.5 | 933.2 | 1,023.5 | ||||||||||||
|
British Pound
|
505.7 | 522.4 | 549.4 | 659.8 | ||||||||||||
|
Others
(1)
|
331.6 | 362.1 | 406.1 | 430.7 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Total liquidity portfolio
|
¥ | 7,646.2 | ¥ | 7,654.3 | ¥ | 8,194.6 | ¥ | 8,418.0 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| (1) |
Includes other currencies such as the Australian Dollar, the Canadian Dollar and the Swiss Franc.
|
|
Billions of yen
|
||||||||
|
March 31, 2023
|
March 31, 2024
|
|||||||
|
NHI and NSC
(1)
|
¥ | 1,806.4 | ¥ | 1,495.2 | ||||
|
Major broker-dealer subsidiaries
|
3,012.6 | 3,592.5 | ||||||
|
Bank subsidiaries
(2)
|
1,178.6 | 1,319.9 | ||||||
|
Other affiliates
|
1,656.7 | 2,010.4 | ||||||
|
|
|
|
|
|||||
|
Total liquidity portfolio
|
¥ | 7,654.3 | ¥ | 8,418.0 | ||||
|
|
|
|
|
|||||
| (1) |
NSC, a broker-dealer located in Japan, holds an account with the Bank of Japan (“BOJ”) and has direct access to the BOJ Lombard facility through which same day funding is available for our securities pool. Any liquidity surplus at NHI is lent to NSC via short-term intercompany loans, which can be unwound immediately when needed.
|
| (2) |
Includes Nomura Bank International plc (“NBI”), Nomura Singapore Limited and Nomura Bank Luxembourg S.A.
|
|
Billions of yen
|
||||||||
|
March 31, 2023
|
March 31, 2024
|
|||||||
|
Net liquidity value of other unencumbered assets
|
¥ | 2,842.5 | ¥ | 3,175.6 | ||||
|
Liquidity portfolio
|
7,654.3 | 8,418.0 | ||||||
|
|
|
|
|
|||||
|
Total
|
¥ | 10,496.8 | ¥ | 11,593.6 | ||||
|
|
|
|
|
|||||
|
Billions of yen
|
||||||||
|
March 31, 2023
|
March 31, 2024
|
|||||||
|
Short-term bank borrowings
|
¥ | 203.3 | ¥ | 177.5 | ||||
|
Other loans
|
256.8 | 356.0 | ||||||
|
Commercial paper
|
300.0 | 224.8 | ||||||
|
Deposits at banking entities
|
1,705.0 | 1,880.9 | ||||||
|
Certificates of deposit
|
224.2 | 232.4 | ||||||
|
Debt securities maturing within one year
|
721.9 | 1,089.8 | ||||||
|
|
|
|
|
|||||
|
Total short-term unsecured debt
|
¥ | 3,411.2 | ¥ | 3,961.4 | ||||
|
|
|
|
|
|||||
|
Billions of yen
|
||||||||
|
March 31, 2023
|
March 31, 2024
|
|||||||
|
Long-term deposits at banking entities
|
¥ | 208.8 | ¥ | 243.0 | ||||
|
Long-term bank borrowings
|
3,004.9 | 3,408.4 | ||||||
|
Other loans
|
265.5 | 292.3 | ||||||
|
Debt securities
(1)
|
5,291.5 | 6,311.2 | ||||||
|
|
|
|
|
|||||
|
Total long-term unsecured debt
|
¥ | 8,770.7 | ¥ | 10,254.9 | ||||
|
|
|
|
|
|||||
| (1) |
Excludes long-term debt securities issued by consolidated special purpose entities and similar entities that meet the definition of variable interest entities under Accounting Standard Codification (“ASC”) 810 “
Consolidation
Long-term borrowings
Transfers and Servicing.
|
| • |
Stressed scenario—To maintain adequate liquidity during a severe market-wide liquidity event without raising funds through unsecured financing or through the liquidation of assets for a year; and
|
| • |
Acute stress scenario—To maintain adequate liquidity during a severe market-wide liquidity event coupled with credit concerns regarding Nomura’s liquidity position, without raising funds through unsecured funding or through the liquidation of assets for 30 days.
|
| • |
No liquidation of assets;
|
| • |
No ability to issue additional unsecured funding;
|
| • |
Upcoming maturities of unsecured debt (maturities less than one year);
|
| • |
Potential buybacks of our outstanding debt;
|
| • |
Loss of secured funding lines particularly for less liquid assets;
|
| • |
Fluctuation of funding needs under normal business circumstances;
|
| • |
Cash deposits and free collateral
roll-off
in a stress event;
|
| • |
Widening of haircuts on outstanding repo funding;
|
| • |
Additional collateralization requirements of clearing banks and depositories;
|
| • |
Drawdown on loan commitments;
|
| • |
Loss of liquidity from market losses;
|
| • |
Assuming a
two-notch
downgrade of our credit ratings, the aggregate fair value of assets that we would be required to post as additional collateral in connection with our derivative contracts; and
|
| • |
Legal and regulatory requirements that can restrict the flow of funds between entities in the Nomura Group.
|
|
Billions of yen
|
||||||||
|
Year Ended March 31
|
||||||||
|
2023
|
2024
|
|||||||
|
Net cash provided by (used in) operating activities
|
¥ | (694.8 | ) | ¥ | 132.6 | |||
|
Net income
|
91.7 | 177.2 | ||||||
|
Trading assets and private equity and debt investments
|
(1,623.0 | ) | (386.5 | ) | ||||
|
Trading liabilities
|
467.3 | (411.8 | ) | |||||
|
Securities purchased under agreements to resell, net of securities sold under agreements to repurchase
|
(590.4 | ) | 290.8 | |||||
|
Securities borrowed, net of securities loaned
|
834.4 | (324.1 | ) | |||||
|
Other net operating cash flow reconciling items
|
125.2 | 787.0 | ||||||
|
Net cash used in investing activities
|
(233.2 | ) | (887.9 | ) | ||||
|
Net cash outflows from time deposits
|
(59.4 | ) | (83.0 | ) | ||||
|
Net cash outflows from loans
|
(299.8 | ) | (791.7 | ) | ||||
|
Net cash inflows from
non-trading
debt securities
|
159.6 | 23.3 | ||||||
|
Other net investing cash outflows
|
(33.6 | ) | (36.5 | ) | ||||
|
Net cash provided by financing activities
|
1,283.9 | 1,012.9 | ||||||
|
Net cash inflows from long-term borrowings
|
1,093.3 | 962.9 | ||||||
|
Net cash inflows / (outflows) from short-term borrowings
|
(64.5 | ) | 98.0 | |||||
|
Net cash inflows from deposits received at banks
|
328.9 | 107.5 | ||||||
|
Other net financing cash outflows
|
(73.8 | ) | (155.5 | ) | ||||
|
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents
|
148.6 | 220.6 | ||||||
|
|
|
|
|
|||||
|
Net increase in cash, cash equivalents, restricted cash and restricted cash equivalents
|
504.4 | 478.2 | ||||||
|
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of the year
|
3,316.4 | 3,820.9 | ||||||
|
|
|
|
|
|||||
|
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of the year
|
¥ | 3,820.9 | ¥ | 4,299.0 | ||||
|
|
|
|
|
|||||
|
Billions of yen, except ratios
|
||||||||
|
March 31
|
||||||||
|
2023
|
2024
|
|||||||
|
NHI shareholders’ equity
|
¥ | 3,148.6 | ¥ | 3,350.2 | ||||
|
Total assets
|
47,771.8 | 55,147.2 | ||||||
|
Adjusted assets
(1)
|
29,654.3 | 34,152.4 | ||||||
|
Leverage ratio
(2)
|
15.2 x | 16.5 x | ||||||
|
Adjusted leverage ratio
(3)
|
9.4 x | 10.2 x | ||||||
| (1) |
Represents total assets less
Securities purchased under agreements to resell
Securities borrowed
non-GAAP
financial measure and is calculated as follows:
|
| (2) |
Equals total assets divided by NHI shareholders’ equity.
|
| (3) |
Equals adjusted assets divided by NHI shareholders’ equity.
|
|
Billions of yen
|
||||||||
|
March 31
|
||||||||
|
2023
|
2024
|
|||||||
|
Total assets
|
¥ | 47,771.8 | ¥ | 55,147.2 | ||||
|
Less:
|
||||||||
|
Securities purchased under agreements to resell
|
13,834.5 | 15,621.1 | ||||||
|
Securities borrowed
|
4,283.0 | 5,373.7 | ||||||
|
|
|
|
|
|||||
|
Adjusted assets
|
¥ | 29,654.3 | ¥ | 34,152.4 | ||||
|
|
|
|
|
|||||
|
Fiscal year ended March 31,
|
First Quarter
|
Second Quarter
|
Third Quarter
|
Fourth Quarter
|
Total
|
|||||||||||||||
|
2019
|
¥ | — | ¥ | 3.00 | ¥ | — | ¥ | 3.00 | ¥ | 6.00 | ||||||||||
|
2020
|
— | 15.00 | — | 5.00 | 20.00 | |||||||||||||||
|
2021
|
— | 20.00 | — | 15.00 | 35.00 | |||||||||||||||
|
2022
|
— | 8.00 | — | 14.00 | 22.00 | |||||||||||||||
|
2023
|
— | 5.00 | — | 12.00 | 17.00 | |||||||||||||||
|
2024
|
— | 8.00 | — | 15.00 | 23.00 | |||||||||||||||
|
Billions of yen, except ratios
|
||||||||
|
March 31
|
||||||||
|
2023
|
2024
|
|||||||
|
Common equity Tier 1 capital
|
¥ | 2,828.8 | ¥ | 3,091.3 | ||||
|
Tier 1 capital
|
3,203.7 | 3,467.8 | ||||||
|
Total capital
|
3,204.1 | 3,468.3 | ||||||
|
Risk-Weighted Assets
|
||||||||
|
Credit risk-weighted assets
|
8,385.8 | 9,764.7 | ||||||
|
Market risk equivalent assets
|
6,270.6 | 6,381.9 | ||||||
|
Operational risk equivalent assets
|
2,667.5 | 2,828.9 | ||||||
|
|
|
|
|
|||||
|
Total risk-weighted assets
|
¥ | 17,323.9 | ¥ | 18,975.5 | ||||
|
|
|
|
|
|||||
|
Consolidated Capital Adequacy Ratios
|
||||||||
|
Common equity Tier 1 capital ratio
|
16.32 | % | 16.29 | % | ||||
|
Tier 1 capital ratio
|
18.49 | % | 18.27 | % | ||||
|
Consolidated capital adequacy ratio
|
18.49 | % | 18.27 | % | ||||
|
Consolidated Leverage Ratio
|
5.63 | % | 5.24 | % | ||||
|
External TLAC Ratios
|
||||||||
|
Risk-weighted assets basis
|
31.78 | % | 33.06 | % | ||||
|
Leverage ratio exposure measure basis
|
10.63 | % | 10.42 | % | ||||
|
Nomura Holdings, Inc.
|
Short-term Debt
|
Long-term Debt
|
||
|
S&P Global Ratings
|
A-2
|
BBB+ | ||
|
Moody’s Investors Service
|
— | Baa1 | ||
|
Fitch Ratings
|
F1 | A- | ||
|
Rating and Investment Information, Inc.
|
a-1
|
A | ||
|
Japan Credit Rating Agency, Ltd.
|
— | AA- | ||
|
Nomura Securities Co., Ltd.
|
Short-term Debt
|
Long-term Debt
|
||
|
S&P Global Ratings
|
A-2
|
A- | ||
|
Moody’s Investors Service
|
P-2
|
A3 | ||
|
Fitch Ratings
|
F1 | A- | ||
|
Rating and Investment Information, Inc.
|
a-1
|
A+ | ||
|
Japan Credit Rating Agency, Ltd.
|
— | AA- | ||
| • |
an obligation under a guarantee contract;
|
| • |
a retained or contingent interest in assets transferred to an
off-balance
sheet entity or similar arrangement that serves to provide credit, liquidity or market risk support to such entity;
|
| • |
any obligation, including a contingent obligation, under a contract that would be accounted for as a derivative instrument; or
|
| • |
any obligation, including a contingent obligation, arising out of a variable interest in an
off-balance
sheet entity that is held by, and material to, us, where such entity provides financing, liquidity, market risk or credit risk support to, or engages in leasing, hedging or research and development services with, us.
|
| • |
In connection with our banking and financing activities, we enter into various guarantee arrangements with counterparties in the form of standby letters of credit and other guarantees, which generally have fixed expiration dates.
|
| • |
In connection with our operating activities, we issue Japanese Yen and
non-Japanese
Yen denominated long-term borrowings which incur variable and fixed interest payments in accordance with our funding policy.
|
| • |
We lease office space, residential facilities for employees, motor vehicles, equipment and technology assets in the ordinary course of business both in Japan and overseas as lessee. These arrangements predominantly consist of operating leases.
|
| • |
Separately we sublease certain real estate and equipment through operating lease arrangements.
|
| • |
We lease certain equipment and facilities in Japan and overseas which are classified as finance lease agreements.
|
| • |
We have purchase obligations for goods and services which include payments for construction, advertising, and computer and telecommunications maintenance agreements.
|
| • |
In connection with our banking and financing activities, we enter into contractual commitments to extend credit, which generally have fixed expiration dates.
|
| • |
In connection with our investment banking activities, we enter into agreements with clients under which we commit to underwrite securities that may be issued by clients.
|
| • |
As a member of certain central clearing counterparties, Nomura is committed to provide liquidity facilities through entering into reverse repurchase transactions backed by government and government agency debt securities with those counterparties in a situation where a default of another clearing member occurs.
|
| • |
We have commitments to invest in interests in various partnerships and other entities and commitments to provide financing for investments related to those partnerships.
|
|
Millions of yen
|
||||||||||||||||||||
|
Total
contractual
amount
|
Years to maturity
|
|||||||||||||||||||
|
Less than
1 year
|
1 to 3
years
|
3 to 5
years
|
More than
5 years
|
|||||||||||||||||
|
Standby letters of credit and other guarantees
|
¥ | 3,561,640 | ¥ | 3,517,487 | ¥ | 24,321 | ¥ | 16,976 | ¥ | 2,856 | ||||||||||
|
Long-term borrowings
(1)
|
11,926,429 | 1,146,494 | 3,374,258 | 2,265,231 | 5,140,446 | |||||||||||||||
|
Contractual interest payments
(2)
|
2,002,724 | 317,600 | 468,572 | 316,353 | 900,199 | |||||||||||||||
|
Operating lease commitments
(3)
|
200,454 | 47,123 | 65,824 | 44,630 | 42,877 | |||||||||||||||
|
Purchase obligations
(4)
|
94,478 | 16,124 | 74,189 | 3,049 | 1,116 | |||||||||||||||
|
Commitments to extend credit
(5)
|
3,105,611 | 1,905,593 | 388,648 | 476,372 | 334,998 | |||||||||||||||
|
Commitments to invest
|
31,989 | 2,305 | 3,698 | 461 | 25,525 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total
|
¥ | 20,923,325 | ¥ | 6,952,726 | ¥ | 4,399,510 | ¥ | 3,123,072 | ¥ | 6,448,017 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| (1) |
The amounts disclosed within long-term borrowings exclude financial liabilities recognized within long-term borrowings as a result of transfers of financial assets that are accounted for as financings rather than sales in accordance with ASC 860. These are not borrowings issued for our own funding purposes and therefore do not represent actual contractual obligations by us to deliver cash.
|
| (2) |
The amounts represent estimated future interest payments related to long-time borrowings based on the period through to their maturity and applicable interest rates as of March 31, 2024.
|
| (3) |
The amounts of operating lease commitments are undiscounted future minimum lease payments. The amounts of finance lease contracts were immaterial.
|
| (4) |
The minimum contractual obligations under enforceable and legally binding contracts that specify all significant terms. Amounts exclude obligations that are already reflected on our consolidated balance sheets as liabilities or payables. Includes the commitment to purchase parts of the redeveloped real estate in Tokyo Nihonbashi district from the redevelopment association.
|
| (5) |
Contingent liquidity facilities to central clearing counterparties are included.
|
|
Critical
accounting policy |
Critical accounting
estimates |
Key subjective assumptions or
judgments by management |
Effect of changes in estimates and
assumptions during year ended March 31, 2024 |
|||
|
Fair value of financial instruments
Note 2
“Fair value measurements”
|
Estimating fair value for financial instruments |
A significant portion of our financial instruments are carried at fair value. The fair values of these financial instruments may not only be measured at quoted prices but also impacted by other factors, including selection of valuation techniques/ models and other assumptions that require judgment.
This may affect the amount and timing of unrealized gains or losses recognized in the consolidated statements of income for a particular financial instrument.
|
See Note 2
“Fair value measurements”
Level 3 financial assets (net of derivative liabilities) during the year increased from ¥868 billion as of March 2023 to ¥1,041 billion as of March 2024. Total level 3 financial assets to total financial assets carried at fair value on a recurring basis ratio was 6 % as of March 31, 2024 (5 % as of March 31, 2023.)
|
|
Critical
accounting policy |
Critical accounting
estimates |
Key subjective assumptions or
judgments by management |
Effect of changes in estimates and
assumptions during year ended March 31, 2024 |
|||
|
Selection of appropriate valuation techniques
• For financial instruments measured at fair values where quoted prices are available in active markets, we typically use quoted prices as level 1 inputs for determining the fair values of these financial instruments.
• For financial instruments where such quoted prices are not available, fair values of these financial instruments are measured using level 2 or level 3 inputs. Significant judgment is involved in selection of appropriate valuation techniques and validation of assumptions applied in models because the estimated fair values measured could vary depending on which models and assumptions are used. When selecting valuation techniques, various factors such as the particular circumstances and markets where these financial instruments are traded, the availability of reliable inputs, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs are considered.
Significance of level 3 inputs
• Fair values are more judgmental when we use level 3 inputs, which are based on significant
non-market
based unobservable inputs.
• For these instruments, fair value is determined based on management’s judgment about the assumption that market participant would use in pricing the instruments, including perception of liquidity, economic environment and the risks affecting the specific instruments.
|
See Note 2
“Fair Value measurement”
|
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
|
Koji Nagai
(Jan. 25, 1959)
|
Director
Chairman of the Board Directors
Member of the Nomination Committee
Member of the Compensation Committee
Director and Chairman of Nomura Securities Co., Ltd.
|
Apr. 1981 | Joined the Company | |||
| Apr. 2003 | Director of Nomura Securities Co., Ltd. | |||||
| Jun. 2003 | Executive Officer of Nomura Securities Co., Ltd. | |||||
| Apr. 2007 | Executive Officer (Executive Managing Director) of Nomura Securities Co., Ltd. | |||||
| Oct. 2008 | Senior Corporate Managing Director of Nomura Securities Co., Ltd. | |||||
| Apr. 2009 | Executive Officer and Executive Vice President of Nomura Securities Co., Ltd. | |||||
| Apr. 2011 |
Co-COO
and Deputy President of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2012 |
Senior Managing Director of the Company
Director, Representative Executive Officer and President of Nomura Securities Co., Ltd.
|
|||||
| Aug. 2012 |
Representative Executive Officer & Group CEO of the Company
Director, Representative Executive Officer and President of Nomura Securities Co., Ltd.
|
|||||
| Jun. 2013 |
Director, Representative Executive Officer & Group CEO of the Company
Director, Representative Executive Officer and President of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2017 |
Director, Representative Executive Officer, President & Group CEO of the Company
Director and Chairman of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2020 |
Director and Chairman of the Company (Current)
Director and Chairman of Nomura Securities Co., Ltd. (Current)
|
|||||
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
|
Kentaro Okuda
(Nov. 7, 1963)
|
Director, Representative Executive Officer, President and Group CEO
Representative Director and President of Nomura Securities Co., Ltd.
|
Apr. 1987 | Joined the Company | |||
| Apr. 2010 | Senior Managing Director of Nomura Securities Co., Ltd. | |||||
| Apr. 2012 | Senior Corporate Managing Director of Nomura Securities Co., Ltd. | |||||
| Aug. 2012 |
Senior Corporate Managing Director of the Company
Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2013 |
Senior Managing Director of the Company
Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2015 |
Senior Managing Director of the Company
Executive Vice President of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2016 |
Senior Managing Director of the Company
Executive Officer and Executive Vice President of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2017 |
Senior Managing Director of the Company
Executive Vice President of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2018 |
Executive Officer and Group
Co-COO
of the Company
Director, Executive Officer and Deputy President of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2019 |
Executive Officer, Deputy President and Group
Co-COO
of the Company
|
|||||
| Apr. 2020 |
Representative Executive Officer, President & Group CEO of the Company
Representative Director of Nomura Securities Co., Ltd.
|
|||||
| Jun. 2020 |
Director, Representative Executive Officer, President & Group CEO of the Company
Representative Director of Nomura Securities Co., Ltd.
|
|||||
| Jun. 2021 |
Director, Representative Executive Officer, President & Group CEO of the Company (Current)
Representative Director and President of Nomura Securities Co., Ltd. (Current)
|
|||||
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
|
Yutaka Nakajima
(Aug. 2, 1965)
|
Director, Representative Executive Officer and Deputy President
Representative Director and Deputy President of Nomura Securities Co., Ltd.
|
Apr. 1988 | Joined the Company | |||
| Apr. 2011 | Senior Managing Director of Nomura Securities Co., Ltd. | |||||
| May. 2015 | Senior Managing Director of the Company | |||||
| Apr. 2016 |
Senior Managing Director of the Company
Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2017 |
Senior Managing Director of the Company
Executive Managing Director and Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2018 |
Senior Managing Director of the Company
Executive Managing Director and Executive Vice President of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2019 |
Senior Managing Director of the Company
Director and Executive Vice President of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2021 |
Senior Managing Director of the Company
Representative Director and Deputy President of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2023 |
Representative Executive Officer and Deputy President of the Company
Representative Director and Deputy President of Nomura Securities Co., Ltd.
|
|||||
| Jun. 2023 |
Director, Representative Executive Officer and Deputy President of the Company (Current)
Representative Director and Deputy President of Nomura Securities Co., Ltd. (Current)
|
|||||
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
|
Shoji Ogawa
(Aug. 9, 1964)
|
Director
Member of the Audit Committee (full-time)
Member of the Board Risk Committee
Corporate Auditor of Nomura Asia Pacific Holdings Co., Ltd
Non-Executive
Director of Nomura Holding America Inc.
Non-Executive
Director of Instinet Incorporated
|
Apr. 1987 | Joined the Company | |||
| Apr. 2007 | Head of Investment Banking Strategic Planning Dept of Nomura Securities Co., Ltd. | |||||
| Oct. 2008 | Head of Capital Markets Dept. and Capital Solutions Dept. of Nomura Securities Co., Ltd. | |||||
| Jul. 2009 | Head of Capital Markets Dept. of Nomura Securities Co., Ltd. | |||||
| Apr. 2012 | Head of Investment Banking Strategic Planning Dept. of Nomura Securities Co., Ltd. | |||||
| Jul. 2013 |
Head of Office of Audit Committee of the Company
Head of Office of Audit Committee of Nomura Securities Co., Ltd.
|
|||||
| Aug. 2016 |
Head of Office of
Non-Executive
Directors and Audit Committee of the Company
Head of Office of
Non-Executive
Directors and Audit Committee of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2017 |
Senior Managing Director and Group Internal Audit of the Company
Senior Managing Director and Internal Audit of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2021 | Advisor of the Company | |||||
| Jun. 2021 | Director of the Company (Current) | |||||
|
Laura Simone Unger
(Jan. 8, 1961)
|
Outside Director
Chairperson of the Board Risk Committee
Independent Director of Nomura Holding America Inc.
Independent Director of Nomura Securities International, Inc.
Independent Director of Nomura Global Financial Products Inc.
Independent Director of Instinet Holdings Incorporated
|
Jan. 1988 | Enforcement Attorney of the U.S. Securities and Exchange Commission (SEC) | |||
| Oct. 1990 | Counsel of the U.S. Senate Committee on Banking, Housing, and Urban Affairs | |||||
| Nov. 1997 | Commissioner of the SEC | |||||
| Feb. 2001 | Acting Chairperson of the SEC | |||||
| Jul. 2002 | Regulatory Expert of CNBC | |||||
| May 2003 | Independent Consultant of JPMorgan Chase & Co. | |||||
| Aug. 2004 | Independent Director of CA Inc. | |||||
| Jan. 2010 | Special Advisor of Promontory Financial Group | |||||
| Dec. 2010 | Independent Director of CIT Group Inc. | |||||
| Nov. 2014 | Independent Director of Navient Corporation | |||||
| Jun. 2018 | Outside Director of the Company (Current) | |||||
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
|
Victor Chu
(Jun. 20, 1957)
|
Outside Director
Member of the Audit Committee
Chairman and Chief Executive Officer of First Eastern Investment Group
Chair of Council, University College London
Co-Chair,
International Business Council of the World Economic Forum
Independent Director of Airbus SE
|
Dec. 1982 | Solicitor of the Supreme Court, Hong Kong | |||
| Jan. 1988 | Chairman and Chief Executive Officer of First Eastern Investment Group (Current) | |||||
| Oct. 1988 | Director and Council Member of the Hong Kong Stock Exchange | |||||
| Jun. 1992 | Advisory Committee Member of the Securities and Futures Commission, Hong Kong | |||||
| Aug. 2003 | Foundation Board Member of the World Economic Forum | |||||
| Apr. 2018 | Independent Director of Airbus SE (Current) | |||||
| Jun. 2021 | Outside Director of the Company (Current) | |||||
|
J.Christopher Giancarlo
(May 12, 1959)
|
Outside Director
Member of the Board Risk Committee
Senior Counsel of Willkie Farr & Gallagher LLP
Chair of the Board of Directors of Digital Dollar Project
Independent Director of Digital Asset Holdings, LLC
Independent Director of Nomura Securities International, Inc.
Independent Director of Nomura Global Financial Products Inc.
|
Sep. 1984 | Associate Attorney of Mudge Rose Guthrie Alexander & Ferdon | |||
| Oct. 1985 | Associate Attorney of Curtis, Mallet-Prevost, Colt & Mosle | |||||
| Jan. 1992 | Attorney, Founding Partner of Giancarlo & Gleiberman | |||||
| Sep. 1997 | Attorney, (Equity) Partner of Thelen Reid Brown Raysman & Steiner | |||||
| Apr. 2000 | Vice President and Legal Counsel of Fenics Software | |||||
| Apr. 2001 | Executive Vice President of GFI Group Inc. | |||||
| Jun. 2014 | Commissioner of the U.S. Commodity Futures Trading Commission | |||||
| Jan. 2017 | Chairman of the U.S. Commodity Futures Trading Commission | |||||
| Oct. 2019 | Independent Director of the American Financial Exchange | |||||
| Jan. 2020 | Senior Counsel of Willkie Farr & Gallagher LLP (Current) | |||||
| Jun. 2021 | Outside Director of the Company (Current) | |||||
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
|
Patricia Mosser
(Feb. 14, 1956)
|
Outside Director
Member of the Board Risk Committee
Senior Research Scholar*
Director of the MPA Program in Economic Policy Management*
Director of Central Banking and Financial Policy*
*Positions at Columbia University, School of International and Public Affairs
Independent Director of Nomura Holding America Inc.
|
Jul. 1986 | Assistant Professor, Economics Department, Columbia University | |||
| Jan. 1991 | Economist and Vice President of the Federal Reserve Bank of New York (FRBNY) | |||||
| Nov. 2006 | Senior Vice President, FRBNY, Member of the FX Forum, Executive Meeting of East Asia and Pacific (EMEAP) Central Banks, Bank for International Settlements | |||||
| Jan. 2007 | Board Member of the American Economic Association’s Committee on the Status of Women in the Economics Profession | |||||
| Jun. 2007 | Member of the Markets Committee, Bank for International Settlements | |||||
| Jan 2009 | Acting Systemic Open Market Account Manager for the Federal Open Market Committee (FOMC) | |||||
| Oct. 2013 | Deputy Director of the Office of Financial Research (OFR), U.S. Treasury Department | |||||
| Oct. 2013 | Member of the Deputies Committee of the Financial Stability Oversight Council (FSOC) | |||||
| Jun. 2015 | Senior Research Scholar and Director of Central Banking and Financial Policy at Columbia University’s School of International and Public Affairs (Current) | |||||
| Jun. 2021 | Outside Director of the Company (Current) | |||||
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
|
Takahisa Takahara
(Jul. 12, 1961)
|
Outside Director
Member of the Nomination Committee
Member of the Compensation Committee
Representative Director, President & CEO of Unicharm Corporation
Outside Director of Sumitomo Corporation
|
Apr. 1986 | Joined The Sanwa Bank, Ltd. (currently MUFG Bank, Ltd.) | |||
| Apr. 1991 | Joined Unicharm Corporation | |||||
| Jun. 1995 | Director of Unicharm Corporation | |||||
| Apr. 1996 | Director, General Manager of Procurement Division and Deputy General Manager of International Division of Unicharm Corporation | |||||
| Jun. 1997 | Senior Director of Unicharm Corporation | |||||
| Apr. 1998 | Senior Director, General Manager of Feminine Hygiene Business Division of Unicharm Corporation | |||||
| Oct. 2000 | Senior Director, Responsible for Management Strategy of Unicharm Corporation | |||||
| Jun. 2001 | Representative Director, President of Unicharm Corporation | |||||
| Jun. 2004 | Representative Director, President & CEO of Unicharm Corporation (Current) | |||||
| Jun. 2021 | Outside Director of the Company (Current) | |||||
|
Miyuki Ishiguro
(Oct. 26, 1964)
|
Outside Director
Member of the Board Risk Committee
Partner of Nagashima Ohno & Tsunematsu
President of the Inter-Pacific Bar Association (IPBA)
Outside Audit & Supervisory Board Member, Lasertec Corporation
|
Apr. 1991 |
Registered as an
Attorney-at-Law
|
|||
| Jan. 1999 | Partner of Tsunematsu Yanase & Sekine | |||||
| Jan. 2000 | Partner of Nagashima Ohno & Tsunematsu(Current) | |||||
| Oct. 2004 | Visiting Professor, Columbia Law School | |||||
| May. 2015 | Secretary General of the Inter-Pacific Bar Association (IPBA) | |||||
| Feb. 2016 | Council Member of the Radio Regulatory Council (Ministry of Internal Affairs and Communications) | |||||
| Apr. 2016 | Council Member of the Management Council of Hitotsubashi University | |||||
| Apr. 2018 | Vice President of the Tokyo Bar Association | |||||
| Jun. 2023 | Outside Director of the Company (Current) | |||||
| Apr. 2024 | President of the Inter-Pacific Bar Association (IPBA) (Current) | |||||
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
|
Masahiro Ishizuka
(Apr. 21, 1960)
|
Outside Director
Chairman of the Audit Committee
Director of Nomura Securities Co., Ltd.
|
Oct. 1984 | Joined Deloitte Haskins and Sells International (*) | |||
| Apr. 1988 | Registered as a Certified Public Accountant | |||||
| Jun. 1997 | Partner of Tohmatsu & Co. (*) | |||||
| Jan. 1998 | Deloitte & Touche LLP based in New York | |||||
| Oct. 2004 | Head of Audit and Technology Dept. of Business Administrative Division, of Tohmatsu & Co. (*) | |||||
| Aug. 2010 | Vice Chairman of the Audit Standards Committee of the Japanese Institute of Certified Public Accountants | |||||
| Oct. 2010 | Head of Office of Manual, of Quality Administrative Division, of Deloitte Touche Tohmatsu LLC | |||||
| Nov. 2015 | The Board Member of Deloitte Tohmatsu LLC | |||||
| Jun. 2017 | Executive Officer, General Manager of the Reputation Quality Risk Management Division of Deloitte Tohmatsu LLC and Deloitte Touche Tohmatsu LLC | |||||
| Jun. 2022 | Ethics Officer of Deloitte Tohmatsu Group | |||||
| Jun. 2023 | Outside Director of the Company (Current) | |||||
| Apr. 2024 | Director of Nomura Securities Co., Ltd. (Current) | |||||
| *Each of the corporations is currently Deloitte Touche Tohmatsu LLC | ||||||
|
Taku Oshima
(Jul. 14, 1956)
|
Outside Director
Chairman of the Nomination Committee
Chairman of the Compensation Committee
Chairman and Representative Director of NGK INSULATORS, LTD.
Outside Director of Central Japan Railway Company
Chairman of Aichi Employers’ Association
Outside Director of Toho Gas
|
Mar. 1980 | Joined NGK INSULATORS, LTD. | |||
| Jun. 2007 | Corporate Officer of NGK INSULATORS, LTD. | |||||
| Jun. 2011 | Corporate Executive Officer of NGK INSULATORS, LTD. | |||||
| Jun. 2014 | President and Representative Director of NGK INSULATORS, LTD. | |||||
| Apr. 2021 | Chairman and Representative Director of NGK INSULATORS, LTD. (Current) | |||||
| Jun. 2024 | Outside Director of the Company (Current) | |||||
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
|
Kentaro Okuda
(Nov. 7, 1963)
|
See “
Directors
|
See “
Directors
|
||||
|
Yutaka Nakajima
(Aug. 2, 1965)
|
See “
Directors
|
See “
Directors
|
||||
|
Toshiyasu Iiyama
(Feb. 24, 1965)
|
Executive Officer and Deputy President
Chief of Staff
Representative Director and Deputy President of Nomura Securities Co., Ltd.
|
Apr. 1987 | Joined the Company | |||
| Apr. 2012 | Senior Managing Director of Nomura Securities Co., Ltd. | |||||
| Apr. 2015 |
Senior Managing Director of the Company
Senior Managing Director of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2016 |
Senior Managing Director of the Company
Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2018 |
Senior Managing Director of the Company
Executive Officer and Executive Vice President of Nomura Securities
Co., Ltd.
|
|||||
| Apr. 2019 |
Senior Managing Director of the Company
Executive Vice President of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2020 |
Senior Managing Director of the Company
Representative Director and Deputy President of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2021 |
Executive Officer and Chief Health Officer of the Company
Representative Director and Deputy President of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2023 |
Executive Officer, Deputy President and Chief of Staff of the Company (Current)
Representative Director and Deputy President of Nomura Securities Co., Ltd. (Current)
|
|||||
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
|
Takumi Kitamura
(Nov. 26, 1966)
|
Executive Officer
Chief Financial Officer
Chief Transformation Officer
Director, Executive Vice President of Nomura Securities Co., Ltd.
Director of Nomura Asia Pacific Holdings Co., Ltd
|
Apr. 1990 | Joined the Company | |||
| Apr. 2016 |
Executive Officer and Chief Financial Officer of the Company
Executive Officer and Financial Officer of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2019 |
Executive Officer and Chief Financial Officer of the Company
Director and Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2021 |
Executive Officer and Chief Financial Officer of the Company
Director, Executive Vice President of Nomura Securities Co., Ltd.
|
|||||
| Oct. 2021 |
Executive Officer, Chief Financial Officer and Chief Administrative Officer of the Company
Director, Executive Vice President of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2022 |
Executive Officer and Chief Financial Officer of the Company
Director, Executive Vice President of Nomura Securities Co., Ltd.
|
|||||
| Apr. 2024 |
Executive Officer, Chief Financial Officer and Chief Transformation Officer of the Company (Current)
Director, Executive Vice President of Nomura Securities Co., Ltd. (Current)
|
|||||
|
Sotaro Kato
(Oct. 9, 1969)
|
Executive Officer
Chief Risk Officer
Director and Senior Corporate Managing Director of Nomura Securities Co., Ltd.
Director of Nomura Holding America Inc.
|
Sep. 2002 | Joined the Company | |||
| Apr. 2020 |
Executive Officer and Chief Risk Officer of the Company (based in New York) (Current)
Director and Senior Corporate Managing Director of Nomura Securities Co., Ltd. (Current)
|
|||||
|
Yosuke Inaida
(Oct. 6, 1967)
|
Executive Officer
Chief Compliance Officer
Senior Corporate Managing Director of Nomura Securities Co., Ltd.
Director of Nomura Asia Pacific Holdings Co., Ltd
|
Apr. 1991 | Joined the Company | |||
| Apr. 2015 | Senior Managing Director of Nomura Securities Co., Ltd. | |||||
| Apr. 2020 | Senior Corporate Managing Director of Nomura Securities Co., Ltd. | |||||
| Apr. 2022 |
Executive Officer and Chief Compliance Officer of the Company (Current)
Senior Corporate Managing Director of Nomura Securities Co., Ltd. (Current)
|
|||||
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
|
Christopher Willcox
(Feb. 25, 1968)
|
Executive Officer
Head of Wholesale
|
May. 2014 | CEO of J.P. Morgan Asset Management Inc. | |||
| May. 2021 |
Director and
Co-CEO
of Nomura Holding America Inc.
Director, President and CEO of Nomura Securities International, Inc.
Director, President and CEO of Nomura Global Financial Products Inc.
|
|||||
| Apr. 2022 |
Director, President and CEO of Nomura Holding America Inc.
Director, President and CEO of Nomura Securities International, Inc.
Director, President and CEO of Nomura Global Financial Products Inc.
|
|||||
| Oct. 2022 | Executive Officer and Head of Wholesale of the Company (based in New York) (Current) | |||||
|
Fixed Compensation
|
Performance-linked Compensation
|
|||
| Base salary | Annual Bonuses | Long-term Incentive Plan | ||
| • |
Base salary is paid in cash and determined based on factors such as professional background, career history, responsibilities and compensation standards of related business fields.
|
| • |
With respect to the Group CEO, given the overall responsibility of business execution of the Nomura Group, the basic amount of the performance-linked compensation is calculated based on the level of achievement in actual value(s) against the target value(s) of key performance indicator(s) and performance metrics that form the basis for their calculation. In addition, qualitative evaluation competitor benchmarking is also reflected when determining final annual bonus amount.
|
| • |
With respect to Directors and other Executive Officers, the amount of annual bonus is determined with the annual bonus of Group CEO as standard baseline, taking into consideration roles and responsibilities, local remuneration regulations and compensation levels in each jurisdiction etc., in addition to a qualitative evaluation of individual performance.
|
| • |
Audit Committee members and Outside Directors are not bonus-eligible in order to maintain and ensure their independence from business execution.
|
| • |
In principle, certain portion of any annual bonus payment should be deferred.
|
| • |
Payments under long-term incentive plans are made when a certain degree of achievements are accomplished. Payments are made in stock-based compensation awards.
|
| • |
Fixed compensation—reflects the role, responsibilities and experience of the employee; and
|
| • |
Variable compensation—designed to incentivize performance, encourage the right behaviors and drive employee growth and development. For higher paid employees, a portion of variable compensation may be deferred, balancing short-term with our medium and long-term interests.
|
|
Type of elements
|
Item
|
Actual for the fiscal year
ended March 31, 2024. |
||
| Profit and loss | Net revenue | 1,562 billions of yen | ||
|
Revenue cost coverage ratio
(1)
|
82.5% | |||
| Income before income taxes | 274 billions of yen | |||
| Per share information | Earnings per Share (“EPS”) | 52.69 yen | ||
| Capital efficiency | ROE | 5.1% | ||
| Shareholder returns |
Total Shareholder Return (“TSR”)
(2)
|
196.3% |
| 1. |
Ratio calculated by dividing Total
non-interest
expenses by Net revenue
|
| 2. |
The value obtained by dividing the total of fluctuations in the price of NHI shares and dividends in the current fiscal year by the NHI share price at the end of the previous business year.
|
|
Type of award
|
Key features
|
|
|
Restricted Stock Units (“RSUs”)
|
• Introduced as the main form of Deferred Compensation since the fiscal year ended March 31, 2018.
• Settled in the Company’s common stock.
• Graded vesting period is set as three years in principle.
|
|
|
Notional Stock Units (“NSUs”)
|
• Linked to the price of the Company’s common stock Cash-settled in local currency.
• Graded vesting period is set as three years in principle.
|
|
|
Performance Share Units (“PSUs”)
|
• Introduced as the Long Term Incentive Plan since the fiscal year ended March 31, 2024.
• The number of shares to be awarded will be determined by depended on the degree of achievement of the performance targets of the three fiscal years.
• Performance evaluation period is set as more than three years in principle.
|
|
|
Performance
Indicators
|
Composition
ratio
|
Change in the
grant ratio
|
Evaluation method
|
|||
| ROE | 50% | 0%~150% |
Calculated based on the actual (average) values for the three-year performance evaluation period
|
|||
| TSR | 50% | 0%~150% |
Calculated based on the actual value (absolute value) during the three-year performance evaluation period
|
|||
| • |
Alignment of interests with shareholders.
|
| • |
Medium-term incentives and retention by providing an opportunity for the economic value of Deferred Compensation at the time of grant to be increased by a rise in shares during a period of time from grant to vesting.
|
| • |
Promotion of cross-divisional collaboration and cooperation by providing a common goal of increasing corporate value over the medium to long term.
|
|
Number of
People
(1)
|
Millions of yen
|
|||||||||||||||||||||||
|
Year ended March 31, 2024
|
||||||||||||||||||||||||
|
Fixed compensation
|
Performance-linked compensation
|
Total
|
||||||||||||||||||||||
|
Base salary
(2,3)
|
Cash Bonuses
|
NSU
(4)
|
RSU
(4)
|
|||||||||||||||||||||
|
Directors
|
13 | ¥ | 389 | ¥ | 116 | ¥ | 221 | ¥ | — | ¥ | 726 | |||||||||||||
|
(Outside Directors included in above)
|
10 | (217 | ) | (— | ) | (— | ) | (— | ) | (217 | ) | |||||||||||||
|
Executive Officers
|
8 | 598 | 1,206 | 2,412 | 241 | 4,457 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Total
|
21 | ¥ | 987 | ¥ | 1,322 | ¥ | 2,633 | ¥ | 241 | ¥ | 5,183 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| (1) |
Includes one Director retired in June 2023, and two Directors who were appointed in June 2023. There were eleven Directors and eight Executive Officers as of March 31, 2024. Compensation to Directors who were concurrently serving as Executive Officers is included within “Executive Officers.”
|
| (2) |
Includes other compensation (commuter pass allowance) of ¥0.27 million.
|
| (3) |
In addition to base salary, ¥16 million of corporate housing benefits, including housing allowance and related tax adjustments, were provided to Executive Officers.
|
| (4) |
Represents deferred stock-based compensation awards granted in prior years recognized as expense in the consolidated financial statement of income for the year ended March 31, 2024. The expense of NSUs are remeasured to fair value at each balance sheet date, while the amounts of RSUs are measured at fair value on the grant date. For more details, see Note 1 “Summary of accounting policies” in our consolidated financial statements. Furthermore, the expenses related to the Long-Term Incentive Plan, which was approved for implementation at the Compensation Committee on March 29, 2024, will be recognized for the performance evaluation period starting from the fiscal year ended March 2025 and are not included in the above figures.
|
| (5) |
Total compensation paid to Outside Directors for their services to subsidiaries of the Company was ¥76 million for the fiscal year ended March 31, 2024.
|
|
Millions of yen
|
||||||||||||||||||||||||
|
Fixed Remuneration
|
Variable Compensation
|
|||||||||||||||||||||||
|
Name
|
Company
|
Role
|
Cash
|
RSU
|
Cash
Bonuses
|
Stock Based
Compensation |
Total
|
|||||||||||||||||
|
Koji Nagai
|
Nomura | Chairman of the Board of Directors | ¥ | 91.2 | ¥ | 0.0 | ¥ | 116.0 | ¥ | 116.0 | ¥ | 323.2 | ||||||||||||
|
Kentaro Okuda
(1)
|
Nomura |
Director,
Representative
Executive Officer
(Group CEO)
|
¥ | 102.0 | ¥ | 17.4 | ¥ | 183.7 | ¥ | 202.9 | ¥ | 506.0 | ||||||||||||
|
Yutaka Nakajima
|
Nomura |
Director,
Representative
Executive Officer
|
¥ | 75.6 | ¥ | 14.4 | ¥ | 106.3 | ¥ | 106.3 | ¥ | 302.6 | ||||||||||||
|
Toshiyasu Iiyama
|
Nomura | Executive Officer | ¥ | 72.0 | ¥ | 14.4 | ¥ | 85.1 | ¥ | 85.1 | ¥ | 256.5 | ||||||||||||
|
Takumi Kitamura
|
Nomura | Executive Officer | ¥ | 60.0 | ¥ | 13.2 | ¥ | 45.9 | ¥ | 45.9 | ¥ | 165.0 | ||||||||||||
|
Sotaro Kato
|
Nomura | Executive Officer | ¥ | 54.0 | ¥ | 9.6 | ¥ | 38.2 | ¥ | 38.2 | ¥ | 140.0 | ||||||||||||
|
Yosuke Inaida
|
Nomura | Executive Officer | ¥ | 54.0 | ¥ | 9.6 | ¥ | 35.7 | ¥ | 35.7 | ¥ | 135.0 | ||||||||||||
|
Toru Otsuka
|
Nomura | Executive Officer | ¥ | 54.0 | ¥ | 9.6 | ¥ | 35.7 | ¥ | 35.7 | ¥ | 135.0 | ||||||||||||
|
Willcox, Christopher
(2)
|
Nomura | Executive Officer | ¥ | 108.4 | ¥ | 9.6 | ¥ | 675.8 | ¥ | 940.6 | ¥ | 1,734.4 | ||||||||||||
| (Equivalent in ’000 USD) | $ | (750.0 | ) | $ | (66.9 | ) | $ | (4,675.8 | ) | $ | (6,507.3 | ) | $ | (12,000.0 | ) | |||||||||
| (1) |
In addition to fixed compensation, ¥16 million of corporate housing costs, including housing allowance and related tax adjustments, were provided.
|
| (2) |
Since appointed as an Executive Officer in October 2022, the compensation for six months converted into millions of JPY were stated in the 20-F for the fiscal year ended March 2023 (1 USD = 135.44 yen basically). In the table above, the compensation for twelve months for the fiscal year ended March 2024 (1 USD = 144.54 yen basically) is stated.
|
|
Date
|
Summary of the discussion and the resolution
|
Attendance records
of the member
|
||||
|
April 21, 2023
|
Discussion: |
• Performance for the year ended March 31, 2023 and the compensation level of the group CEO.
|
All members attended | |||
|
April 24, 2023
|
Discussion: |
• The compensation level of the group CEO during the year end March 31, 2023.
|
All members attended | |||
|
April 26, 2023
|
Resolution: |
• The bonus plan for the year ended March 31, 2023.
• Amendment of policies governing compensation for Directors and Executive Officers.
|
All members attended | |||
|
June 27, 2023
|
Resolution: |
• The appointment of the Director with the right to convoke the board of directors meetings.
• The Director who reports the executions of the committee’s duties to the board of the directors meetings.
• The Compensation Policy of Nomura Group and base salary of the Directors and Executive Officers.
• Individual base salary of the Directors and Executive Officers.
• Granting RSUs to the Directors and Executive Officers.
|
All members attended | |||
| Reporting: |
• Schedule for current fiscal year
|
|||||
|
August 29, 2023
|
Discussion |
• Review of policies governing pay for Directors and Executive Officers.
|
All members attended | |||
|
September 27, 2023
|
Discussion: |
• Individual base salary of the Directors and Executive Officers.
• Group CEO Pay levels.
|
All members attended | |||
|
November 6, 2023
|
Resolution: |
• Introduction of the U.S. SEC Clawback Regulations and the Company’s Response.
|
All members attended | |||
|
December 5, 2023
|
Reporting: |
• Compensation levels for executives in major competitive regions domestically and internationally.
|
All members attended | |||
|
January 31, 2024
|
Discussion: |
• Review of executive compensation levels and the determination method for executive compensation for the fiscal year ended March 2024.
|
All members attended | |||
|
February 20, 2024
|
Discussion: |
• Review of the method for determining executive compensation.
|
All members attended | |||
|
March 29, 2024
|
Resolution: |
• The annual base salary of the next fiscal year.
• Introduction of Long-Term Incentive Plans (LTI).
|
All members attended | |||
| Discussion: |
• Expected performance and compensation level outlook for the fiscal year ended March 2024.
|
|||||
|
March 31, 2024
|
||||||||||||||||
|
Series of SARs
|
Allotment Date
|
Number of
Shares
under
SARs
(1)
|
Exercise Period of SARs
|
Exercise
Price per
Share
under
SARs
|
Paid-in
Amount
for
SARs
|
|||||||||||
|
Stock Acquisition Rights No.71
|
June 7, 2016 | 185,300 |
From April 20, 2019
to April 19, 2024
|
¥ | 1 | ¥ | 198 | |||||||||
|
Stock Acquisition Rights No.76
|
June 9, 2017 | 151,900 |
From April 20, 2019
to April 19, 2024
|
¥ | 1 | ¥ | 334 | |||||||||
|
Stock Acquisition Rights No.77
|
June 9, 2017 | 553,600 |
From April 20, 2020
to April 19, 2025
|
¥ | 1 | ¥ | 325 | |||||||||
|
Stock Acquisition Rights No.78
|
June 9, 2017 | 142,800 |
From April 20, 2021
to April 19, 2026
|
¥ | 1 | ¥ | 312 | |||||||||
|
Stock Acquisition Rights No.79
|
June 9, 2017 | 177,700 |
From April 20, 2022
to April 19, 2027
|
¥ | 1 | ¥ | 303 | |||||||||
|
Stock Acquisition Rights No.80
|
June 9, 2017 | 47,000 |
From April 20, 2023
to April 19, 2028
|
¥ | 1 | ¥ | 282 | |||||||||
|
Stock Acquisition Rights No.81
|
June 9, 2017 | 132,100 |
From April 20, 2024
to April 19, 2029
|
¥ | 1 | ¥ | 273 | |||||||||
|
Stock Acquisition Rights No.84
|
November 17, 2017 | 1,805,200 |
From November 17, 2019
to November 16, 2024
|
¥ | 684 | ¥ | 398 | |||||||||
|
Stock Acquisition Rights No.85
|
November 20, 2018 | 1,728,200 |
From November 20, 2020
to November 19, 2025
|
¥ | 573 | ¥ | 329 | |||||||||
| (1) |
The number of NHI shares issuable under SARs is subject to adjustments under certain circumstances including stock splits.
|
|
March 31, 2024
|
||||||||
|
Numbers of Holders
|
||||||||
|
Series of SARs
|
Number of
Shares
under
SARs
|
Directors and
Executive Officers
(excluding
Outside Directors)
|
||||||
|
Stock Acquisition Rights No.77
|
79,000 | 4 | ||||||
|
Stock Acquisition Rights No.78
|
2,800 | 1 | ||||||
|
Stock Acquisition Rights No.79
|
2,800 | 1 | ||||||
|
Stock Acquisition Rights No.80
|
2,800 | 1 | ||||||
|
March 31,
|
||||||||||||
|
2022
|
2023
|
2024
|
||||||||||
|
Japan
|
15,213 | 15,131 | 14,870 | |||||||||
|
Europe
|
2,820 | 2,937 | 3,053 | |||||||||
|
Americas
|
2,257 | 2,387 | 2,440 | |||||||||
|
Asia and Oceania
|
6,295 | 6,320 | 6,487 | |||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
26,585 | 26,775 | 26,850 | |||||||||
|
|
|
|
|
|
|
|||||||
|
Name
|
Number of
Shareholdings
|
|||
|
Koji Nagai
|
512,942 | |||
|
Kentaro Okuda
|
439,490 | |||
|
Yutaka Nakajima
|
658,392 | |||
|
Shoji Ogawa
|
51,789 | |||
|
Laura Simone Unger
|
(1,000ADR |
)
(1)
|
||
|
Victor Chu
|
—
|
|||
|
J.Christopher Giancarlo
|
—
|
|||
|
Patricia Mosser
|
(100ADR |
)
(1)
|
||
|
Takahisa Takahara
|
881 | |||
|
Miyuki Ishiguro
|
—
|
|||
|
Masahiro Ishizuka
|
3,610 | |||
|
Taku Oshima
|
— | |||
|
|
|
|||
|
Total
|
1,667,104 | |||
|
|
|
|||
| (1) |
ADRs are not included in the total.
|
|
Name
|
Number of
Shareholdings
|
|||
|
Kentaro Okuda
|
See above |
(1)
|
||
|
Yutaka Nakajima
|
See above |
(1)
|
||
|
Toshiyasu Iiyama
|
188,929 | |||
|
Takumi Kitamura
|
120,037 | |||
|
Sotaro Kato
|
28,059 | |||
|
Yosuke Inaida
|
192,308 | |||
|
Christopher Willcox
|
4,894 | |||
|
|
|
|||
|
Total
|
534,227 | |||
|
|
|
|||
| (1) |
The number of shares owned by Executive Officers who are concurrently serving as Directors is not included in the total.
|
| (1) |
Financial instruments business prescribed in the Financial Instruments and Exchange Law;
|
| (2) |
Banking business prescribed in the Banking Law and trust business prescribed in the Trust Business Law; and
|
| (3) |
Any other financial services and any business incidental or related to such financial services.
|
| (4) |
Other than as prescribed in the items above, any other business ancillary or related to survey and research in connection with the economy, financial or capital markets, or infrastructure or undertaking the outsourcing thereof.
|
| • |
a dealer in securities,
|
| • |
a trader in securities that elects to use a
mark-to-market
|
| • |
a
tax-exempt
organization,
|
| • |
a life insurance company,
|
| • |
a person that actually or constructively owns 10% or more of the combined voting power of our voting stock or of the total value of our stock,
|
| • |
a person that holds shares or ADSs as part of a straddle or a hedging, conversion, integrated or constructive sale transaction,
|
| • |
a person that purchases or sells shares or ADSs as part of a wash sale for tax purposes, or
|
| • |
a person whose functional currency is not the U.S. Dollar.
|
| • |
a citizen or resident of the U.S.,
|
| • |
a corporation created or organized in or under the laws of the U.S. or any political subdivision thereof,
|
| • |
an estate whose income is subject to U.S. federal income tax regardless of its source, or
|
| • |
a trust if a U.S. court can exercise primary supervision over the trust’s administration and one or more U.S. persons are authorized to control all substantial decisions of the trust.
|
| • |
at least 75% of our gross income for the taxable year is passive income, or
|
| • |
at least 50% of the value, determined on the basis of a quarterly average, of our assets is attributable to assets that produce or are held for the production of passive income.
|
| • |
any gain you realize on the sale or other disposition of your shares or ADSs, and
|
| • |
any excess distribution that we make to you (generally, any distributions to you during a single taxable, other than distributions in the first taxable year that you hold the shares or ADSs, year that are greater than 125% of the average annual distributions received by you in respect of the shares or ADSs during the three preceding taxable years or, if shorter, your holding period for the shares or ADSs that preceded the taxable year in which you receive the distribution).
|
| • |
the gain or excess distribution will be allocated ratably over your holding period for the shares or ADSs,
|
| • |
the amount allocated to the taxable year in which you realized the gain or excess distribution, or to prior years before the first year in which we were a PFIC with respect to you, will be taxed as ordinary income,
|
| • |
the amount allocated to each other previous year will be taxed at the highest tax rate in effect for that year, and
|
| • |
the interest charge generally applicable to underpayments of tax will be imposed in respect of the tax attributable to each such year.
|
| • |
the overall tax consequences of the acquisition, ownership and disposition of shares or ADSs, including specifically the tax consequences under Japanese law,
|
| • |
the laws of the jurisdiction of which they are resident, and
|
| • |
any tax treaty between Japan and their country of residence.
|
| • |
First Line of Defense: All executives and employees of the front office for Financial Risk and all executives and employees for
Non-Financial
Risk are primarily responsible for risk management and assume the consequences associated with business execution and to provide evidence and justify that the risk arising from their business activities is in line with risk appetite.
|
| • |
Second Line of Defense: The department responsible for risk management supports and monitors management activities on the First Line of Defense and reports to the board and the senior management. In addition, the Second Line independently evaluates risk management governance established by the First Line.
|
| • |
Third Line of Defense: The Internal Audit function examines and evaluates the risk management from an independent standpoint, provides advice for improvement, and reports the examination and evaluation results to the Audit Committee.
|
| • |
Amendment and abolition of the Risk Appetite Statement
|
| • |
Change in risk management framework
|
| • |
Results of analysis and verification or future forecasts of risk environment
|
| • |
Execution state of the overall risk management and medium- to long-term risk strategies
|
| • |
Resource Allocation—At the beginning of each financial year, the EMB determines the allocation of management resources and financial resources such as risk-weighted asset and unsecured funding to business units and establishes usage limits for these resources;
|
| • |
Business Plan—At the beginning of each financial year, the EMB approves the business plan and budget of Nomura. Introduction of significant new businesses, changes to business plans, the budget and the allocation of management resources during the year are also approved by the EMB; and
|
| • |
Reporting—The EMB reports the status of its deliberations to the BoD.
|
|
Risk Category
|
Definition
|
|
|
Financial Risk
|
||
|
Market risk
|
Risk of loss arising from fluctuations in values of financial assets or debts (including
off-balance
sheet items) due to fluctuations in market risk factors (interest rates, foreign exchange rates, prices of securities and others).
|
|
|
Credit risk
|
Risk of loss arising from an obligor’s default, insolvency or administrative proceeding which results in the obligor’s failure to meet its contractual obligations in accordance with agreed terms. It is also the risk of loss arising through a credit valuation adjustment (the “CVA”) associated with deterioration in the creditworthiness of a counterparty. | |
|
Model risk
|
Risk of financial loss, incorrect decision making, or damage to the firm’s credibility arising from model errors or incorrect or inappropriate model application. | |
|
Non-financial
Risk
|
||
|
Operational risk
|
Risk of financial loss or
non-financial
impact arising from inadequate or failed internal processes, people and systems, or from external events. Operational risk includes in its definition Compliance, Legal, IT and Cyber Security, Fraud, Third Party and other
non-financial
risks.
|
|
|
Reputational risk
|
Possible damage to Nomura’s reputation and associated risk to earnings, capital or liquidity arising from any association, action or inaction which could be perceived by stakeholders to be inappropriate, unethical or inconsistent with Nomura Group’s values and corporate philosophy. | |
|
Liquidity risk
|
||
|
Liquidity risk
|
Risk of loss arising from difficulty in securing the necessary funding or from a significantly higher cost of funding than normal levels due to deterioration of the Nomura Group’s creditworthiness or deterioration in market conditions. | |
|
Other Risks
|
||
|
ESG: Environmental,
Social and
Governance
|
ESG is a collective term for Environmental (E), Social (S) and Governance (G) factors. “Environmental” includes issues related to impacts on the natural environment, including climate change. “Social” includes interactions with stakeholders and communities, for example the approach to human rights, workplace related issues and engagement on social issues. “Governance” includes issues related to corporate governance, corporate behavior and the approach to transparent reporting. | |
|
Strategic risk
|
Risk to current or anticipated earning, capital, liquidity, enterprise value, or the Nomura Group’s reputation arising from adverse business decisions, poor implementation of business decisions, or lack of responsiveness to change in the industry or external environment. | |
|
Billions of yen
|
||||||||
|
As of
|
||||||||
|
March 31,
2023
|
March 31,
2024
|
|||||||
|
Equity
|
¥ | 3.3 | ¥ | 3.3 | ||||
|
Interest rate
|
4.7 | 2.6 | ||||||
|
Foreign exchange
|
1.4 | 2.1 | ||||||
|
|
|
|
|
|||||
|
Subtotal
|
9.4 | 8.0 | ||||||
|
Less: Diversification Benefit
|
(3.2 | ) | (2.5 | ) | ||||
|
|
|
|
|
|||||
|
VaR
|
¥ | 6.2 | ¥ | 5.5 | ||||
|
|
|
|
|
|||||
|
Billions of yen
|
||||||||
|
For the twelve months ended
|
||||||||
|
March 31,
2023
|
March 31,
2024
|
|||||||
|
Maximum daily VaR
(1)
|
¥ | 6.8 | ¥ | 6.8 | ||||
|
Average daily VaR
(1)
|
4.8 | 5.6 | ||||||
|
Minimum daily VaR
(1)
|
2.7 | 4.3 | ||||||
| (1) |
Represents the maximum, average and minimum VaR based on all daily calculations for the fiscal year ended March 31, 2024.
|
| • |
Evaluation of likelihood that a counterparty defaults on its payments and obligations;
|
| • |
Assignment of internal ratings to all active counterparties;
|
| • |
Approval of extensions of credit and establishment of credit limits;
|
| • |
Measurement, monitoring and management of Nomura’s current and potential future credit exposures;
|
| • |
Setting credit terms in legal documentation; and
|
| • |
Use of appropriate credit risk mitigants including netting, collateral and hedging.
|
| • |
Establishing the amount of counterparty credit risk that Nomura is willing to take to an individual counterparty or counterparty group (setting of credit limits);
|
| • |
Determining the level of delegated authority for setting credit limits (including tenor);
|
| • |
The frequency of credit reviews (renewal of credit limits);
|
| • |
Reporting counterparty credit risk to senior management within Nomura; and
|
| • |
Reporting counterparty credit risk to stakeholders outside of Nomura.
|
|
Billions of yen
|
||||||||||||||||||||||||||||||||||||
|
Years to Maturity
|
Cross-
Maturity
Netting
(1)
|
Total
Fair Value
|
Collateral
obtained
|
Replacement
cost
(3)
|
||||||||||||||||||||||||||||||||
|
Credit Rating
|
Less than
1 year
|
1 to 3
years
|
3 to 5
years
|
5 to 7
years
|
More
than
7 years
|
|||||||||||||||||||||||||||||||
|
(a)
|
(b)
|
(a)-(b)
|
||||||||||||||||||||||||||||||||||
|
AAA
|
¥ | 16 | ¥ | 13 | ¥ | 5 | ¥ | 12 | ¥ | 52 | ¥ | (85 | ) | ¥ | 13 | ¥ | 1 | ¥ | 12 | |||||||||||||||||
|
AA
|
359 | 336 | 156 | 100 | 712 | (1,272 | ) | 391 | 103 | 288 | ||||||||||||||||||||||||||
|
A
|
517 | 397 | 209 | 219 | 864 | (1,748 | ) | 458 | 168 | 290 | ||||||||||||||||||||||||||
|
BBB
|
302 | 109 | 65 | 39 | 315 | (492 | ) | 338 | 157 | 181 | ||||||||||||||||||||||||||
|
BB and lower
|
161 | 92 | 67 | 8 | 52 | (238 | ) | 142 | 568 | — | ||||||||||||||||||||||||||
|
Other
(2)
|
63 | 82 | 104 | 128 | 831 | (1,246 | ) | (38 | ) | 90 | — | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
Sub-total
|
¥ | 1,418 | ¥ | 1,029 | ¥ | 606 | ¥ | 506 | ¥ | 2,826 | ¥ | (5,081 | ) | ¥ | 1,304 | ¥ | 1,087 | ¥ | 771 | |||||||||||||||||
|
Listed
|
587 | 38 | 13 | 5 | 0 | (423 | ) | 220 | 244 | — | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
Total
|
¥ | 2,005 | ¥ | 1,067 | ¥ | 619 | ¥ | 511 | ¥ | 2,826 | ¥ | (5,504 | ) | ¥ | 1,524 | ¥ | 1,331 | ¥ | 771 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| (1) |
Represents netting of derivative liabilities against derivatives assets entered into with the same counterparty across different maturity bands. Derivative assets and derivative liabilities with the same counterparty in the same maturity band are net within the relevant maturity band. Cash collateral netting against net derivative assets in accordance with ASC
210-20
“
Balance Sheet
—
Offsetting
Derivatives and Hedging
|
| (2) |
“Other” comprises unrated counterparties and certain portfolio level valuation adjustments not allocated to specific counterparties.
|
| (3) |
Zero balances represent instances where total collateral received is in excess of the total fair value; therefore, Nomura’s credit exposure is zero.
|
|
Top 10 Country (Region) Exposures
(1)
|
Billions of yen
|
|||
|
(As of March 31, 2024)
|
||||
|
United States
|
7,477 | |||
|
Japan
|
2,635 | |||
|
United Kingdom
|
1,105 | |||
|
Singapore
|
301 | |||
|
Canada
|
257 | |||
|
India
|
249 | |||
|
South Korea
|
223 | |||
|
Germany
|
217 | |||
|
Luxembourg
|
186 | |||
|
Hong Kong S.A.R
|
169 | |||
| (1) |
The table represents the Top 10 country (region) exposures as of March 31, 2024 based on country of risk, combining counterparty and inventory exposures
|
| - |
Counterparty exposures include cash and cash equivalents held at banks; the outstanding default fund and initial margin balances posted by Nomura to central clearing counterparties as legally required under its direct and affiliate clearing memberships; the aggregate
marked-to-market
|
| - |
Inventory exposures are the market value of debt and equity securities, and equity and credit derivatives, using the net of long versus short positions.
|
| • |
Policy framework: Sets standards for managing operational risk and details how to monitor adherence to these standards.
|
| • |
Training and awareness: Action taken by the Operational Risk Management (“ORM”) to improve business understanding of operational risk.
|
| • |
Event Reporting: This process is used to identify and report any event which resulted in or had the potential to result in a loss or gain or other impact associated with inadequate or failed internal processes, people and systems, or from external events.
|
|
|
•
|
|
Risk and Control Self-Assessment (the “RCSA”): This process is used to identify the inherent risks the business faces, the key controls associated with those risks and relevant actions to mitigate the residual risks. Global ORM are responsible for developing the RCSA process and supporting the business in its implementation.
|
|
|
•
|
|
Key Risk Indicators (the “KRI”): KRIs are metrics used to monitor the business’ exposure to operational risk and trigger appropriate responses as thresholds are breached.
|
|
|
•
|
|
Scenario Analysis: The process used to assess and quantify potential high impact, low likelihood operational risk events. During the process actions may be identified to enhance the control environment.
|
|
|
•
|
|
Analysis and reporting: A key aspect of ORM’s role is to analyze, report, and challenge operational risk information provided by business units, and work with business units to develop action plans to mitigate risks.
|
|
|
•
|
|
Operational risk capital calculation: Calculate operational risk capital as required under applicable Basel regulations and local regulatory requirements.
|
|
|
|
|
|
|
|
|
|
Business Line
|
|
Description
|
|
Beta Factor
|
|
|
|
Retail Banking
|
|
Retail deposit and loan-related services
|
|
|
12%
|
|
|
Commercial Banking
|
|
Deposit and loan-related services except for Retail Banking business
|
|
|
15%
|
|
|
Payment and Settlement
|
|
Payment and settlement services for clients’ transactions
|
|
|
18%
|
|
|
Retail Brokerage
|
|
Securities-related services mainly for individuals
|
|
|
12%
|
|
|
Trading and Sales
|
|
Market-related business
|
|
|
18%
|
|
|
Corporate Finance
|
|
M&A, underwriting, secondary and private offerings, and other funding services for clients
|
|
|
18%
|
|
|
Agency Services
|
|
Agency services for clients such as custody
|
|
|
15%
|
|
|
Asset Management
|
|
Fund management services for clients
|
|
|
12%
|
|
|
|
•
|
|
Nomura calculates the required amount of operational risk capital for each business line by multiplying the allocated annual gross income amount by the appropriate Beta Factor defined above. The operational risk capital for any gross income amount not allocated to a specific business line is determined by multiplying such unallocated gross income amount by a fixed percentage of 18%.
|
|
|
•
|
|
The total operational risk capital for Nomura is calculated by aggregating the total amount of operational risk capital required for each business line and unallocated amount and by determining a three-year average. Where the aggregated amount for a given year is negative, then the total operational risk capital amount for that year will be calculated as zero. In any given year, negative amounts in any business line are offset against positive amounts in other business lines. However, negative unallocated amounts are not offset against positive amounts in other business lines and are calculated as zero.
|
|
|
•
|
|
Operational risk capital is calculated at the end of September and March each year.
|
|
|
(1)
|
Transaction committees are in place to provide formal governance over the review and decision-making process for individual transactions. The liability for
non-compliance
is also clarified.
|
|
|
(2)
|
The new product approval process allows business unit sponsors to submit applications for new products and obtain approval from relevant departments prior to execution of the new products. The process is designed to capture and assess risks across various risk classes as a result of the new product or business.
|
|
|
•
|
|
Sensitivity analysis is used to quantify the impact of a market move in one or two associated risk factors (for example, equity prices, equity volatilities) in order primarily to capture those risks which may not be readily identified by other risk models;
|
|
|
•
|
|
Scenario analysis is used to quantify the impact of a specified event across multiple asset classes and risk classes. This is a primary approach used in performing stress testing at the different hierarchical levels of the Nomura Group;
|
|
|
•
|
|
Nomura Group establishes several stress scenarios to validate risk appetite for capital and liquidity soundness, taking into account the business environment, business’s risk profile, economic environment and forecasts.
|
|
|
•
|
|
Group-wide stress to assess the capital adequacy of the Nomura Group under severe but plausible market scenarios is conducted on a quarterly basis at a minimum; and
|
|
|
•
|
|
Reverse stress testing, a process of considering the vulnerabilities of the firm and hence how it may react to situations where it becomes difficult to continue its business, and reviewing the results of that analysis, is conducted on an annual basis at a minimum.
|
|
|
|
|
|
Type of Services:
|
|
Amount of Fee (U.S. Dollars)
|
|
Taxes and other governmental charges
|
|
As applicable. The depositary may offset any taxes or governmental charges it is obligated to withhold, if applicable, against the proceeds from sale of the property received.
|
|
|
|
|
|
Transfers of the Company’s shares to or from the name of the depositary (or its nominee) or the Custodian (or its nominee) in connection with deposits or withdrawals
|
|
Such registration fees as may be in effect for the registration of transfers of the Company’s shares on the Company’s share register (or any entity that presently carries out the duties of registrar).
|
|
|
|
|
|
Cable, telex and facsimile transmission expenses
|
|
As applicable.
|
|
|
|
|
|
Expenses incurred by the depositary in the conversion of foreign currency
|
|
As applicable.
|
|
|
|
|
|
Execution and delivery of Receipts in connection with deposits, stock splits or exercise of subscription rights
|
|
$5.00 or less per 100 ADSs (or portion thereof).
|
|
|
|
|
|
Surrender of Receipts in connection with a withdrawal or termination of the Deposit Agreement
|
|
$5.00 or less per 100 ADSs (or portion thereof).
|
|
|
|
|
|
Any cash distribution pursuant to the Deposit Agreement, including, but not limited to, cash distribution(s) made in connection with cash dividends; distributions in securities, property or subscription rights; and stock splits.
|
|
$.02 or less per ADS (or portion thereof). Only the cash amounts net of this fee, if applicable, are distributed.
|
|
|
|
|
|
Distribution by the depositary of securities (other than common shares of the Company) that accrued on the underlying shares to owners of the Receipts
|
|
Treating for the purpose of this fee all such securities as if they were common shares of the Company, $5.00 or less per 100 ADSs (or portion thereof).
|
|
|
|
|
|
General depositary services
|
|
$.02 or less per ADS (or portion thereof), accruing on the last day of each calendar year, except where the fee for cash distribution described above was assessed during that calendar year.
|
|
|
|
|
|
Any other charge payable by the depositary, any of the depositary’s agents, including the Custodian, or the agents of the depositary’s agents in connection with the servicing of the Company’s shares or other deposited securities
|
|
As applicable.
|
|
|
•
|
|
The Company has performed a detailed review of the consolidated statements of cash flow in this annual report, in order to identify other related issues or improvements in both classification and presentation of cash flows matters;
|
|
|
•
|
|
The Company has released a comprehensive internal policy documentation and has provided training to relevant personnel specifically focusing on classification and presentation within the consolidated statement of cash flows; and
|
|
|
•
|
|
The Company has implemented a new annual control whereby senior finance and accounting policy personnel perform an
in-depth
comprehensive review of the consolidated statement of cash flows, including a review of underlying calculations and methodologies used as the basis of reported amounts, to evaluate compliance with applicable accounting requirements under ASC 230 “
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||
|
|
|
Year ended March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
Audit Fees
|
|
¥
|
4,138
|
|
|
¥
|
4,282
|
|
|
Audit-Related Fees
|
|
|
224
|
|
|
|
261
|
|
|
Tax Fees
|
|
|
330
|
|
|
|
294
|
|
|
All Other Fees
|
|
|
264
|
|
|
|
51
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
¥
|
4,956
|
|
|
¥
|
4,888
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Month
|
|
Total
Number of
Shares
Purchased
|
|
|
Average Price
Paid per Share
(in yen)
|
|
|
Total
Number of
Shares
Purchased
as Part of
Publicly
Announced
Program
|
|
|
Maximum
Number of
Shares that
May Yet Be
Purchased
Under the
Program
|
|
||||
|
April 1 to 30, 2023
|
|
|
902
|
|
|
¥
|
515
|
|
|
|
—
|
|
|
|
—
|
|
|
May 1 to 31, 2023
|
|
|
1,547
|
|
|
|
493
|
|
|
|
—
|
|
|
|
35,000,000
|
|
|
June 1 to 30, 2023
|
|
|
2,001
|
|
|
|
531
|
|
|
|
—
|
|
|
|
35,000,000
|
|
|
July 1 to 31, 2023
|
|
|
2,333
|
|
|
|
549
|
|
|
|
—
|
|
|
|
35,000,000
|
|
|
August 1 to 31, 2023
|
|
|
17,294,762
|
|
|
|
547
|
|
|
|
17,292,000
|
|
|
|
17,708,000
|
|
|
September 1 to 30, 2023
|
|
|
17,079,619
|
|
|
|
617
|
|
|
|
17,076,500
|
|
|
|
631,500
|
|
|
October 1 to 31, 2023
|
|
|
1,520
|
|
|
|
593
|
|
|
|
—
|
|
|
|
—
|
|
|
November 1 to 30, 2023
|
|
|
1,266
|
|
|
|
605
|
|
|
|
—
|
|
|
|
—
|
|
|
December 1 to 31, 2023
|
|
|
2,066
|
|
|
|
620
|
|
|
|
—
|
|
|
|
—
|
|
|
January 1 to 31, 2024
|
|
|
2,034
|
|
|
|
703
|
|
|
|
—
|
|
|
|
—
|
|
|
February 1 to 28, 2024
|
|
|
18,466,880
|
|
|
|
843
|
|
|
|
18,464,500
|
|
|
|
106,535,500
|
|
|
March 1 to 31, 2024
|
|
|
27,762,213
|
|
|
|
917
|
|
|
|
27,759,100
|
|
|
|
78,776,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
80,617,143
|
|
|
¥
|
757
|
|
|
|
80,592,100
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Governance Practices Followed
by NYSE-listed U.S. Companies
|
|
Corporate Governance Practices Followed by the Company
|
|
A NYSE-listed U.S. company must have a majority of Directors meeting the independence requirements under Section 303A of the NYSE Listed Company Manual.
|
|
Under the Companies Act, a company which adopts the Company with Three Board Committees structure is not required to have a majority of outside directors, but is required to have a majority of outside directors on each of the audit, nomination and compensation committees.
The Company currently has eight outside directors among its twelve Directors.
|
|
|
|
|
|
A NYSE-listed U.S. company must have an audit committee that satisfies the requirements under Section 303A of the NYSE Listed Company Manual, including those imposed by Rule
10A-3
under the U.S. Securities Exchange Act of 1934. The audit committee must be composed entirely of independent directors and have at least three members.
|
|
The Company has an Audit Committee consisting of three Directors, two of whom are outside directors in compliance with the requirements under the Companies Act. All three Audit Committee members are independent directors under Rule
10A-3
under the U.S. Securities Exchange Act of 1934 with one member qualified as audit committee financial expert.
|
|
|
|
|
|
A NYSE-listed U.S. company must have a nominating/corporate governance committee with responsibilities described under Section 303A of the NYSE Listed Company Manual. The nominating/corporate governance committee must be composed entirely of independent directors.
|
|
The Company has a Nomination Committee in compliance with the requirements under the Companies Act, consisting of three Directors, two of whom are outside directors. Further, the Company appoints an outside director as the chairman of the Committee.
|
|
|
|
|
|
A NYSE-listed U.S. company must have a compensation committee composed entirely of independent directors. Compensation committee members must satisfy the additional independence requirements under Section 303A.02(a)(ii) of the NYSE Listed Company Manual. A compensation committee must also have authority to retain or obtain the advice of compensation and other advisers, subject to prescribed independence criteria that the committee must consider prior to engaging any such adviser.
|
|
The Company has a Compensation Committee in compliance with the requirements under the Companies Act, consisting of three Directors, two of whom are outside directors. Further, the Company appoints an outside director as the chairman of the Committee.
|
|
|
|
|
|
A NYSE-listed U.S. company must generally obtain shareholder approval with respect to any equity compensation plan.
|
|
Under the Companies Act, companies with three Board Committees are not required to obtain shareholder approval with respect to compensation of Directors and Executive Officers, including RSUs and PSUs. The Company’s Compensation Committee establishes policies, based on which individual compensation for Directors and Executive Officers is determined, and the Company’s Human Resources Committee establishes policies for determining compensation for officers and employees other than the Company’s Directors and Executive Officers. Additionally, under the Companies Act, shares granted in connection with RSUs and PSUs do not require shareholder approval unless offered at a favorable price.
|
|
|
|
|
|
Corporate Governance Practices Followed
by NYSE-listed U.S. Companies
|
|
Corporate Governance Practices Followed by the Company
|
|
|
|
|
|
A NYSE-listed U.S. company must adopt and disclose corporate governance guidelines.
|
|
Under the Companies Act, the Company is not required to adopt and disclose corporate governance guidelines. However, in response to Japan’s Corporate Governance Code, which was incorporated into the Tokyo Stock Exchange’s Securities Listing Regulations, the Company has established and publicly disclosed the “Nomura Holdings Corporate Governance Guidelines.”
|
|
|
|
|
|
The
non-management
directors of a NYSE-listed U.S. company must meet at regularly scheduled executive sessions without management.
|
|
Under the Companies Act, outside directors of the Company are not required to meet at regularly scheduled executive sessions without management. However, in accordance with the “Nomura Holdings Corporate Governance Guidelines,” outside directors hold meetings consisting solely of outside directors in order to discuss matters such as the business and corporate governance of the Company.
|
|
|
|
|
|
A NYSE-listed U.S. company must adopt and disclose a code of business conduct and ethics for directors, officers and employees, and promptly disclose any waivers of the code for directors or executive officers.
|
|
Under the Companies Act, the Company is not required to adopt and disclose a code of business conduct and ethics for directors, officers or employees. However, the Company has adopted the “Nomura Group Code of Conduct”. Please see Item 16B of this annual report for further information regarding the “Nomura Group Code of Conduct.”
|
|
|
|
|
|
Exhibit
Number
|
|
Description
|
|
1.1
|
|
Articles of Incorporation of Nomura Holdings, Inc. (English translation) (filed on June 24, 2022 as an exhibit to the Annual Report on Form
20-F
(File
No. 001-15270)
and incorporated herein by reference)
|
|
|
|
|
|
1.2
|
|
Share Handling Regulations of Nomura Holdings, Inc. (English translation) (filed on June 28, 2023 as an exhibit to the Annual Report on Form
20-F
(File
No. 001-15270)
and incorporated herein by reference)
|
|
|
|
|
|
1.3
|
|
Regulations of the Board of Directors of Nomura Holdings, Inc. (English translation) (filed on June 24, 2022 as an exhibit to the Annual Report on Form
20-F
(File
No. 001-15270)
and incorporated herein by reference)
|
|
|
|
|
|
1.4
|
|
Regulations of the Nomination Committee of Nomura Holdings, Inc. (English translation) (filed on June 23, 2016 as an exhibit to the Annual Report on Form
20-F
(File
No. 001-15270)
and incorporated herein by reference)
|
|
|
|
|
|
1.5
|
|
Regulations of the Audit Committee of Nomura Holdings, Inc. (English translation) (filed on June 24, 2022 as an exhibit to the Annual Report on Form
20-F
(File
No. 001-15270)
and incorporated herein by reference)
|
|
|
|
|
|
1.6
|
|
Regulations of the Compensation Committee of Nomura Holdings, Inc. (English translation) (filed on June 27, 2012 as an exhibit to the Annual Report on Form
20-F
(File
No. 001-15270)
and incorporated herein by reference)
|
|
|
|
|
|
2.1
|
|
Form of Deposit Agreement among Nomura Holdings, Inc., The Bank of New York Mellon as depositary and all owners and holders from time to time of American Depositary Receipts, including the form of American Depositary Receipt (filed on June 11, 2024 as an exhibit to the Registration Statement on Form
F-6
(File
No. 333-280111)
and incorporated herein by reference)
|
|
|
|
|
|
2.2
|
|
Description of rights of each class of securities registered under Section 12 of the Securities Exchange Act of 1934 (filed on June 24, 2022 as an exhibit to the Annual Report on Form
20-F
(File
No. 001-15270)
and incorporated herein by reference)
|
|
|
|
|
|
4.1
|
|
Form of Limitation of Liability Agreement
(1)
|
|
|
|
|
|
8.1
|
|
Subsidiaries of Nomura Holdings, Inc.—See Item 4.C. “
Organizational Structure
|
|
|
|
|
|
11.1
|
|
Nomura Group Code of Conduct (English translation)
|
|
|
|
|
|
11.2
|
|
Nomura Group Code of Ethics for Financial Professionals (English translation) (filed on June 30, 2020 as an exhibit to the Annual Report on Form
20-F
(File
No. 001-15270)
and incorporated herein by reference)
|
|
Exhibit
Number
|
Description
|
|
| 11.3 |
Rules on Trading, etc. of Nomura Holdings Stocks, etc. by Nomura Group’s Officers and Employees (English translation)
|
|
| 11.4 |
Nomura Group Personal Account Dealing Policy (English translation)
|
|
| 12.1 |
Certification of the principal executive officer required by 17 C.F.R. 240.
13a-14(a)
|
|
| 12.2 |
Certification of the principal financial officer required by 17 C.F.R. 240.
13a-14(a)
|
|
| 13.1 |
Certification of the chief executive officer required by 18 U.S.C. Section 1350
|
|
| 13.2 |
Certification of the chief financial officer required by 18 U.S.C. Section 1350
|
|
| 15.1 |
Consent of Ernst & Young ShinNihon LLC, an independent registered public accounting firm
|
|
| 17.1 |
Subsidiary Issuer of Registered Guaranteed Securities
|
|
| 97.1 |
Nomura Holdings, Inc. Compensation Recovery Policy
|
|
| 101.INS |
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
|
| 101.SCH |
Inline XBRL Taxonomy Extension Schema Document
|
|
| 101.CAL |
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
|
| 101.DEF |
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
|
| 101.LAB |
Inline XBRL Taxonomy Extension Label Linkbase Document
|
|
| 101.PRE |
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
|
| 104 |
The cover page for the Company’s Annual Report on Form
20-F
for the year ended March 31, 2023, has been formatted in Inline XBRL
|
|
|
(1)
|
The Company has entered into Limitation of Liability Agreements substantially in the form of this exhibit with all of its outside directors and director Shoji Ogawa.
|
|
Page
|
||||
|
Consolidated Financial Statements of Nomura Holdings, Inc.:
|
||||
|
F-2
|
||||
|
F-
5
|
||||
|
F-
8
|
||||
|
F-
9
|
||||
|
F-1
0
|
||||
|
F-1
2
|
||||
|
F-1
4
|
||||
|
|
|
|
|
|
|
Fair value of less liquid financial instruments
|
|
|
|
|
|
Description of the Matter
|
|
The Company holds financial instruments for trading, customer facilitation and investment purposes. As disclosed in Note 2 to the consolidated financial statements as of March 31, 2024, the Company had ¥1,296 billion and ¥812 billion of financial instrument assets and liabilities recorded at their fair value on a recurring basis, respectively, categorized within Level 3 of the fair value hierarchy. In determining the fair value of these financial instruments, the Company used valuation models and unobservable inputs which reflect its assumptions and specific data. These inputs are significant to the fair value of the financial instruments and are supported by little or no market activity as of March 31, 2024. The valuation techniques applied by management to determine the fair value of such instruments are described in Note 2 to the consolidated financial statements.
Auditing the fair value of the Company’s Level 3 financial instruments was complex and highly judgmental due to the subjectivity of the judgments used and estimations made by management in determining the fair value for these financial instruments. In particular, to value certain financial instruments, management used a variety of valuation techniques which involved certain underlying valuation assumptions and significant unobservable inputs, including weighted average cost of capital, growth rates, volatilities, correlations, credit spreads, recovery rates, loss severities, prepayment rates, default probabilities and yields.
|
|
|
|
|
|
How We Addressed
the Matter in Our
Audit
|
|
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls relating to the valuation models and significant unobservable inputs used in fair value measurement. This included the testing of model validation controls by various departments within the Company.
Our audit procedures to evaluate the valuation techniques used by the Company included, among others, testing valuation models and significant unobservable inputs. For certain of these financial instruments, we independently developed fair value estimates for which we involved our valuation specialists to assist with the application of these procedures and compared them to the Company’s results, on a sample basis. We also agreed significant unobservable inputs and underlying data used in the Company’s valuation models to information available from third party sources and market data, where available. We evaluated subsequent transactions and considered whether they corroborate or contradict the Company’s
year-end
valuations.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||
|
|
|
March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
ASSETS
|
|
|
|
|
|
|
|
|
|
Cash and cash deposits:
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
¥ |
|
¥ |
|
||||
|
Time deposits
|
|
|
||||||
|
Deposits with stock exchanges and other segregated cash
|
|
|
||||||
|
|
|
|
|
|||||
|
Total cash and cash deposits
|
|
|
||||||
|
|
|
|
|
|||||
|
Loans and receivables:
|
||||||||
|
Loans receivable (includes ¥
option
)
|
|
|
||||||
|
Receivables from customers (includes ¥
option
)
|
|
|
||||||
|
Receivables from other than customers
|
|
|
||||||
|
Allowance for credit losses
|
(
|
) |
(
|
)
|
||||
|
|
|
|
|
|||||
|
Total loans and receivables
|
|
|
||||||
|
|
|
|
|
|||||
|
Collateralized agreements:
|
||||||||
|
Securities purchased under agreements to resell (includes ¥
option
)
|
|
|
||||||
|
Securities borrowed
|
|
|
||||||
|
|
|
|
|
|||||
|
Total collateralized agreements
|
|
|
||||||
|
|
|
|
|
|||||
|
Trading assets and private equity and debt investments:
|
||||||||
|
Trading assets (includes assets pledged of ¥
option
)
|
|
|
||||||
|
Private equity and debt investments (includes ¥
option
)
|
|
|
||||||
|
|
|
|
|
|||||
|
Total trading assets and private equity and debt investments
|
|
|
||||||
|
|
|
|
|
|||||
|
Other assets:
|
||||||||
|
Office buildings, land, equipment and facilities (net of accumulated depreciation and amortization of ¥
|
|
|
||||||
|
Non-trading
debt securities
|
|
|
||||||
|
Investments in equity securities (includes assets pledged of ¥
|
|
|
||||||
|
Investments in and advances to affiliated companies (includes assets pledged of ¥
; includes ¥
)
|
|
|
||||||
|
Other (includes ¥
option
)
|
|
|
||||||
|
|
|
|
|
|||||
|
Total other assets
|
|
|
||||||
|
|
|
|
|
|||||
|
Total assets
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||
|
|
|
March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
LIABILITIES AND EQUITY
|
|
|
|
|
|
|
|
|
|
Short-term borrowings (includes ¥
option
)
|
¥ |
|
¥ |
|
||||
|
Payables and deposits:
|
||||||||
|
Payables to customers
|
|
|
||||||
|
Payables to other than customers
|
|
|
||||||
|
Deposits received at banks (includes ¥
option
)
|
|
|
||||||
|
|
|
|
|
|||||
|
Total payables and deposits
|
|
|
||||||
|
|
|
|
|
|||||
|
Collateralized financing:
|
||||||||
|
Securities sold under agreements to repurchase (includes ¥
option
)
|
|
|
||||||
|
Securities loaned (includes ¥
option
)
|
|
|
||||||
|
Other secured borrowings
|
|
|
||||||
|
|
|
|
|
|||||
|
Total collateralized financing
|
|
|
||||||
|
|
|
|
|
|||||
|
Trading liabilities
|
|
|
||||||
|
Other liabilities (includes ¥
option
)
|
|
|
||||||
|
Long-term borrowings (includes ¥
option
)
|
|
|
||||||
|
|
|
|
|
|||||
|
Total liabilities
|
|
|
||||||
|
|
|
|
|
|||||
|
Commitments and contingencies (Note 19)
|
|
|
||||||
|
Equity:
|
||||||||
|
Nomura Holdings, Inc. (“NHI”) shareholders’ equity:
|
||||||||
|
Common stock
|
||||||||
|
No par value shares;
Authorized— Issued—
and
shares
Outstanding— |
|
|
||||||
|
Additional
paid-in
capital
|
|
|
||||||
|
Retained earnings
|
|
|
||||||
|
Accumulated other comprehensive income
|
|
|
||||||
|
|
|
|
|
|||||
|
Total NHI shareholders’ equity before treasury stock
|
|
|
||||||
|
Common stock held in treasury, at cost—
|
(
|
) |
(
|
)
|
||||
|
|
|
|
|
|||||
|
Total NHI shareholders’ equity
|
|
|
||||||
|
|
|
|
|
|||||
|
Noncontrolling interests
|
|
|
||||||
|
Total equity
|
|
|
||||||
|
|
|
|
|
|||||
|
Total liabilities and equity
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
Billions of yen
|
||||||||
|
March 31
|
||||||||
|
2023
|
2024
|
|||||||
|
Cash and cash deposits
|
¥ |
|
¥ |
|
||||
|
Trading assets and private equity and debt investments
|
|
|
||||||
|
Other assets
|
|
|
||||||
|
|
|
|
|
|||||
|
Total assets
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
Trading liabilities
|
¥ |
|
¥ |
|
||||
|
Other liabilities
|
|
|
||||||
|
Borrowings
|
|
|
||||||
|
|
|
|
|
|||||
|
Total liabilities
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
Millions of yen
|
||||||||||||
|
Year ended March 31
|
||||||||||||
|
2022
|
2023
|
2024
|
||||||||||
|
Revenue:
|
||||||||||||
|
Commissions
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Fees from investment banking
|
|
|
|
|||||||||
|
Asset management and portfolio service fees
|
|
|
|
|||||||||
|
Net gain on trading
|
|
|
|
|||||||||
|
Gain on private equity and debt investments
|
|
|
|
|||||||||
|
Interest and dividends
|
|
|
|
|||||||||
|
Gain (loss) on investments in equity securities
|
|
(
|
) |
|
||||||||
|
Other
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total revenue
|
|
|
|
|||||||||
|
Interest expense
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Net revenue
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Non-interest
expenses:
|
||||||||||||
|
Compensation and benefits
|
|
|
|
|||||||||
|
Commissions and floor brokerage
|
|
|
|
|||||||||
|
Information processing and communications
|
|
|
|
|||||||||
|
Occupancy and related depreciation
|
|
|
|
|||||||||
|
Business development expenses
|
|
|
|
|||||||||
|
Other
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total
non-interest
expenses
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Income before income taxes
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Income tax expense
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Net income
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Less: Net income (loss) attributable to noncontrolling interests
|
|
(
|
) |
|
||||||||
|
|
|
|
|
|
|
|||||||
|
Net income attributable to NHI shareholders
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Yen
|
||||||||||||
|
Per share of common stock:
|
||||||||||||
|
Basic
—
|
||||||||||||
|
Net income attributable to NHI shareholders per share
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Diluted
—
|
||||||||||||
|
Net income attributable to NHI shareholders per share
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Net income
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Other comprehensive income (loss):
|
||||||||||||
|
Change in cumulative translation adjustments:
|
||||||||||||
|
Change in cumulative translation adjustments
|
|
|
|
|||||||||
|
Deferred income taxes
|
(
|
) |
(
|
) |
(
|
)
|
||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Defined benefit pension plans:
|
||||||||||||
|
Pension liability adjustment
|
(
|
) |
|
|
||||||||
|
Deferred income taxes
|
|
(
|
) |
(
|
) | |||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
(
|
) |
|
|
||||||||
|
|
|
|
|
|
|
|||||||
|
Own credit adjustments:
|
||||||||||||
|
Own credit adjustments
|
|
|
(
|
) | ||||||||
|
Deferred income taxes
|
(
|
) |
(
|
) |
|
|||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
|
|
(
|
) | ||||||||
|
|
|
|
|
|
|
|||||||
|
Total other comprehensive income
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Comprehensive income
|
|
|
|
|||||||||
|
Less: Comprehensive income (loss) attributable to noncontrolling interests
|
|
(
|
) |
|
||||||||
|
|
|
|
|
|
|
|||||||
|
Comprehensive income attributable to NHI shareholders
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Common stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at beginning of year
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Balance at end of year
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Additional
paid-in
capital
|
||||||||||||
|
Balance at beginning of year
|
|
|
|
|||||||||
|
Stock-based compensation awards
|
|
|
|
|||||||||
|
Changes in ownership interests in subsidiaries
|
|
|
|
|
||||||||
|
Changes in an affiliated company’s interests
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
|
|
|
|
|
|
|||||||
|
Balance at end of year
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Retained earnings
|
||||||||||||
|
Balance at beginning of year
|
|
|
|
|||||||||
|
Net income attributable to NHI shareholders
|
|
|
|
|||||||||
|
Cash dividends
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
L
oss on sales of treasury stock
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
Cancellation of treasury stock
|
|
|
(
|
) | ||||||||
|
|
|
|
|
|
|
|||||||
|
Balance at end of year
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Accumulated other comprehensive income (loss)
|
||||||||||||
|
Cumulative translation adjustments
|
||||||||||||
|
Balance at beginning of year
|
|
|
|
|||||||||
|
Net change during the year
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Balance at end of year
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Defined benefit pension plans
|
||||||||||||
|
Balance at beginning of year
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
Pension liability adjustment
|
(
|
) |
|
|
||||||||
|
|
|
|
|
|
|
|||||||
|
Balance at end of year
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
|
|
|
|
|
|
|||||||
|
Own credit adjustments
|
||||||||||||
|
Balance at beginning of year
|
(
|
) |
|
|
||||||||
|
Own credit adjustments
|
|
|
(
|
) | ||||||||
|
|
|
|
|
|
|
|||||||
|
Balance at end of year
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Balance at end of year
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Common stock held in treasury
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at beginning of year
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
Repurchases of common stock
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
Sales of common stock
|
|
|
|
|||||||||
|
Common stock issued to employees
|
|
|
|
|||||||||
|
Cancellation of treasury stock
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Balance at end of year
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
|
|
|
|
|
|
|||||||
|
Total NHI shareholders’ equity
|
||||||||||||
|
Balance at end of year
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Noncontrolling interests
(1)
|
||||||||||||
|
Balance at beginning of year
|
|
|
|
|||||||||
|
Cash dividends
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
Net income (loss) attributable to noncontrolling interests
|
|
(
|
) |
|
||||||||
|
Accumulated other comprehensive income attributable to noncontrolling interests
|
||||||||||||
|
Cumulative translation adjustments
|
|
|
|
|||||||||
|
Transaction between NHI group and noncontrolling interest holders, net
|
|
|
|
|||||||||
|
Other net change in noncontrolling interests
|
(
|
) |
(
|
) |
|
|||||||
|
|
|
|
|
|
|
|||||||
|
Balance at end of year
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total equity
|
||||||||||||
|
Balance at end of year
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
| (1) |
Certain reclassifications of previously reported amounts have been made to conform to the current period presentation.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
|
|
|
|||||||||
|
Depreciation and amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for credit losses
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
Stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Gain) loss on investments in equity securities
|
|
|
(
|
)
|
|
|
|
|
|
|
(
|
)
|
|
Gain on investments in subsidiaries and affiliates
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Equity in earnings of affiliates, net of dividends received
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
(Gain) loss on disposal of office buildings, land, equipment and facilities
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
Deferred income taxes
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
Changes in operating assets and liabilities:
|
|
|
|
|||||||||
|
Deposits with stock exchanges and other segregated cash
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
Trading assets and private equity and debt investments
|
|
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Trading liabilities
|
|
|
(
|
)
|
|
|
|
|
|
|
(
|
)
|
|
Securities purchased under agreements to resell, net of securities sold under agreements to repurchase
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
Securities borrowed, net of securities loaned
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
Margin loans and receivables
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
Payables
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
Bonus accrual
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
Accrued income taxes, net
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
Other, net
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) operating activities
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|||||||||
|
Payments for placements of time deposits
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Proceeds from redemption or maturity of time deposits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments for purchases of office buildings, land, equipment and facilities
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Proceeds from sales of office buildings, land, equipment and facilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments for purchases of equity investments
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Proceeds from sales of equity investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash outflows from loans receivable at banks
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Payments for purchases or origination of other non-trading loans
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Proceeds from sales or repayments of other non-trading loans
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash outflows from interbank money market loans
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
Payments for purchases of non-trading debt securities
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Proceeds from sales or maturity of non-trading debt securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisitions, net of cash acquired
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
Divestures, net of cash disposed of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments for purchases of investments in affiliated companies
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Proceeds from sales of investments in affiliated companies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other, net
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|||||||||
|
Proceeds from issuances of long-term borrowings
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments for repurchases or maturity of long-term borrowings
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Proceeds from issuances of short-term borrowings
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments for repurchases or maturity of short-term borrowings
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Net cash inflows (outflows) from interbank money market borrowings
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
Net cash inflows (outflows) from other secured borrowings
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
Net cash inflows from deposits received at banks
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments for withholding taxes on stock-based compensation
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Proceeds from sales of common stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments for repurchases of common stock
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Payments for cash dividends
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Contributions from noncontrolling interests
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions to noncontrolling interests
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of year
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental information:
|
|
|
|
|||||||||
|
Cash paid during the year for—
|
|
|
|
|||||||||
|
Interest
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax payments, net
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
||||||||||||
|
Year ended March 31
|
||||||||||||
|
2022
|
2023
|
2024
|
||||||||||
|
Cash and cash equivalents reported in
Cash and cash equivalents
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Restricted cash and restricted cash equivalents reported in
Deposits with stock exchanges and other segregated cash
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total cash, cash equivalent, restricted cash and restricted cash equivalents
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
|
•
|
|
The financial assets are originated or acquired with the intention to generate profit through sale in the short-term;
|
|
|
•
|
|
The financial assets are part of a portfolio of identified financial instruments that are managed together for the purposes of short-term profit or arbitrage profit-taking; or
|
|
|
•
|
|
The financial assets are derivative assets.
|
|
|
•
|
|
Fair value hedges
non-trading
debt securities, respectively. These derivatives are effective in reducing the risk associated with the exposure being hedged and they are highly correlated with changes in the fair value of the underlying hedged items, both at inception and throughout the life of the hedging relationship. Changes in fair value of the hedging derivatives are reported together with those of the hedged financial assets and liabilities through the consolidated statements of income within
Interest expense
Revenue
—
Other
|
|
|
•
|
|
Net investment hedges
Revenue
—
Net gain on trading
Accumulated other comprehensive income (loss)
|
|
|
•
|
|
Economic expense hedges
|
|
|
|
|
|
|
|
Office buildings
|
|
|
|
|
|
Equipment and facilities
|
|
|
|
|
|
Software
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pronouncement
|
|
Summary of new guidance
|
|
Adoption date and
method of adoption
|
|
Effect on these
consolidated financial statements |
|
ASU
2022-02
“Financial instruments – Credit losses (Topic 326): Troubled debt restructurings and vintage disclosures”
|
|
• Eliminates specific recognition and measurement guidance for troubled debt restructurings (“TDRs”). Single guidance to be applied to all modifications when determining whether a modification results in a new receivable or a continuation of an existing receivable.
• Requires to use a discounted cash flow (“DCF”) or reconcilable method for measurement of current expected credit losses for modified receivables is removed; where a DCF method is used for the measurement, an effective interest rate (EIR) derived from the modified contractual terms should be applied.
• Enhances disclosures by creditors for modifications of receivables from debtors experiencing financial difficulty in the form of principal forgiveness, an interest rate reduction, other-than-insignificant payment delay or term extension.
|
|
Nomura has adopted the amendments prospectively from April 1, 2023.
|
|
No material financial impact on initial adoption and since adoption.
See Note 7. “
Financing receivables
|
|
|
|
|
|
|
|
|
|
Pronouncement
|
|
Summary of new guidance
|
|
Adoption date and
method of adoption
|
|
Effect on these
consolidated financial statements |
|
|
|
• Augments the current requirements for public business entity creditors to disclose current-period gross write-offs by year of origination (i.e., the vintage year) for financing receivables and net investments in leases.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pronouncement
|
|
Summary of new guidance
|
|
Expected adoption
date and method of adoption |
|
Effect on these
consolidated financial
statements
|
|
ASU
2022-03
“Fair value measurement (Topic 820)”
|
|
• Clarifies that a contractual sale restriction is an entity-specific characteristic and therefore should not be considered in the fair value measurement of an equity security.
• Enhances disclosures for fair value of investments in equity securities subject to contractual sale restrictions, nature and remaining duration of the restrictions and circumstances that could cause a lapse in the restrictions.
|
|
Nomura will adopt the amendments prospectively from April 1, 2024.
|
|
No material financial impact expected.
|
|
|
|
|
|
|||
|
ASU
2023-07
“Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”
|
|
• Enhances segment reporting by introducing incremental interim and annual disclosure requirements for more disaggregated expense information about a public entity’s reportable segments and expanding frequency of existing segment disclosures.
• Requires annual disclosures of information about the chief operating decision maker.
• Clarifies circumstances where disclosure of more than one measure of a segment’s profit or loss are permitted.
|
|
Nomura currently plans to adopt the amendments retrospectively from March 31, 2025.
|
|
No material financial impact expected.
|
|
|
|
|
|
|||
|
ASU
2023-08
“Intangibles—Goodwill and Other—Crypto Assets
(Subtopic 350-60):
Accounting for and Disclosure of Crypto Assets”
|
|
• Requires all
in-scope
crypto assets be subsequently measured at fair value at each reporting period through earnings.
• Presentation of
in-scope
crypto assets in the financial statements to be shown separately from other intangible assets.
|
|
Nomura currently plans to adopt the amendments based on a modified retrospective approach from April 1, 2025.
|
|
No material financial impact expected.
|
|
|
|
|
|
|
|
|
|
Pronouncement
|
|
Summary of new guidance
|
|
Expected adoption
date and method of adoption |
|
Effect on these
consolidated financial
statements
|
|
|
|
• Introduces new disclosure requirements for
in-scope
crypto assets applicable to all entities.
|
|
|
|
|
|
|
|
|
|
|||
|
ASU
2023-09
“Income Taxes (Topic 740): Improvements to Income Tax Disclosures”
|
|
• Introduces incremental annual disclosures for disaggregated information about an entity’s effective tax rate reconciliation and information on income taxes paid.
• Removes certain existing disclosure requirements in relation to unrecognized tax benefits and temporary differences for which a deferred tax liability is not recognized.
|
|
Nomura currently plans to adopt the amendments prospectively from April 1, 2025.
|
|
No material financial impact expected.
|
|
Billions of yen
|
||||||||||||||||||||
|
March 31, 2023
|
||||||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Counterparty
and
Cash Collateral
Netting
(1)
|
Balance as of
March 31, 2023
|
||||||||||||||||
|
Assets:
|
||||||||||||||||||||
|
Trading assets and private equity and debt investments
(2)
|
||||||||||||||||||||
|
Equities
(3)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Private equity and debt investments
(5)
|
|
|
|
|
|
|||||||||||||||
|
Japanese government securities
|
|
|
|
|
|
|||||||||||||||
|
Japanese agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
|
Foreign government, agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
|
Bank and corporate debt securities and loans for trading purposes
|
|
|
|
|
|
|||||||||||||||
|
Commercial mortgage-backed securities (“CMBS”)
|
|
|
|
|
|
|||||||||||||||
|
Residential mortgage-backed securities (“RMBS”)
|
|
|
|
|
|
|||||||||||||||
|
Issued/Guaranteed by government sponsored entity
|
|
|
|
|
|
|||||||||||||||
|
Other
|
|
|
|
|
|
|||||||||||||||
|
Real estate-backed securities
|
|
|
|
|
|
|||||||||||||||
|
Collateralized debt obligations (“CDOs”) and other
(6)
|
|
|
|
|
|
|||||||||||||||
|
Investment trust funds and other
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total trading assets and private equity and debt investments
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Derivative assets
(7)
|
||||||||||||||||||||
|
Equity contracts
|
|
|
|
|
|
|||||||||||||||
|
Interest rate contracts
|
|
|
|
|
|
|||||||||||||||
|
Credit contracts
|
|
|
|
|
|
|||||||||||||||
|
Foreign exchange contracts
|
|
|
|
|
|
|||||||||||||||
|
Commodity contracts
|
|
|
|
|
|
|||||||||||||||
|
Netting
|
|
|
|
(
|
) |
(
|
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total derivative assets
|
|
|
|
(
|
) |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Subtotal
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Loans and receivables
(8)
|
|
|
|
|
|
|||||||||||||||
|
Collateralized agreements
(9)
|
|
|
|
|
|
|||||||||||||||
|
Other assets
(2)
|
||||||||||||||||||||
|
Non-trading
debt securities
|
|
|
|
|
|
|||||||||||||||
|
Other
(3)(4)
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Liabilities:
|
||||||||||||||||||||
|
Trading liabilities
|
||||||||||||||||||||
|
Equities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Japanese government securities
|
|
|
|
|
|
|||||||||||||||
|
Japanese agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
|
Foreign government, agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
|
Bank and corporate debt securities
|
|
|
|
|
|
|||||||||||||||
|
Residential mortgage-backed securities (“RMBS”)
|
|
|
|
|
|
|||||||||||||||
|
Investment trust funds and other
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total trading liabilities
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Derivative liabilities
(7)
|
||||||||||||||||||||
|
Equity contracts
|
|
|
|
|
|
|||||||||||||||
|
Interest rate contracts
|
|
|
|
|
|
|||||||||||||||
|
Credit contracts
|
|
|
|
|
|
|||||||||||||||
|
Foreign exchange contracts
|
|
|
|
|
|
|||||||||||||||
|
Commodity contracts
|
|
|
|
|
|
|||||||||||||||
|
Netting
|
|
|
|
(
|
) |
(
|
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total derivative liabilities
|
|
|
|
(
|
) |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Subtotal
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Short-term borrowings
(11)
|
¥
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|||||||||||
|
Payables and deposits
(10)(12)
|
|
|
|
|
|
|||||||||||||||
|
Collateralized financing
(9)
|
|
|
|
|
|
|||||||||||||||
|
Long-term borrowings
(11)(13)(14)
|
|
|
|
|
|
|||||||||||||||
|
Other liabilities
(15)
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
|||||||||||||||||
|
|
March 31, 2024
|
|
||||||||||||||||||
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Counterparty
and
Cash Collateral
Netting
(1)
|
|
|
Balance as of
March 31, 2024
|
|
||||||
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading assets and private equity and debt investments
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equities
(3)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Private equity and debt investments
(5)
|
|
|
|
|
|
|||||||||||||||
|
Japanese government securities
|
|
|
|
|
|
|||||||||||||||
|
Japanese agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
|
Foreign government, agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
|
Bank and corporate debt securities and loans for trading purposes
|
|
|
|
|
|
|||||||||||||||
|
Commercial mortgage-backed securities (“CMBS”)
|
|
|
|
|
|
|||||||||||||||
|
Residential mortgage-backed securities (“RMBS”)
|
|
|
|
|
|
|||||||||||||||
|
Issued/Guaranteed by government sponsored entity
|
|
|
|
|
|
|||||||||||||||
|
Other
|
|
|
|
|
|
|||||||||||||||
|
Real estate-backed securities
|
|
|
|
|
|
|||||||||||||||
|
Collateralized debt obligations (“CDOs”) and other
(6)
|
|
|
|
|
|
|||||||||||||||
|
Investment trust funds and other
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total trading assets and private equity and debt investments
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Derivative assets
(7)
|
||||||||||||||||||||
|
Equity contracts
|
|
|
|
|
|
|||||||||||||||
|
Interest rate contracts
|
|
|
|
|
|
|||||||||||||||
|
Credit contracts
|
|
|
|
|
|
|||||||||||||||
|
Foreign exchange contracts
|
|
|
|
|
|
|||||||||||||||
|
Commodity contracts
|
|
|
|
|
|
|||||||||||||||
|
Netting
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total derivative assets
|
|
|
|
(
|
) |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Subtotal
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Loans and receivables
(8)
|
|
|
|
|
|
|||||||||||||||
|
Collateralized agreements
(9)
|
|
|
|
|
|
|||||||||||||||
|
Other assets
(2)
|
||||||||||||||||||||
|
Non-trading
debt securities
|
|
|
|
|
|
|||||||||||||||
|
Other
(3)(4)
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Liabilities:
|
||||||||||||||||||||
|
Trading liabilities
|
||||||||||||||||||||
|
Equities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Japanese government securities
|
|
|
|
|
|
|||||||||||||||
|
Japanese agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
|
Foreign government, agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
|
Bank and corporate debt securities
|
|
|
|
|
|
|||||||||||||||
|
Residential mortgage-backed securities (“RMBS”)
|
|
|
|
|
|
|||||||||||||||
|
Investment trust funds and other
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total trading liabilities
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Derivative liabilities
(7)
|
||||||||||||||||||||
|
Equity contracts
|
|
|
|
|
|
|||||||||||||||
|
Interest rate contracts
|
|
|
|
|
|
|||||||||||||||
|
Credit contracts
|
|
|
|
|
|
|||||||||||||||
|
Foreign exchange contracts
|
|
|
|
|
|
|||||||||||||||
|
Commodity contracts
|
|
|
|
|
|
|||||||||||||||
|
Netting
|
|
|
|
(
|
) |
(
|
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total derivative liabilities
|
|
|
|
(
|
) |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Subtotal
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Short-term borrowings
(11)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Payables and deposits
(10)(12)
|
|
|
|
|
|
|||||||||||||||
|
Collateralized financing
(9)
|
|
|
|
|
|
|||||||||||||||
|
Long-term borrowings
(11)(13)(14)
|
|
|
|
|
|
|||||||||||||||
|
Other liabilities
(15)
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
(1)
|
Represents the amount offset under counterparty netting of derivative assets and liabilities as well as cash collateral netting against net derivatives assets or liabilities.
|
| (2) |
Investments that are carried at fair value using NAV per share as a practical expedient have not been classified in the fair value hierarchy. As of March 31, 2023 and March 31, 2024, the fair values of these investments which are included in
Trading assets and private equity and debt investments
Other assets—Others
|
| (3) |
Includes equity investments that would have been accounted for under the equity method had Nomura not chosen to elect the fair value option.
|
| (4) |
Includes equity investments which comprise listed and unlisted equity securities held for operating purposes in the amounts of ¥
|
| (5) |
Private equity and debt investments
include minority private equity and venture capital equity investments and other junior debt investments such as mezzanine debt held for
non-trading
purposes, and
post-IPO
investments. These investments also include equity investments that would have been accounted for under the equity method had Nomura not chosen to elect the fair value option.
|
| (6) |
Includes collateralized loan obligations (“CLOs”) and asset-backed securities (“ABS”) such as those secured on credit card loans, auto loans and student loans.
|
| (7) |
Derivatives which contain multiple types of risk are classified based on the primary risk type of the instrument.
|
| (8) |
Includes loans and receivables for which the fair value option has been elected.
|
| (9) |
Includes collateralized agreements or collateralized financing for which the fair value option has been elected.
|
| (10) |
Includes deposits received at banks for which the fair value option has been elected.
|
| (11) |
Includes structured notes for which the fair value option has been elected.
|
| (12) |
Includes embedded derivatives bifurcated from deposits received at banks. Deposits are adjusted for fair value changes in corresponding embedded derivatives for presentation in the consolidated balance sheets.
|
| (13) |
Includes embedded derivatives bifurcated from issued structured notes. Structured notes are adjusted for fair value changes in corresponding embedded derivatives for presentation in the consolidated balance sheets
|
| (14) |
Includes liabilities recognized from secured financing transactions that are accounted for as financings rather than sales. Nomura elected the fair value option for these liabilities.
|
| (15) |
Includes loan commitments for which the fair value option has been elected.
|
|
March 31, 2023
|
||||||||||||||||
|
Financial Instrument
|
Fair
value in billions of yen |
Valuation
technique
|
Significant
unobservable
valuation input |
Range of
valuation
inputs
(1)
|
Weighted
Average
(2)(3)
|
Impact of
increases in significant unobservable valuation
inputs
(4)(5)
|
Interrelationships
between valuation
inputs
(6)
|
|||||||||
|
Assets:
|
||||||||||||||||
|
Trading assets and private equity and debt investments
|
||||||||||||||||
|
Equities
|
¥ |
|
DCF | Liquidity discounts |
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Private equity and debt investments
|
|
|
|
DCF
|
WACC
Growth rates
Credit spreads
Liquidity discounts
|
0.0
–
|
|
|
|
|||||||
|
|
|
|
|
|
|
|||||||||||
| Market multiples | EV/EBITDA ratios |
|
|
|
|
|||||||||||
| PE Ratios |
|
|
|
|||||||||||||
| Liquidity discounts |
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Foreign government, agency and municipal securities
|
|
|
|
DCF
|
Credit spreads
Recovery rates
|
0.0
–
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Bank and corporate debt securities and loans for trading purposes
|
|
|
|
DCF
|
Credit spreads
Recovery rates
|
0.0
–
0.0
–
|
|
|
|
|||||||
|
March 31, 2023
|
||||||||||||||||
|
Financial Instrument
|
Fair
value in billions of yen |
Valuation
technique
|
Significant
unobservable
valuation input |
Range of
valuation
inputs
(1)
|
Weighted
Average
(2)(3)
|
Impact of
increases in significant unobservable valuation
inputs
(4)(5)
|
Interrelationships
between valuation
inputs
(6)
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential mortgage backed securities (“RMBS”)
|
|
|
|
DCF
|
Yields
Prepayment rates
Loss severities
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Real estate-backed securities
|
|
|
|
DCF
|
Loss severities
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Collateralized debt obligations (“CDOs”) and other
|
|
|
|
DCF
|
Yields
Prepayment rates
Default probabilities
Loss severities
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Investment trust funds and other
|
|
|
|
DCF
|
Liquidity discounts
|
0.0
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Derivatives, net:
|
||||||||||||||||
|
Equity contracts
|
¥ |
|
Option models |
Dividend yield
Volatilities
Correlations
|
0.0
(
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Interest rate contracts
|
|
|
|
DCF/
Option models
|
Interest rates Volatilities Volatilities Correlations
|
(
.00
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Credit contracts
|
(
|
DCF/
Option models
|
Credit spreads Recovery rates Volatilities Correlations |
0.0
0
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Foreign exchange contracts
|
|
|
|
Option models
|
Volatilities Correlations
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Loans and receivables
|
|
|
|
DCF
|
Credit spreads Recovery rates
|
0.0
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Collateralized agreements
|
|
|
|
DCF
|
Repo rate
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Other assets
|
||||||||||||||||
|
Non-trading
debt securities
|
|
|
|
DCF
|
Credit spreads
|
0.0
|
0.0
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Other
(7)
|
|
DCF |
WACC
Growth rates
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Market multiples |
EV/EBITDA ratios
PE Ratios
Price/Book ratios
Liquidity discounts
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2023
|
||||||||||||||
|
Financial Instrument
|
|
Fair
value in billions of yen |
|
|
Valuation
technique
|
|
Significant
unobservable
valuation input |
|
Range of
valuation
inputs
(1)
|
|
Weighted
Average
(2)(3)
|
|
Impact of
increases in significant unobservable valuation
inputs
(4)(5)
|
|
Interrelationships
between valuation
inputs
(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|||||||||||||||
|
Trading Liabilities
|
||||||||||||||||
|
Bank and corporate debt securities
|
|
|
|
DCF
|
Recovery rates
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Short-term borrowings
|
|
|
|
DCF/
Option models
|
Volatilities Correlations
|
(
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Payable and deposits
|
|
DCF/ Option models | Volatilities Correlations |
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Long-term borrowings
|
|
|
|
DCF
|
Loss severities
|
0.0
|
|
|
|
|||||||
|
|
|
|
|
|
|
|||||||||||
|
DCF/
Option models
|
Volatilities Volatilities Correlations |
(
|
|
Higher
fair value
Higher fair
value
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Other liabilities
|
|
DCF | Recovery rates |
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
March 31, 2024
|
||||||||||||||||
|
Financial Instrument
|
Fair
value in billions of yen |
Valuation
technique
|
Significant
unobservable
valuation input |
Range of
valuation
inputs
(1)
|
Weighted
Average
(2)(3)
|
Impact of
increases in significant unobservable valuation
inputs
(4)(5)
|
Interrelationships
between valuation
inputs
(6)
|
|||||||||
|
Assets:
|
||||||||||||||||
|
Trading assets and private equity and debt investments
|
||||||||||||||||
|
Equities
|
¥ |
|
DCF | Liquidity discounts |
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Private equity and debt investments
|
|
|
|
DCF
|
WACC
Growth rates
Credit spreads
Liquidity discounts
|
0.0
|
|
|
|
|||||||
|
|
|
|
|
|
|
|||||||||||
| Market multiples | EV/EBITDA ratios |
.0
x
|
|
|
|
|||||||||||
| PE Ratios |
|
|
|
|||||||||||||
| Liquidity discounts |
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Foreign government, agency and municipal securities
|
|
|
|
DCF
|
Credit spreads
Recovery rates
|
0.0
–
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bank and corporate debt securities and loans for trading purposes
|
|
|
|
DCF
|
Credit spreads Recovery rates
|
0.0
–
0.0
–
|
|
|
|
|||||||
|
March 31, 2024
|
||||||||||||||||
|
Financial Instrument
|
Fair
value in billions of yen |
Valuation
technique
|
Significant
unobservable
valuation input |
Range of
valuation
inputs
(1)
|
Weighted
Average
(2)(3)
|
Impact of
increases in significant unobservable valuation
inputs
(4)(5)
|
Interrelationships
between valuation
inputs
(6)
|
|||||||||
|
Residential mortgage backed securities (“RMBS”)
|
|
|
|
DCF
|
Yields
Prepayment rates
Loss severities
|
.0
.0
0.0
.0
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Real estate-backed securities
|
|
|
|
DCF
|
Loss severities
|
0.0
–
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Collateralized debt obligations
(“CDOs”) and other |
|
|
|
DCF
|
Yields
Prepayment rates
Default probabilities Loss severities
Credit spreads
|
.0
%
.0
%
0.0
–
.0
%
0.0
–
|
.0
%
.0
%
0.0
%
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Investment trust funds and other
|
|
|
|
DCF
|
Liquidity discounts
|
0.0
–
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Derivatives, net:
|
||||||||||||||||
|
Equity contracts
|
¥ |
|
Option models | Dividend yield Volatilities Correlations |
0.0
–
(
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Interest rate contracts
|
|
|
|
DCF/ Option models
|
Interest rates Volatilities Volatilities Correlations
|
(
.00
) –
.00
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Credit contracts
|
(
|
DCF/ Option models | Credit spreads Recovery rates Volatilities Correlations |
0.0
–
.0
%
.0
–
.0
%
.0
–
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Foreign exchange contracts
|
|
|
|
Option models
|
Volatilities Correlations
|
0
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Loans and receivables
|
|
|
|
DCF
|
Credit spreads Recovery rates
|
0.0
–
.0
%
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Collateralized agreements
|
|
DCF | Repo rate |
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Other assets
|
||||||||||||||||
|
Non-trading
debt securities
|
|
DCF | Credit spreads |
|
.0
%
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Other
(7)
|
|
DCF |
WACC
Growth rates
|
.0
%
|
.0
%
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Market multiples |
EV/EBITDA ratios PE Ratios
Price/Book ratios Liquidity discounts
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
March 31, 2024
|
||||||||||||||||
|
Financial Instrument
|
Fair
value in billions of yen |
Valuation
technique
|
Significant
unobservable
valuation input |
Range of
valuation
inputs
(1)
|
Weighted
Average
(2)(3)
|
Impact of
increases in significant unobservable valuation
inputs
(4)(5)
|
Interrelationships
between valuation
inputs
(6)
|
|||||||||
|
Liabilities:
|
||||||||||||||||
|
Short-term borrowings
|
|
|
|
DCF/
option models
|
Volatilities Correlations
|
.0
–
(
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Payable and deposits
|
|
DCF/
option models
|
Volatilities Correlations |
0
–
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Long-term borrowings
|
|
|
|
DCF
|
Loss severities
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|||||||||||
|
DCF/
Option models
|
Volatilities |
.0
–
|
|
|
|
|||||||||||
| Volatilities Correlations |
(
.00)
–
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Other liabilities
|
|
DCF | Recovery rates |
.0
–
.0
%
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| (1) |
Range information is provided in percentages, coefficients and multiples and represents the highest and lowest level significant unobservable valuation input used to value that type of financial instrument. A wide dispersion in the range does not necessarily reflect increased uncertainty or subjectivity in the valuation input and is typically just a consequence of the different characteristics of the financial instruments themselves.
|
| (2) |
Weighted average information for
non-derivatives
is calculated by weighting each valuation input by the fair value of the financial instrument.
|
| (3) |
Nomura has not provided weighted average information for derivatives as unlike cash products the risk on such products is distinct from the balance sheet value and is subject to netting.
|
| (4) |
The above table only considers the impact of an increase in each significant unobservable valuation input on the fair value measurement of the financial instrument. However, a decrease in the significant unobservable valuation input would have the opposite effect on the fair value measurement of the financial instrument. For example, if an increase in a significant unobservable valuation input would result in a lower fair value measurement, a decrease in the significant unobservable valuation input would result in a higher fair value measurement.
|
| (5) |
The impact of an increase in the significant unobservable valuation input on the fair value measurement for a derivative assumes Nomura is long risk to the input (such as being long volatility). Where Nomura is short such risk, the impact of an increase would have a converse effect on the fair value measurement of the derivative.
|
| (6) |
Consideration of the interrelationships between significant unobservable valuation inputs is only relevant where more than one unobservable valuation input is used to determine the fair value measurement of the financial instrument.
|
| (7) |
Valuation techniques and unobservable valuation inputs in respect of equity securities reported within
Other assets
|
|
Billions of yen
|
||||||||||||||||||||||||||||||||||||||||
|
Year ended March 31, 2023
|
||||||||||||||||||||||||||||||||||||||||
|
Balance
as of
April 1,
2022
|
Total gains
(losses)
recognized
in net
revenu
e
(1)
|
Total gains
(losses)
recognized in
other
comprehensive
income
|
Purchases /
issues
(2)
|
Sales /
redemptions
(2)
|
Settlements
|
Foreign
exchange
movements
|
Transfers
into
Level 3
(4)(5)
|
Transfers
out of
Level 3
(5)
|
Balance
as of
March 31,
2023
|
|||||||||||||||||||||||||||||||
|
Assets:
|
||||||||||||||||||||||||||||||||||||||||
|
Trading assets and private equity and debt investments
|
||||||||||||||||||||||||||||||||||||||||
|
Equities
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||||
|
Private equity and debt investments
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
|
Japanese agency and municipal securities
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
Foreign government, agency and municipal securities
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
|
Bank and corporate debt securities and loans for trading purposes
|
|
(
|
) |
|
|
(
|
) |
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||
|
Commercial mortgage-backed securities (“CMBS”)
|
|
|
|
|
|
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||||
|
Residential mortgage-backed securities (“RMBS”)
|
|
(
|
) |
|
|
(
|
) |
|
|
|
|
|
||||||||||||||||||||||||||||
|
Real estate-backed securities
|
|
(
|
) |
|
|
(
|
) |
|
|
|
|
|
||||||||||||||||||||||||||||
|
Collateralized debt obligations (“CDOs”) and other
|
|
(
|
) |
|
|
(
|
) |
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||
|
Investment trust funds and other
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Total trading assets and private equity and debt investments
|
|
(
|
) |
|
|
(
|
) |
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Derivatives, net
(3)
|
||||||||||||||||||||||||||||||||||||||||
|
Equity contracts
|
|
(
|
) |
|
|
|
(
|
) |
(
|
) |
|
|
|
|||||||||||||||||||||||||||
|
Interest rate contracts
|
(
|
) |
(
|
) |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||
|
Credit contracts
|
(
|
) |
|
|
|
|
(
|
) |
(
|
) |
|
(
|
) |
(
|
) | |||||||||||||||||||||||||
|
Foreign exchange contracts
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Total derivatives, net
|
(
|
) |
|
|
|
|
(
|
) |
(
|
) |
|
|
|
|||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Subtotal
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Loans and receivables
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||||
|
Collateralized agreements
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
Other assets
|
||||||||||||||||||||||||||||||||||||||||
|
Non-trading
debt securities
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
Other
|
|
(
|
) |
|
|
(
|
) |
|
|
|
|
|
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Liabilities:
|
||||||||||||||||||||||||||||||||||||||||
|
Trading liabilities
|
||||||||||||||||||||||||||||||||||||||||
|
Equities
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||||
|
Foreign government, agency and municipal securities
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
Bank and corporate debt securities
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
|
Collateralized debt obligations (“CDOs”) and other
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
|
Investment trust funds and other
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Total trading liabilities
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Short-term borrowings
|
|
(
|
) |
|
|
(
|
) |
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||
|
Payables and deposits
|
|
|
|
|
|
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||||
|
Long-term borrowings
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
|
Other liabilities
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
¥ |
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
||||||||||||||||||||||||||||||||||||||||
|
Year ended March 31, 2024
|
||||||||||||||||||||||||||||||||||||||||
|
Balance
as of
April 1,
2023
|
Total gains
(losses)
recognized
in net
revenu
e
(1)
|
Total gains
(losses)
recognized in
other
comprehensive
income
|
Purchases /
issues
(2)
|
Sales /
redemptions
(2)
|
Settlements
|
Foreign
exchange
movements
|
Transfers
into
Level 3
(4)(5)
|
Transfers
out of
Level 3
(5)
|
Balance
as of
March 31,
2024
|
|||||||||||||||||||||||||||||||
|
Assets:
|
||||||||||||||||||||||||||||||||||||||||
|
Trading assets and private equity and debt investments
|
||||||||||||||||||||||||||||||||||||||||
|
Equities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||||
|
Private equity and debt investments
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
|
Japanese agency and municipal securities
|
|
|
|
|
|
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||||
|
Foreign government, agency and municipal securities
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
|
Bank and corporate debt securities and loans for trading purposes
|
|
(
|
) |
|
|
(
|
) |
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||
|
Commercial mortgage-backed securities (“CMBS”)
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
Residential mortgage-backed securities (“RMBS”)
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
|
Real estate-backed securities
|
|
(
|
) |
|
|
(
|
) |
|
|
|
|
|
||||||||||||||||||||||||||||
|
Collateralized debt obligations (“CDOs”) and other
|
|
(
|
) |
|
|
(
|
) |
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||
|
Investment trust funds and other
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Total trading assets and private equity and debt investments
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Derivatives, net
(3)
|
||||||||||||||||||||||||||||||||||||||||
|
Equity contracts
|
|
(
|
) |
|
|
|
(
|
) |
|
|
(
|
) |
|
|||||||||||||||||||||||||||
|
Interest rate contracts
|
|
(
|
) |
|
|
|
(
|
) |
|
(
|
) |
|
|
|||||||||||||||||||||||||||
|
Credit contracts
|
(
|
)
|
(
|
) |
|
|
|
|
(
|
)
|
(
|
) |
(
|
) |
(
|
) | ||||||||||||||||||||||||
|
Foreign exchange contracts
|
|
(
|
) |
|
|
|
(
|
) |
|
|
(
|
) |
|
|||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Total derivatives, net
|
|
(
|
) |
|
|
|
(
|
) |
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Subtotal
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
)
|
¥ |
(
|
)
|
¥ |
|
¥ |
|
¥ |
(
|
)
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Loans and receivables
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||||
|
Collateralized agreements
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
|
Other assets
|
||||||||||||||||||||||||||||||||||||||||
|
Non-trading
debt securities
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
|
Other
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Liabilities:
|
||||||||||||||||||||||||||||||||||||||||
|
Trading liabilities
|
||||||||||||||||||||||||||||||||||||||||
|
Equities
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||||
|
Foreign government, agency and municipal securities
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
Bank and corporate debt securities
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
|
Collateralized debt obligations (“CDOs”) and other
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
Investment trust funds and other
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Total trading liabilities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Short-term borrowings
|
|
(
|
) |
|
|
(
|
) |
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||
|
Payables and deposits
|
|
|
|
|
|
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||||
|
Long-term borrowings
|
|
(
|
) |
(
|
) |
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||
|
Other liabilities
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Total
|
¥ |
|
¥ |
(
|
)
|
¥ |
(
|
)
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| (1) |
Includes gains and losses reported primarily within
Net gain on trading, Gain on private equity and debt investments,
Gain (loss) on investments in equity securities, Revenue
—Other
Non-interest
expenses
—Other, Interest and dividends
Interest expense
|
| (2) |
Amounts reported in
Purchases / issues
Sales / redemptions
|
| (3) |
Derivatives which contain multiple types of risk are classified based on the primary risk type of the instrument.
|
| (4) |
Amounts of gains and losses on these transfers which were recognized in the period when the
Transfers into Level
3
|
| (5) |
Transfers into Level
3
Transfers out of Level
3
Quantitative and qualitative information regarding significant unobservable valuation inputs”
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
|||||
|
|
|
March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
Unrealized gains / (losses)
(1)
|
|
|||||
|
Assets:
|
||||||||
|
Trading assets and private equity and debt investments
|
||||||||
|
Equities
|
¥ |
(
|
) | ¥ |
|
|||
|
Private equity and debt investments
|
|
|
||||||
|
Japanese agency and municipal securities
|
|
|
||||||
|
Foreign government, agency and municipal securities
|
(
|
) |
|
|||||
|
Bank and corporate debt securities and loans for trading purposes
|
|
(
|
) | |||||
|
Commercial mortgage-backed securities (“CMBS”)
|
|
|
||||||
|
Residential mortgage-backed securities (“RMBS”)
|
|
|
||||||
|
Real estate-backed securities
|
|
|
||||||
|
Collateralized debt obligations (“CDOs”) and other
|
(
|
) |
(
|
) | ||||
|
Investment trust funds and other
|
|
|
||||||
|
|
|
|
|
|||||
|
Total trading assets and private equity and debt investments
|
|
|
||||||
|
|
|
|
|
|||||
|
Derivatives, net
(2)
|
||||||||
|
Equity contracts
|
|
|
||||||
|
Interest rate contracts
|
(
|
) |
(
|
) | ||||
|
Credit contracts
|
|
|
||||||
|
Foreign exchange contracts
|
|
(
|
)
|
|||||
|
|
|
|
|
|||||
|
Total derivatives, net
|
|
(
|
) | |||||
|
|
|
|
|
|||||
|
Subtotal
|
¥ |
|
¥ |
(
|
) | |||
|
|
|
|
|
|||||
|
Loans and receivables
|
|
|
||||||
|
Collateralized agreements
|
|
|
||||||
|
Other assets
|
||||||||
|
Non-Trading
debt Securities
|
|
|
||||||
|
Other
|
(
|
) |
|
|||||
|
|
|
|
|
|||||
|
Tota
l
|
¥ |
|
¥ |
(
|
) | |||
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
||||||||
|
Trading liabilities
|
||||||||
|
Equities
|
¥ |
|
¥ |
|
||||
|
Foreign government, agency and municipal securities
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
|||||
|
|
|
March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
Unrealized gains / (losses)
(1)
|
|
|||||
|
Bank and corporate debt securities
|
|
|
||||||
|
|
|
|
|
|||||
|
Total trading liabilities
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
Short-term borrowings
(3)
|
(
|
) |
|
|||||
|
Payables and deposits
(3)
|
|
|
||||||
|
Long-term borrowings
(3)
|
|
(
|
)
|
|||||
|
Other liabilities
|
|
|
||||||
|
|
|
|
|
|||||
|
Tota
l
|
¥ |
|
¥ |
(
|
) | |||
|
|
|
|
|
|||||
| (1) |
Includes gains and losses reported within
Net gain on trading, Gain on private equity and debt investments
Gain(loss) on investments in equity securities, Revenue
—
Other
Non-interest
expenses
—
Other, Interest and dividends
Interest expense
|
| (2) |
Derivatives which contain multiple types of risk are classified based on the primary risk type of the instrument.
|
| (3) |
Includes unrealized gains and losses of ¥
Other comprehensive income (loss) fo
|
|
Billions of yen
|
||||||||||||||||
|
March 31, 2023
|
||||||||||||||||
|
Fair
value |
Unfunded
commitments
(1)
|
Redemption frequency
(if currently eligible)
(2)
|
Redemption notice
(3)
|
|||||||||||||
|
Hedge funds
|
¥ |
|
¥ |
|
|
Same day
-
|
||||||||||
|
Venture capital funds
|
|
|
|
|
||||||||||||
|
Private equity funds
|
|
|
|
|
||||||||||||
|
Real estate funds
|
|
|
|
|
||||||||||||
|
|
|
|
|
|||||||||||||
|
Total
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|||||||||||||
|
Billions of yen
|
||||||||||||||||
|
March 31, 2024
|
||||||||||||||||
|
Fair
value |
Unfunded
commitments
(1)
|
Redemption frequency
(if currently eligible)
(2)
|
Redemption notice
(3)
|
|||||||||||||
|
Hedge funds
|
¥ |
|
¥ |
|
|
Sam
e
day-
days
|
||||||||||
|
Venture capital funds
|
|
|
|
|
||||||||||||
|
Private equity funds
|
|
|
|
|
||||||||||||
|
Real estate funds
|
|
|
|
|
||||||||||||
|
|
|
|
|
|||||||||||||
|
Total
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|||||||||||||
| (1) |
The contractual amount of any unfunded commitments Nomura is required to make to the entities in which the investment is held.
|
| (2) |
The frequency with which Nomura is permitted to redeem investments.
|
| (3) |
The range in prior notice period for redemption.
|
|
|
•
|
|
Equity method investments reported within
Trading assets and private equity and debt investments
Other assets
|
| • |
Certain loans receivables and receivables from customers reported within
Loans and Receivables
which are risk managed on a fair value basis and undrawn loan commitments related to such loans receivable expected to be funded. Nomura elects the fair value option to mitigate volatility through earnings caused by the difference in measurement basis that otherwise would arise between loans and the derivatives used to risk manage those instruments.
|
|
|
•
|
|
Reverse repurchase and repurchase agreements reported within
Collateralized agreements
Collateralized financing
|
|
|
•
|
|
All structured notes issued on or after April 1, 2008 reported within
Short-term borrowings
Long-term borrowings
|
|
|
•
|
|
Certain structured deposit issuances reported within
Deposits received at banks.
|
|
|
•
|
|
Financial liabilities reported within
Long-term borrowings
|
|
|
the transferred financial assets, they remain on the consolidated balance sheets and continue to be carried at fair value, with changes in fair value recognized through earnings.
|
|
|
•
|
|
Financial reinsurance contracts reported within
Other assets
|
|
Billions of yen
|
||||||||||||
|
Year ended March 31
|
||||||||||||
|
2022
|
2023
|
2024
|
||||||||||
|
Gains/(Losses)
(1)
|
||||||||||||
|
Assets:
|
||||||||||||
|
Trading assets and private equity and debt investments
(2)
|
||||||||||||
|
Trading assets
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
|
Private equity and debt investments
|
|
|
|
|||||||||
|
Loans and receivables
|
|
|
|
|||||||||
|
Collateralized agreements
(3)
|
(
|
) |
|
|
||||||||
|
Other assets
(2)
|
(
|
) |
(
|
) |
|
|||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Liabilities:
|
||||||||||||
|
Short-term borrowings
(4)
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Payables and deposits
|
|
|
|
|||||||||
|
Collateralized financing
(3)
|
|
(
|
) |
(
|
) | |||||||
|
Long-term borrowings
(4)(5)
|
|
|
(
|
)
|
||||||||
|
Other liabilities
(6)
|
|
|
(
|
) | ||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
(
|
) | |||||
|
|
|
|
|
|
|
|||||||
| (1) |
Includes gains and losses reported primarily within
Revenue – Net gain on trading
Revenue
—Other
|
| (2) |
Includes equity investments that would have been accounted for under the equity method had Nomura not chosen to elect the fair value option.
|
| (3) |
Includes reverse repurchase and repurchase agreements.
|
| (4) |
Includes structured notes and other financial liabilities.
|
| (5) |
Includes secured financing transactions arising from transfers of financial assets which did not meet the criteria for sales accounting.
|
| (6) |
Includes unfunded written loan commitments.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
|||||
|
|
|
Year ended March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
Changes recognized as a credit (debit) to other comprehensive income
|
¥ |
|
¥ |
(
|
)
|
|||
|
Credit (debit) amounts reclassified to earnings
|
|
|
||||||
|
Cumulative credit balance recognized in accumulated other comprehensive income
|
|
|
||||||
|
Billions of yen
|
||||||||||||||||||||
|
March 31, 2023
|
||||||||||||||||||||
|
Japan
|
U.S.
|
EU & U.K.
|
Other
|
Total
(1)
|
||||||||||||||||
|
Government, agency and municipal securities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
|||||||||||||||||
|
|
|
March 31, 2024
|
|
|||||||||||||||||
|
|
|
Japan
|
|
|
U.S.
|
|
|
EU & U.K.
|
|
|
Other
|
|
|
Total
(1)
|
|
|||||
|
Government, agency and municipal securities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
| (1) |
Other than above, there were ¥
Other assets
—
Non-trading
debt securities
|
|
Billions of yen
|
||||||||||||||||||||
|
March 31, 2023
(1)
|
||||||||||||||||||||
|
Fair value by level
|
||||||||||||||||||||
|
Carrying
value
|
Fair
value |
Level 1
|
Level 2
|
Level 3
|
||||||||||||||||
|
Assets:
|
||||||||||||||||||||
|
Cash and cash equivalents
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Time deposits
|
|
|
|
|
|
|||||||||||||||
|
Deposits with stock exchanges and other segregated cash
|
|
|
|
|
|
|||||||||||||||
|
Loans receivable
(2)
|
|
|
|
|
|
|||||||||||||||
|
Securities purchased under agreements to resell
|
|
|
|
|
|
|||||||||||||||
|
Securities borrowed
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Liabilities:
|
||||||||||||||||||||
|
Short-term borrowings
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Deposits received at banks
|
|
|
|
|
|
|||||||||||||||
|
Securities sold under agreements to repurchase
|
|
|
|
|
|
|||||||||||||||
|
Securities loaned
|
|
|
|
|
|
|||||||||||||||
|
Other secured borrowings
|
|
|
|
|
|
|||||||||||||||
|
Long-term borrowings
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
|||||||||||||||||
|
|
|
March 31, 2024
(1)
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
Fair value by level
|
|
|||||||||||
|
|
|
Carrying
value
|
|
|
Fair
value |
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|||||
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Time deposits
|
|
|
|
|
|
|||||||||||||||
|
Deposits with stock exchanges and other segregated cash
|
|
|
|
|
|
|||||||||||||||
|
Loans receivable
(2)
|
|
|
|
|
|
|||||||||||||||
|
Securities purchased under agreements to resell
|
|
|
|
|
|
|||||||||||||||
|
Securities borrowed
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Liabilities:
|
||||||||||||||||||||
|
Short-term borrowings
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Deposits received at banks
|
|
|
|
|
|
|||||||||||||||
|
Securities sold under agreements to repurchase
|
|
|
|
|
|
|||||||||||||||
|
Securities loaned
|
|
|
|
|
|
|||||||||||||||
|
Other secured borrowings
|
|
|
|
|
|
|||||||||||||||
|
Long-term borrowings
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| (1) |
Includes financial instruments which are carried at fair value on a recurring basis.
|
| (2) |
Carrying values are shown after deducting relevant allowances for credit losses.
|
|
Billions of yen
|
||||||||||||||||
|
March 31, 2023
|
||||||||||||||||
|
Gross fair value of
derivative assets
|
Impact of
master netting
agreements
|
Impact of
collateral
|
Net exposure to
credit risk
|
|||||||||||||
|
Financial institutions
|
¥ |
|
¥ |
(
)
|
¥ |
(
|
¥ |
|
||||||||
|
Billions of yen
|
||||||||||||||||
|
March 31, 2024
|
||||||||||||||||
|
Gross fair value of
derivative assets
|
Impact of
master netting
agreements
|
Impact of
collateral
|
Net exposure to
credit risk
|
|||||||||||||
|
Financial institutions
|
¥ |
|
¥ |
(
|
¥ |
(
|
¥ |
|
||||||||
|
Billions of yen
|
||||||||||||
|
March 31, 2023
|
||||||||||||
|
Derivative
assets
|
Derivative
liabilities
|
|||||||||||
|
Total notional
(1)
|
Fair value
|
Fair value
(1)
|
||||||||||
|
Derivatives used for trading and
non-trading
purposes
(2)
:
|
||||||||||||
|
Equity contracts
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Interest rate contracts
|
|
|
|
|||||||||
|
Credit contracts
|
|
|
|
|||||||||
|
Foreign exchange contracts
|
|
|
|
|||||||||
|
Commodity contracts
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Derivatives designated as formal fair value or net investment accounting hedges:
|
||||||||||||
|
Interest rate contracts
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Foreign exchange contracts
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Total derivatives
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
||||||
|
|
|
|
|
|
March 31, 2024
|
|
||||||
|
|
|
|
|
|
Derivative
assets
|
|
|
Derivative
liabilities
|
|
|||
|
|
|
Total notional
(1)
|
|
|
Fair value
|
|
|
Fair value
(1)
|
|
|||
|
Derivatives used for trading and
non-trading
purposes
(2)
:
|
||||||||||||
|
Equity contracts
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Interest rate contracts
|
|
|
|
|||||||||
|
Credit contracts
|
|
|
|
|||||||||
|
Foreign exchange contracts
|
|
|
|
|||||||||
|
Commodity contracts
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Derivatives designated as formal fair value or net investment accounting hedges:
|
||||||||||||
|
Interest rate contracts
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Foreign exchange contracts
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Total derivatives
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
(1)
|
Includes the amount of embedded derivatives bifurcated in accordance with ASC 815.
|
|
(2)
|
The amounts reported include derivatives used for
non-trading
purposes other than those designated as formal fair value or net investment accounting hedges. These amounts have not been separately presented since such amounts were not significant as of March 31, 2023 and March 31, 2024.
|
|
Billions of yen
|
Billions of yen
|
|||||||||||||||
|
March 31, 2023
|
March 31, 2024
|
|||||||||||||||
|
Derivative
assets
|
Derivative
liabilities
(1)
|
Derivative
assets
|
Derivative
liabilities
(1)
|
|||||||||||||
|
Equity contracts
|
||||||||||||||||
|
OTC settled bilaterally
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
Exchange-traded
|
|
|
|
|
||||||||||||
|
Interest rate contracts
|
||||||||||||||||
|
OTC settled bilaterally
|
|
|
|
|
||||||||||||
|
OTC centrally-cleared
|
|
|
|
|
||||||||||||
|
Exchange-traded
|
|
|
|
|
||||||||||||
|
Credit contracts
|
||||||||||||||||
|
OTC settled bilaterally
|
|
|
|
|
||||||||||||
|
OTC centrally-cleared
|
|
|
|
|
||||||||||||
|
Exchange-traded
|
|
|
|
|
||||||||||||
|
Foreign exchange contracts
|
||||||||||||||||
|
OTC settled bilaterally
|
|
|
|
|
||||||||||||
|
Commodity contracts
|
||||||||||||||||
|
OTC settled bilaterally
|
|
|
|
|
||||||||||||
|
Exchange-traded
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Total gross derivative balances
(2)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
Less: Amounts offset in the consolidated balance sheets
(3)
|
(
|
) |
(
|
) |
(
|
)
|
(
|
)
|
||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Total net amounts
reported on the face
of the consolidated
balance sheets
(4)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Less: Additional amounts not offset in the consolidated balance sheets
(5)
|
||||||||||||||||
|
Financial instruments and
non-cash
collateral
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
(
|
) | ¥ |
(
|
) | ||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Net amount
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| (1) |
Includes the amount of embedded derivatives bifurcated in accordance with ASC 815.
|
| (2) |
Includes all gross derivative asset and liability balances irrespective of whether they are transacted under a master netting agreement or whether Nomura has obtained sufficient evidence of enforceability of the master netting agreement. As of March 31, 2023, the gross balance of derivative assets and derivative liabilities which are not documented under master netting agreements or are documented under master netting agreements for which Nomura has not yet obtained sufficient evidence of enforceability was ¥
|
| (3) |
Represents amounts offset through counterparty offsetting of derivative assets and liabilities as well as cash collateral offsetting against net derivatives under master netting and similar agreements for which Nomura has obtained sufficient evidence of enforceability in accordance with ASC
210-20 and ASC
815. As of March 31, 2023, Nomura offset a total of ¥
|
| (4) |
Net derivative assets and net derivative liabilities are generally reported within
Trading assets and private equity and debt investments
—
Trading assets
Trading liabilities
Short-term borrowings
Long-term borrowings
|
| (5) |
Represents amounts which are not permitted to be offset on the consolidated balance sheets in accordance with ASC
210-20
and ASC 815 but which provide Nomura with a legally enforceable right of offset in the event of counterparty default. Amounts relating to derivative and collateral agreements where Nomura has not yet obtained sufficient evidence of enforceability of such offsetting rights are excluded. As of March 31, 2023, a total of ¥
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Derivatives used for trading and
non-trading
purposes
(1)
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity contracts
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
)
|
||||
|
Interest rate contracts
|
|
|
|
|||||||||
|
Credit contracts
|
(
|
) |
|
|
||||||||
|
Foreign exchange contracts
|
|
|
|
|||||||||
|
Commodity contracts
|
|
(
|
) |
|
||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
(1) Includes
|
net gains (losses) on derivatives used for
non-trading
purposes which are not designated as fair value or net investment hedges. For the year ended March 31, 2022, 2023 and 2024, net gains (losses) for these
non-trading
derivatives were not significant.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
|||||||||||||||||||||
|
Balance sheet line
item in which the hedged item is included: |
|
Carrying amount of the hedged
liabilities |
|
|
Cumulative gains of fair value
hedging adjustment included in the carrying amount of the hedged liabilities |
|
|
Cumulative amount of fair value
hedging adjustment remaining for the liabilities which hedge accounting has been discontinued |
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
March 31, 2023
|
|
|
March 31, 2024
|
|
|
March 31, 2023
|
|
|
March 31, 2024
|
|
|
March 31, 2023
|
|
|
March 31, 2024
|
|
||||||
|
Long-term borrowing
s
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Derivatives designated as hedging instruments:
|
||||||||||||
|
Interest rate contracts
|
¥ |
|
¥ |
|
¥ |
(
|
)
|
|||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
(
|
) | |||||
|
|
|
|
|
|
|
|||||||
|
Billions of yen
|
||||||||||||
|
Year ended March 31
|
||||||||||||
|
2022
|
2023
|
2024
|
||||||||||
|
Hedged items :
|
||||||||||||
|
Long-term borrowings
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
|
|||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
||||
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange contracts
|
¥ |
|
¥ |
|
¥ |
|
|
|||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
|||||||||||||||||||||||||
|
|
|
March 31, 2023
|
|
|||||||||||||||||||||||||
|
|
|
Carrying value
(1)
(Asset) / Liability
|
|
|
Maximum potential payout/Notional
|
|
|
Notional
|
|
|||||||||||||||||||
|
|
|
|
|
|
Years to maturity
|
|
|
Purchased
credit
protection
|
|
|||||||||||||||||||
|
|
|
Total
|
|
|
Less than
1 year
|
|
|
1 to 3
years
|
|
|
3 to 5
years
|
|
|
More than
5 years
|
|
|||||||||||||
|
Single-name credit default swaps
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|||||||||||||
|
Credit default swap indices
|
(
|
) |
|
|
|
|
|
|
||||||||||||||||||||
|
Other credit risk related portfolio products
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Credit-risk related options and swaptions
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Total
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Billions of yen
|
||||||||||||||||||||||||||||
|
March 31, 2024
|
||||||||||||||||||||||||||||
|
Carrying value
(1)
(Asset) /Liability |
Maximum potential payout/Notional
|
Notional
|
||||||||||||||||||||||||||
|
Years to maturity
|
Purchased
credit protection |
|||||||||||||||||||||||||||
|
Total
|
Less than
1 year
|
1 to 3
years
|
3 to 5
years
|
More than
5 years
|
||||||||||||||||||||||||
|
Single-name credit default swaps
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|||||||||||||
|
Credit default swap indices
|
(
|
) |
|
|
|
|
|
|
||||||||||||||||||||
|
Other credit risk related portfolio products
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Credit-risk related options and swaptions
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Total
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| (1) |
Carrying value amounts are shown on a gross basis prior to cash collateral or counterparty offsetting. Asset balances represent positive fair value amounts caused by tightening of credit spreads of underlyings since inception of the credit derivatives.
|
|
Billions of yen
|
||||||||||||||||||||||||||||
|
March 31, 2023
|
||||||||||||||||||||||||||||
|
Maximum potential payout/Notional
|
||||||||||||||||||||||||||||
|
AAA
|
AA
|
A
|
BBB
|
BB
|
Other
(1)
|
Total
|
||||||||||||||||||||||
|
Single-name credit default swaps
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
|
Credit default swap indices
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Other credit risk-related portfolio products
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Credit risk-related options and swaptions
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Billions of yen
|
||||||||||||||||||||||||||||
|
March 31, 2024
|
||||||||||||||||||||||||||||
|
Maximum potential payout/Notional
|
||||||||||||||||||||||||||||
|
AAA
|
AA
|
A
|
BBB
|
BB
|
Other
(1)
|
Total
|
||||||||||||||||||||||
|
Single-name credit default swaps
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
|
Credit default swap indices
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Other credit risk-related portfolio products
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Credit risk-related options and swaptions
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| (1) |
Other includes credit derivatives where the credit rating of the underlying reference asset is below investment grade or where a credit rating is unavailable.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||
|
|
|
March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
Gross cash proceeds received at transfer dates
|
¥ |
|
¥ |
|
||||
|
Fair value of transferred securities at transfer dates
|
¥ |
|
¥ |
|
||||
|
Fair value of transferred securities at reporting dates
|
¥ |
|
¥ |
|
||||
|
Gross derivative liabilities arising from the transactions at reporting dates
(1)
|
¥ |
|
¥
|
|
||||
| (1) |
Amounts presented on
a
gross basis, before the application of counterparty offsetting are included in
Trading liabilities
¥
s
as of March 31, 2023 and March 31, 2024 respectively as disclosed in Note 3 “
Derivative instruments and hedging activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Commissions
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Fees from investment banking
|
|
|
|
|||||||||
|
Asset management and portfolio service fees
|
|
|
|
|||||||||
|
Other revenue
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Brokerage commissions
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Commissions for distribution of investment trust
|
|
|
|
|||||||||
|
Other commissions
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Millions of yen
|
||||||||||||
|
Year ended March 31
|
||||||||||||
|
2022
|
2023
|
2024
|
||||||||||
|
Equity underwriting and distribution fees
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Debt underwriting and distribution fees
|
|
|
|
|||||||||
|
Financial advisory fees
|
|
|
|
|||||||||
|
Other fees
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Millions of yen
|
||||||||||||
|
Year ended March 31
|
||||||||||||
|
2022
|
2023
|
2024
|
||||||||||
|
Asset management fees
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Administration fees
|
|
|
|
|||||||||
|
Custodial fees
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Type of service provided to
customers
|
Overview of key services provided
|
Key revenue recognition policies,
assumptions and
judgments
|
||
| Trade execution, clearing services and distribution of fund units |
• Buying and selling of securities on behalf of customers
• Distribution of fund units
• Clearing of securities and derivatives on behalf of customers
|
• Trade execution and clearing commissions recognized at a point in time, namely trade date.
• Distribution fees are recognized at a point in time when the fund units have been sold to third party investors.
• Commissions recognized net of soft dollar credits provided to
customers where Nomura is acting as agent in providing investment research and
|
|
|
|
|
|
|
|
Type of service provided to
customers
|
|
Overview of key services provided
|
|
Key revenue recognition policies,
assumptions and
judgments
|
|
|
|
|
|
similar services to the customer.
|
|
|
|
|
||
|
Financial advisory services
|
|
• Provision of financial advice to customers in connection with a specific forecasted transaction or transactions such as mergers and acquisitions
• Provision of financial advice not in connection with a specific forecasted transaction or transactions such as general corporate intelligence and similar research
• Issuance of fairness opinions
• Structuring complex financial instruments for customers
|
|
• Fees contingent on the success of an underlying transaction are variable consideration recognized when the underlying transaction has been completed since only at such point is it probable that a significant reversal of revenue will not occur.
• Retainer and milestone fees are recognized either over the period to which they relate or are deferred until consummation of the underlying transaction depending on whether the underlying performance obligation is satisfied at a point in time or over time.
• Judgment is required to make this determination with factors influencing this determination including, but not limited to, whether the fee is in connection with an engagement designed to achieve a specific transaction or outcome for the customer (such as the purchase or sale of a business), the nature and extent of benefit to be provided to the customer prior to, and in addition to such specific transaction or outcome and the fee structure for the engagement.
• Retainer and milestone fees recognized over time are
|
|
|
|
|
|
|
|
Type of service provided to
customers
|
|
Overview of key services provided
|
|
Key revenue recognition policies,
assumptions and
judgments
|
|
|
|
|
|
normally recognized on a straight-line basis over the term of the contract based on time elapsed.
|
|
|
|
|
||
|
Underwriting and syndication services
|
|
• Underwriting of debt, equity and other financial instruments on behalf of customers
• Distributing securities on behalf of issuers
• Arranging loan financing for customers
• Syndicating loan financing on behalf of customer
|
|
• Underwriting and syndication fees are recognized at a point in time when the underlying transaction is complete.
• Commitment fees where draw down of the facility is deemed remote are recognized on a straight-line basis over the life of the facility based on time elapsed.
• Underwriting and syndication costs are recognized either as a reduction of revenue or on a gross basis depending on whether Nomura is acting as principal or agent for such amounts.
|
|
|
|
|
||
|
Asset management services
|
|
• Management of funds, investment trusts and other investment vehicles
• Provision of investment advisory services
• Provision of custodial and administrative services to customers
|
|
• Management fees earned by Nomura in connection with managing a fund, investment trust or other vehicle generally are recognized on a straight-line basis over the term of the contract based on time elapsed.
• Performance-based fees are variable consideration recognized when the performance metric has been determined since only at such point is it probable that a significant reversal of revenue will not occur.
• Custodial and administrative fees are recognized on a straight-line basis over time based on time elapsed.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||
|
|
|
March 31, 2023
|
|
|
March 31, 2024
|
|
||
|
Customer contract receivables
|
¥ |
|
¥ |
|
||||
|
Contract liabilities
(1)
|
|
|
||||||
| (1) |
Contract liabilities primarily rise from investment advisory services and are recognized over the term of the contract based on time elapsed.
|
|
Billions of yen
|
||||||||||||||||
|
March 31, 2023
|
||||||||||||||||
|
Assets
|
Liabilities
|
|||||||||||||||
|
Reverse
repurchase
agreements
|
Securities
borrowing
transactions
|
Repurchase
agreements
|
Securities
lending
transactions
|
|||||||||||||
|
Total gross balance
(1)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
Less: Amounts offset in the consolidated balance sheets
(2)
|
(
|
) |
|
(
|
) |
|
||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Total net amounts as reported on the face of the consolidated balance sheets
(3)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Less: Additional amounts not offset in the consolidated balance sheets
(4)
|
||||||||||||||||
|
Financial instruments and
non-cash
collateral
|
(
|
) |
(
|
) |
(
|
) |
(
|
) | ||||||||
|
Cash collateral
|
(
|
) |
|
(
|
) |
|
||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Net amount
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Billions of yen
|
||||||||||||||||
|
March 31, 2024
|
||||||||||||||||
|
Assets
|
Liabilities
|
|||||||||||||||
|
Reverse
repurchase
agreements
|
Securities
borrowing
transactions
|
Repurchase
agreements
|
Securities
lending
transactions
|
|||||||||||||
|
Total gross balance
(1)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
Less: Amounts offset in the consolidated balance sheets
(2)
|
(
|
)
|
|
(
|
) |
|
||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Total net amounts as reported on the face of the consolidated balance sheets
(3)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Less: Additional amounts not offset in the consolidated balance sheets
(4)
|
||||||||||||||||
|
Financial instruments and
non-cash
collateral
|
(
|
) |
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Cash collateral
|
(
|
) |
|
(
|
) |
|
||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Net amount
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| (1) |
Include all recognized balances irrespective of whether they are transacted under a master netting agreement or whether Nomura has obtained sufficient evidence of enforceability of the master netting agreement. Amounts include transactions carried at fair value through election of the fair value option. As of March 31, 2023, the gross balance of reverse repurchase agreements and repurchase agreements which were not transacted under master netting agreements or are documented under master netting agreements for which Nomura has not yet obtained sufficient evidence of enforceability amounted to ¥
4
, the gross balance of securities borrowing transactions and securities lending transactions which were not transacted under master netting agreements or are documented under master netting agreements for which Nomura has not yet obtained sufficient evidence of enforceability amounted to ¥
|
| (2) |
Represent amounts offset through counterparty netting under master netting or similar agreements for which Nomura has obtained sufficient evidence of enforceability in accordance with ASC
210-20.
Amounts offset include transactions carried at fair value through election of the fair value option.
|
| (3) |
Reverse repurchase agreements and securities borrowing transactions are reported within
Collateralized agreements
—
Securities purchased under agreements to resell
Collateralized agreements
—
Securities borrowed
Collateralized financing
—
Securities sold under agreements to repurchase
Collateralized financing
—
Securities loaned
Other liabilities
|
| (4) |
Represent amounts which are not permitted to be offset on the face of the consolidated balance sheets in accordance with ASC
210-20
but which provide Nomura with the right of offset in the event of counterparty
|
|
|
default. Amounts relating to agreements where Nomura has not yet obtained sufficient evidence of enforceability of such offsetting rights are excluded.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
|||||||||||||||||||||
|
|
|
March 31, 2023
|
|
|||||||||||||||||||||
|
|
|
Overnight
and open
(1)
|
|
|
Up to
30 days
|
|
|
30 - 90
days
|
|
|
90 days -
1 year
|
|
|
Greater
than 1 year
|
|
|
Total
|
|
||||||
|
Repurchase agreements
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
Securities lending transactions
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Total gross recognized liabilities
(2)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Billions of yen
|
||||||||||||||||||||||||
|
March 31, 2024
|
||||||||||||||||||||||||
|
Overnight
and open
(1)
|
Up to
30 days
|
30 - 90
days
|
90 days -
1 year
|
Greater
than 1 year
|
Total
|
|||||||||||||||||||
|
Repurchase agreements
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
Securities lending transactions
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Total gross recognized liabilities
(2)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| (1) |
Open transactions do not have an explicit contractual maturity date and are terminable on demand by Nomura or the counterparty.
|
| (2) |
Repurchase agreements and securities lending transactions are reported within
Collateralized financing
—
Securities sold under agreements to repurchase
Collateralized financing
—
Securities loaned
Other liabilities
|
|
Billions of yen
|
||||||||||||
|
March 31, 2023
|
||||||||||||
|
Repurchase
agreements
|
Securities
lending
transactions
|
Total
|
||||||||||
|
Equities and convertible securities
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Japanese government, agency and municipal securities
|
|
|
|
|||||||||
|
Foreign government, agency and municipal securities
|
|
|
|
|||||||||
|
Bank and corporate debt securities
|
|
|
|
|||||||||
|
Commercial mortgage-backed securities (“CMBS”)
|
|
|
|
|||||||||
|
Residential mortgage-backed securities (“RMBS”)
(1)
|
|
|
|
|||||||||
|
Collateralized debt obligations (“CDOs”) and other
|
|
|
|
|||||||||
|
Investment trust funds and other
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total gross recognized liabilities
(2)
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Billions of yen
|
||||||||||||
|
March 31, 2024
|
||||||||||||
|
Repurchase
agreements
|
Securities
lending
transactions
|
Total
|
||||||||||
|
Equities and convertible securities
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Japanese government, agency and municipal securities
|
|
|
|
|||||||||
|
Foreign government, agency and municipal securities
|
|
|
|
|||||||||
|
Bank and corporate debt securities
|
|
|
|
|||||||||
|
Commercial mortgage-backed securities (“CMBS”)
|
|
|
|
|||||||||
|
Residential mortgage-backed securities (“RMBS”)
(1)
|
|
|
|
|||||||||
|
Collateralized debt obligations (“CDOs”) and other
|
|
|
|
|||||||||
|
Investment trust funds and other
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total gross recognized liabilities
(2)
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
| (1) |
Includes ¥
|
| (2) |
Repurchase agreements and securities lending transactions are reported within
Collateralized financing
—
Securities sold under agreements to repurchase
Collateralized financing
—
Securities loaned
Other liabilities
|
|
Billions of yen
|
||||||||
|
March 31
|
||||||||
|
2023
|
2024
|
|||||||
|
The fair value of collateral received
|
¥ |
|
¥ |
|
||||
|
The portion of the above received that has been sold (as reported as short sales within
Trading liabilities
|
|
|
||||||
|
Millions of yen
|
||||||||
|
March 31
|
||||||||
|
2023
|
2024
|
|||||||
|
Trading assets:
|
||||||||
|
Equities and convertible securities
|
¥ |
|
¥ |
|
||||
|
Government and government agency securities
|
|
|
||||||
|
Bank and corporate debt securities
|
|
|
||||||
|
Residential mortgage-backed securities (“RMBS”)
|
|
|
||||||
|
Collateralized debt obligations (“CDOs”) and other
(1)
|
|
|
||||||
|
Investment trust funds and other
|
|
|
||||||
|
|
|
|
|
|||||
| ¥ |
|
¥ |
|
|||||
|
|
|
|
|
|||||
|
Non-trading
debt securities
(2)
|
|
|
||||||
|
Investments in and advances to affiliated companies
(3)
|
¥ |
|
¥ |
|
||||
| (1) |
Includes collateralized loan obligations (“CLOs”) and asset-backed securities (“ABSs”) such as those secured on credit card loans, auto loans and student loans.
|
| (2) |
Non-trading
debt securities are primarily Japanese municipal securities issued by prefectures or ordinance-designated city.
|
| (3) |
Investments in and advances to affiliated companies comprise shares in Nomura Research Institute, Ltd.
|
|
Millions of yen
|
||||||||
|
March 31
|
||||||||
|
2023
|
2024
|
|||||||
|
Loans and receivables
|
¥ |
|
¥ |
|
||||
|
Trading assets and private equity and debt investments
|
|
|
||||||
|
Office buildings, land, equipment and facilities
|
|
|
||||||
|
Non-trading
debt securities
|
|
|
||||||
|
Investments in and advances to affiliated companies
|
|
|
||||||
|
Other
|
|
|
||||||
|
|
|
|
|
|||||
| ¥ |
|
¥ |
|
|||||
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
|||||||||||||||||||||
|
|
|
March 31, 2023
|
|
|||||||||||||||||||||
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
|
Investment
grade
|
|
|
Other
|
|
||||||
|
Government, agency and municipal securities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
Bank and corporate debt securities
|
|
|
|
|
|
|
||||||||||||||||||
|
CMBS and RMBS
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Billions of yen
|
||||||||||||||||||||||||
|
March 31, 2024
|
||||||||||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
Investment
grade
|
Other
|
|||||||||||||||||||
|
Government, agency and municipal securities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
Bank and corporate debt securities
|
|
|
|
|
|
|
||||||||||||||||||
|
CMBS and RMBS
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
|||||
|
|
March 31
|
|
||||||
|
|
|
2023
|
|
|
2024
|
|
||
|
Assets
|
|
|
|
|
|
|
|
|
|
Trading assets
|
|
|
|
|
|
|
|
|
|
Japanese government securities
|
¥ |
|
¥ |
|
||||
|
Loans for trading purposes
|
|
|
||||||
|
Loans receivable
|
|
|
||||||
|
|
|
|
|
|||||
|
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
Liabilities
|
||||||||
|
Long-term borrowings
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
|||||
|
|
|
March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
Consolidated VIE assets
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
¥ |
|
¥ |
|
||||
|
Trading assets
|
||||||||
|
Equities
|
|
|
||||||
|
Debt securities
|
|
|
||||||
|
CMBS and RMBS
|
|
|
||||||
|
Derivatives
|
|
|
||||||
|
Private equity and debt investments
|
|
|
||||||
|
Office buildings, land, equipment and facilities
|
|
|
||||||
|
Other
|
|
|
||||||
|
|
|
|
|
|||||
|
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
Consolidated VIE liabilities
|
||||||||
|
Trading liabilities
|
||||||||
|
Derivatives
|
|
|
||||||
|
Borrowings
|
||||||||
|
Short-term borrowings
|
|
|
||||||
|
Long-term borrowings
|
|
|
||||||
|
Other
|
|
|
||||||
|
|
|
|
|
|||||
|
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
Billions of yen
|
||||||||||||
|
March 31, 2023
|
||||||||||||
|
Carrying amount of variable interests
|
Maximum exposure
to loss to
unconsolidated VIEs
|
|||||||||||
|
Assets
|
Liabilities
|
|||||||||||
|
Trading assets and liabilities
|
||||||||||||
|
Equities
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Debt securities
|
|
|
|
|||||||||
|
CMBS and RMBS
|
|
|
|
|||||||||
|
Investment trust funds and other
|
|
|
|
|||||||||
|
Private equity and debt investments
|
|
|
|
|||||||||
|
Loans
|
|
|
|
|||||||||
|
Other
|
|
|
|
|||||||||
|
Commitments to extend credit and other guarantees
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Billions of yen
|
||||||||||||
|
March 31, 2024
|
||||||||||||
|
Carrying amount of variable interests
|
Maximum exposure
to loss to
unconsolidated VIEs
|
|||||||||||
|
Assets
|
Liabilities
|
|||||||||||
|
Trading assets and liabilities
|
||||||||||||
|
Equities
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Debt securities
|
|
|
|
|||||||||
|
CMBS and RMBS
|
|
|
|
|||||||||
|
Investment trust funds and other
|
|
|
|
|||||||||
|
Private equity and debt investments
|
|
|
|
|||||||||
|
Loans
|
|
|
|
|||||||||
|
Other
|
|
|
|
|||||||||
|
Commitments to extend credit and other guarantees
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Millions of yen
|
||||||||||||
|
March 31, 2023
|
||||||||||||
|
Carried at
amortized cost
|
Carried at
fair value
(1)
|
Total
|
||||||||||
|
Loans receivables
|
||||||||||||
|
Loans at banks
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Short-term secured margin loans
|
|
|
|
|||||||||
|
Inter-bank money market loans
|
|
|
|
|||||||||
|
Corporate loans
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total loans receivables
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Advances to affiliated companies
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Millions of yen
|
||||||||||||
|
March 31, 2024
|
||||||||||||
|
Carried at
amortized cost
|
Carried at
fair value
(1)
|
Total
|
||||||||||
|
Loans receivables
|
||||||||||||
|
Loans at banks
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Short-term secured margin loans
|
|
|
|
|||||||||
|
Inter-bank money market loans
|
|
|
|
|||||||||
|
Corporate loans
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total loans receivables
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Advances to affiliated companies
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
| (1) |
Includes loans receivable and loan commitments carried at fair value through election of the fair value option.
|
|
|
•
|
|
Loans receivable;
|
|
|
•
|
|
Written unfunded loan commitments and other off-balance sheet financial instruments;
|
|
|
•
|
|
Cash deposits;
|
|
|
•
|
|
Collateralized agreements such as reverse repos and securities borrowing transactions;
|
|
|
•
|
|
Customer contract assets and receivables; and
|
|
|
•
|
|
Other receivables including margin receivables, security deposits, default fund contributions to central clearing counterparties, reinsurance benefits, and net investments in finance leases.
|
|
|
|
|
|
Financial instrument
|
|
Methodology to determine current expected credit losses
|
|
Loans, written loan commitments, other off-balance sheet financial instruments and certain deposits
|
|
• Full loss rate model developed by Nomura’s Risk department
• Measures expected credit losses based on probability of default (“PD”), Loss Given Default (“LGD”) and Exposure at Default (“EAD”) inputs.
• PD inputs incorporate forward-looking scenarios used by Nomura for internal risk management and capital purposes.
• Immediate reversion method used for periods beyond which reasonable and supportable forecast is not available.
• For financial instruments which have defaulted or are probable of defaulting, expected credit losses measured using discounted cash flow analyses or, where the financial instrument is collateral dependent, based on any shortfall of fair value of the underlying collateral.
|
|
|
|
|
|
Collateralized agreements, short-term secured margin loans and cash prime brokerage loans
|
|
• For reverse repos and short-term secured margin loans and cash prime brokerage loans where frequent margining is required and the counterparty has ability to replenish margin, as permitted by a practical expedient provided by ASC 326 expected credit losses are limited to difference between carrying value of the reverse repo or margin loan and fair value of underlying collateral.
• Securities borrowing transactions typically have very short expected lives and are collateralized and therefore expected credit losses are generally determined qualitatively to be insignificant based on historical experience and consistent monitoring of collateral.
|
|
|
|
|
|
Customer contract assets and receivables
|
|
• Expected credit losses typically based on aging analysis where loss rates are applied to the carrying value based on historical experience, the current economic climate and specific information about the ability of the client to pay.
|
|
Millions of yen
|
||||||||||||||||||||||||
|
Year ended March 31, 2022
|
||||||||||||||||||||||||
|
Allowances for current expected credit losses
against loans
|
Allowances
against
receivables
other than
loans
(1)
|
Total
allowances for current expected credit losses |
||||||||||||||||||||||
|
Loans
at banks
|
Short-term
secured
margin
loans
|
Corporate
loans
|
Subtotal
|
|||||||||||||||||||||
|
Opening balance
|
|
|
|
|
|
|
||||||||||||||||||
|
Provision for credit losses
(2)
|
|
|
|
|
|
|
||||||||||||||||||
|
Write-offs
|
|
|
|
|
(
|
) |
(
|
) | ||||||||||||||||
|
Other
(4)(5)
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Ending balance
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||||||||||||||
|
|
|
Year ended March 31, 2023
|
|
|||||||||||||||||||||
|
|
|
Allowances for current expected credit losses
against loans
|
|
|
Allowances
against
receivables
other than
loans
(1)
|
|
|
Total
allowances for current expected credit losses |
|
|||||||||||||||
|
|
|
Loans
at banks
|
|
|
Short-term
secured
margin
loans
|
|
|
Corporate
loans
|
|
|
Subtotal
|
|
||||||||||||
|
Opening balance
|
|
|
|
|
|
|
||||||||||||||||||
|
Provision for credit losses
|
|
|
|
|
|
|
||||||||||||||||||
|
Write-offs(3)
|
(
|
) |
|
(
|
) |
(
|
) |
|
(
|
) | ||||||||||||||
|
Other
(4)(5)
|
(
|
) |
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Ending balance
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Millions of yen
|
||||||||||||||||||||||||
|
Year ended March 31, 2024
|
||||||||||||||||||||||||
|
Allowances for current expected credit losses
against loans
|
Allowances
against
receivables
other than
loans
(1)
|
Total
allowances for current expected credit losses |
||||||||||||||||||||||
|
Loans
at banks
|
Short-term
secured
margin
loans
|
Corporate
loans
|
Subtotal
|
|||||||||||||||||||||
|
Opening balance
|
|
|
|
|
|
|
||||||||||||||||||
|
Provision for credit losses
(2)
|
(
|
) |
|
|
|
|
|
|||||||||||||||||
|
Write-offs
|
|
|
(
|
) |
(
|
) |
|
(
|
) | |||||||||||||||
|
Other
(5)
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Ending balance
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| (1) |
Includes amounts recognized against collateralized agreements, customer contract assets and receivables and other receivables.
|
| (2) |
Following default by a U.S. client in connection with the U.S. Prime Brokerage Event in March 2021, an additional provision for credit losses of ¥
million was recognized during the year ended March 31, 2022. A provision for credit losses in connection with settlement failures with a broker cou
n
terparty was recognized during the year ended March 31, 2024.
|
| (3) |
Includes ¥
million of write-offs in connection with the U.S. Prime Brokerage Event during the year ended March 31, 2023.
|
| (4) |
Includes a reduction in allowances for current expected credit losses of
million in connection with the U.S. Prime Brokerage Event during the years ended March 31, 2022 and 2023
respectively
.
|
| (5) |
Primarily includes recoveries and foreign exchange movements. The amounts of recoveries
for
the year ended March 31, 2022 and 2023 and 2024 were not significant.
|
| Millions of yen | ||||||||||||||||||||||||||||||||
| March 31, 2023 | ||||||||||||||||||||||||||||||||
| 2023 | 2022 | 2021 | 2020 | 2019 |
2018 or
earlier |
Revolving | Total | |||||||||||||||||||||||||
|
Secured loans at banks:
|
||||||||||||||||||||||||||||||||
|
AAA-BBB
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
BB-CCC
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
CC-D
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Others
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Total secured loans at banks
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Unsecured loans at banks:
|
||||||||||||||||||||||||||||||||
|
AAA-BBB
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
BB-CCC
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
CC-D
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Others
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Total unsecured loans at banks
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Short-term secured margin loans:
|
||||||||||||||||||||||||||||||||
|
AAA-BBB
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
BB-CCC
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
CC-D
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Others
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Total short-term secured margin loans
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Secured corporate loans:
|
||||||||||||||||||||||||||||||||
|
AAA-BBB
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
BB-CCC
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
CC-D
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Others
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Total secured corporate loans
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Unsecured corporate loans:
|
||||||||||||||||||||||||||||||||
|
AAA-BBB
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
BB-CCC
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
CC-D
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Others
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Total unsecured corporate loans
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Advances to affiliated companies
|
||||||||||||||||||||||||||||||||
|
AAA-BBB
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
BB-CCC
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
CC-D
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Others
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Total advances to affiliated companies
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| (1) |
Relate
s
to collateralized exposures where a specified ratio of LTV is maintained.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||||||||||||||||||||||
|
|
March 31, 2024
|
|
||||||||||||||||||||||||||||||
|
|
2024
|
|
|
2023
|
|
|
2022
|
|
|
2021
|
|
|
2020
|
|
|
2019 or
earlier |
|
|
Revolving
|
|
|
Total
|
|
|||||||||
|
Secured loans at banks:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AAA-BBB
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
BB-CCC
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
CC-D
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Others
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Total secured loans at
banks
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Unsecured loans at banks:
|
||||||||||||||||||||||||||||||||
|
AAA-BBB
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
BB-CCC
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
CC-D
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Others
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Total unsecured loans at
banks
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Short-term secured margin loans:
|
||||||||||||||||||||||||||||||||
|
AAA-BBB
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
BB-CCC
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
CC-D
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Others
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Total short-term secured margin loans
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Secured corporate loans:
|
||||||||||||||||||||||||||||||||
|
AAA-BBB
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
BB-CCC
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
CC-D
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Others
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Total secured corporate loans
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Unsecured corporate loans:
|
||||||||||||||||||||||||||||||||
|
AAA-BBB
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
BB-CCC
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
CC-D
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Others
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Total unsecured corporate loans
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Advances to affiliated companies
|
||||||||||||||||||||||||||||||||
|
AAA-BBB
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
BB-CCC
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
CC-D
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Others
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Total advances to affiliated companies
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥
|
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
(1)
|
Relate
s
to collateralized exposures where a specified ratio of LTV is maintained.
|
|
(2)
|
The amounts of write offs
for
the year ended March 31, 2024 were not significant.
|
|
|
|
|
|
Rating Range
|
|
Definition
|
|
AAA
|
|
Highest credit quality category. An obligor or facility has extremely strong capacity to meet its financial commitments. ‘AAA range’ is the highest credit rating assigned by Nomura. Extremely low probability of default.
|
|
|
|
|
|
AA
|
|
Very high credit quality category. An obligor or facility has very strong capacity to meet its financial commitments. Very low probability of default but higher that of ‘AAA range.’
|
|
|
|
|
|
A
|
|
High credit quality category. An obligor or facility has strong capacity to meet its financial commitments but is somewhat more susceptible to the adverse effects of changes in circumstances and economic conditions than those in higher-rated categories. Low probability of default but higher than that of ‘AA range.’
|
|
|
|
|
|
BBB
|
|
Good credit quality category. An obligor or facility has adequate capacity to meet its financial commitments. However, adverse economic conditions or changes in circumstances are more likely to lead to a weakened capacity to meet its financial commitments. Medium probability of default but higher than that of ‘A range.’
|
|
|
|
|
|
BB
|
|
Speculative credit quality category. An obligor or facility is less vulnerable in the near term than other lower-ratings. However, it faces major ongoing uncertainties and exposure to adverse business, financial, or economic conditions which could lead to the inadequate capacity to meet its financial commitments. Medium to high probability of default but higher than that of ‘BBB range.’
|
|
|
|
|
|
B
|
|
Highly speculative credit quality category. An obligor or facility is more vulnerable than those rated ‘BB range’, but the obligor currently has the capacity to meet its financial commitments. Adverse business, financial, or economic conditions will likely impair the issuer’s or obligor’s capacity or willingness to meet its financial commitments. High probability of default—higher than that of ‘BB range.’
|
|
|
|
|
|
CCC
|
|
Substantial credit risk. An obligor or facility is currently vulnerable, and is dependent upon favorable business, financial, and economic conditions to meet its financial commitments. Strong probability of default – higher than that of ‘B range.’
|
|
|
|
|
|
CC
|
|
An obligor or facility is currently highly vulnerable to insolvency or is under distressed debt restructuring. Due to insolvency concern or payment failure, a termination notice and close out is initiated. It also includes a solvent obligor past due on financial obligations by more than 3 months. The obligor continues to be a going-concern.
|
|
|
|
|
|
C
|
|
An obligor or facility is imminent to file for bankruptcy (i.e. Chapter 11 or equivalent) in the near-term. The going-concern status is about to cease; unless for an extraordinary turnaround event.
|
|
|
|
|
|
D
|
|
An Obligor or facility has filed for bankruptcy, administration, receivership, liquidation or other winding up or cessation of business of an obligor or other similar situations. D range includes sale of assets (i.e. loans) at a material loss of more than 30%, or the obligor is externally rated ‘D’ by any Designated External Rating Agencies.
|
|
Millions of yen
|
||||||||||||||||||||||||
|
March 31
|
||||||||||||||||||||||||
|
2023
|
2024
|
|||||||||||||||||||||||
|
Cost
|
Accumulated
depreciation
|
Net carrying
amount
|
Cost
|
Accumulated
depreciation
|
Net carrying
amount
|
|||||||||||||||||||
|
Real estate
(1)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
Aircraft
|
|
(
|
) |
|
|
(
|
) |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
)
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| (1) |
Cost, accumulated depreciation and net carrying amounts include amounts relating to real estate u
s
ed by Nomura.
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|
|
|
|
March 31, 2024
|
|
|
|
|
|
Minimum lease payments
to be received
|
|
|
|
Years of receipt
|
||||
|
Less than 1 year
|
¥ |
|
||
|
1 to 2 years
|
|
|||
|
2 to 3 years
|
|
|||
|
3 to 4 years
|
|
|||
|
4 to 5 years
|
|
|||
|
More than 5 years
|
|
|||
|
|
|
|||
|
Total
|
¥ |
|
||
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Lease expense:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating lease costs
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Other income and expenses:
|
||||||||||||
|
Gross sublease income
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
Year ended March 31
|
|
||||||||||
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
||||
|
Cash flows for operating leases
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
ROU assets recognized in connection with new operating leases
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Millions of yen
|
||||
|
March 31, 2024
|
||||
|
Operating leases
|
||||
|
Years of payment
|
||||
|
Less than 1 year
|
¥ |
|
||
|
1 to 2 years
|
|
|||
|
2 to 3 years
|
|
|||
|
3 to 4 years
|
|
|||
|
4 to 5 years
|
|
|||
|
More than 5 years
|
|
|||
|
|
|
|||
|
Total undiscounted lease payments
|
¥ |
|
||
|
Less: Impact of discounting
|
(
|
)
|
||
|
|
|
|||
|
Lease liabilities
as reported in the consolidated balance sheets
|
¥ |
|
||
|
|
|
|||
|
Year ended March 31
|
||||
|
2023
|
2024
|
|||
|
Operating leases
|
Operating leases
|
|||
|
Weighted-average discount rate used to measure lease liabilities
|
|
|
||
|
Weighted-average remaining lease term
|
|
|
||
|
Millions of yen
|
||||||||
|
March 31
|
||||||||
|
2023
|
2024
|
|||||||
|
Land
|
¥ |
|
¥ |
|
||||
|
Office buildings
|
|
|
||||||
|
Equipment and facilities
|
|
|
||||||
|
Software
|
|
|
||||||
|
Construction in progress
|
|
|
||||||
|
Operating lease
ROU
assets
|
|
|
||||||
|
|
|
|
|
|||||
|
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
Millions of yen
|
||||||||
|
March 31
|
||||||||
|
2023
|
2024
|
|||||||
|
Other assets
—
Other:
|
||||||||
|
Securities received as collateral
|
¥ |
|
¥ |
|
||||
|
Goodwill and other intangible assets
|
|
|
||||||
|
Net deferred tax assets
(1)
|
|
|
||||||
|
Investments in equity securities for other than operating purposes
(2)
|
|
|
||||||
|
Deposit receivables
(4)
|
|
|
||||||
|
Prepaid expenses
|
|
|
||||||
|
Other
|
|
|
||||||
|
|
|
|
|
|||||
|
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
Other liabilities:
|
||||||||
|
Obligation to return securities received as collateral
|
¥ |
|
¥ |
|
||||
|
Accrued income taxes
|
|
|
||||||
|
Net deferred tax liabilities
(1)
|
|
|
|
|
|
|
|
|
|
Other accrued expenses and provisions
(3)
|
|
|
||||||
|
Operating lease
liabilities
|
|
|
||||||
|
Other
|
|
|
||||||
|
|
|
|
|
|||||
|
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
(1)
|
Net deferred tax assets are deferred tax assets offset by deferred tax liabilities which relate to the same tax-paying component within a particular tax jurisdiction. Net deferred tax liabilities are deferred tax liabilities offset by deferred tax assets which relate to the same tax-paying component within a particular tax jurisdiction. See Note 14 “Income taxes” for further information.
|
|
(
2
)
|
Includes equity securities held for other than trading or operating purposes. These investments comprise listed equity securities and unlisted equity securities of ¥
Revenue
—
Other
|
|
(
3
)
|
Includes a liability of ¥
all
outstanding and unsettled investigations, lawsuits and other legal proceedings where loss is considered probable and the amount of such loss can be reasonably estimated. See Note 19 “
Commitments, contingencies and guarantees
|
|
(
4
)
|
Includes Japan Securities Clearing Corporation’s clearing fund.
|
|
Millions of yen
|
||||||||||||||||||||||||||||||||||||
|
Year ended March 31, 2023
|
||||||||||||||||||||||||||||||||||||
|
Beginning of year
|
Changes during year
|
End of year
|
||||||||||||||||||||||||||||||||||
|
Gross
carrying
amount
|
Accumulated
Impairment
|
Net
carrying
amount
|
Acquisition
|
Impairment
|
Other
(1)
|
Gross
carrying
amount
|
Accumulated
Impairment
|
Net
carrying
amount
|
||||||||||||||||||||||||||||
|
Wholesale
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||
|
Other
|
|
|
|
|
|
(
|
) |
|
|
|
||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||||||||||||||||||||||||||
|
|
|
Year ended March 31, 2024
|
|
|||||||||||||||||||||||||||||||||
|
|
|
Beginning of year
|
|
|
Changes during year
|
|
|
End of year
|
|
|||||||||||||||||||||||||||
|
|
|
Gross
carrying
amount
|
|
|
Accumulated
Impairment
|
|
|
Net
carrying
amount
|
|
|
Acquisition
|
|
|
Impairment
|
|
|
Other
(1)
|
|
|
Gross
carrying
amount
|
|
|
Accumulated
Impairment
|
|
|
Net
carrying
amount
|
|
|||||||||
|
Wholesale
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||
|
Other
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
Total
|
¥ |
|
¥ |
(
|
)
|
¥ |
|
¥ |
|
¥ |
(
|
)
|
¥ |
|
¥ |
|
¥ |
(
|
)
|
¥ |
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
(1)
|
Includes currency translation adjustments.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||||||||||||||
|
|
|
March 31, 2023
|
|
|
March 31, 2024
|
|
||||||||||||||||||
|
|
|
Gross
carrying
amount
|
|
|
Accumulated
amortization
|
|
|
Net
carrying
amount
|
|
|
Gross
carrying
amount
|
|
|
Accumulated
amortization
|
|
|
Net
carrying
amount
|
|
||||||
|
Client relationships
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||
|
Other
|
|
(
|
) |
|
|
(
|
) |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|
|
Year ending March 31
|
|
Estimated
amortization expense
|
|
|
|
2025
|
¥ |
|
||
|
2026
|
|
|||
|
2027
|
|
|||
|
2028
|
|
|||
|
2029
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||
|
|
|
March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
Balance at beginning of year
|
¥ |
|
¥ |
|
||||
|
Provision for the year
|
|
|
||||||
|
Settled during the year
|
(
|
) |
(
|
)
|
||||
|
|
|
|
|
|||||
|
Balance at end of year
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||
|
|
|
March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
Short-term borrowings
(1)
:
|
|
|
|
|
|
|
|
|
|
Commercial paper
|
¥ |
|
¥ |
|
||||
|
Bank borrowings
|
|
|
||||||
|
Other
|
|
|
||||||
|
|
|
|
|
|||||
|
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
Long-term borrowings:
|
||||||||
|
Long-term borrowings from banks and other financial institutions
(2)
|
¥ |
|
¥ |
|
||||
|
Bonds and notes issued
(3)
:
|
||||||||
|
Fixed-rate obligations:
|
||||||||
|
Japanese Yen denominated
|
|
|
||||||
|
Non-Japanese
Yen denominated
|
|
|
||||||
|
Floating-rate obligations:
|
||||||||
|
Japanese Yen denominated
|
|
|
||||||
|
Non-Japanese
Yen denominated
|
|
|
||||||
|
Index / Equity-linked obligations:
|
||||||||
|
Japanese Yen denominated
|
|
|
||||||
|
Non-Japanese
Yen denominated
|
|
|
||||||
|
|
|
|
|
|||||
|
|
|
|||||||
|
|
|
|
|
|||||
|
Subtotal
|
|
|
||||||
|
|
|
|
|
|||||
|
Trading balances of secured borrowings
|
|
|
||||||
|
|
|
|
|
|||||
|
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
| (1) |
Includes secured borrowings of ¥
|
| (2) |
Includes secured borrowings of ¥
|
| (3) |
Includes secured borrowings of ¥
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||
|
|
|
March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
Debt issued by the Company
|
¥ |
|
¥ |
|
||||
|
Debt issued by subsidiaries
—
(1)
|
|
|
||||||
|
Debt issued by subsidiaries
—
(1)
|
|
|
||||||
|
|
|
|
|
|||||
|
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
| (1) |
Includes trading balances of secured borrowings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
Short-term borrowings
|
|
% |
|
% | ||||
|
Long-term borrowings
|
|
% |
|
% | ||||
|
Fixed-rate obligations
|
|
% |
|
% | ||||
|
Floating-rate obligations
|
|
% |
|
% | ||||
|
Index / Equity-linked obligations
|
|
% |
|
% | ||||
|
|
|
|
|
|
|
Year ending March 31
|
|
Millions of yen
|
|
|
|
2025
|
¥ |
|
||
|
2026
|
|
|||
|
2027
|
|
|||
|
2028
|
|
|||
|
2029
|
|
|||
|
2030 and thereafter
|
|
|||
|
|
|
|||
|
Subtotal
|
|
|||
|
|
|
|||
|
Trading balances of secured borrowings
|
|
|||
|
|
|
|||
|
Total
|
¥ |
|
||
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
except per share data presented in yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Basic—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to NHI shareholders
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Weighted average number of NHI shares outstanding
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Net income attributable to NHI shareholders per share
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Diluted—
|
||||||||||||
|
Net income attributable to NHI shareholders
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Weighted average number of NHI shares outstanding
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Net income attributable to NHI shareholders per share
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Service cost
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Interest cost
|
|
|
|
|||||||||
|
Expected return on plan assets
|
(
|
) |
(
|
) |
(
|
)
|
||||||
|
Amortization of net actuarial losses
|
|
|
|
|||||||||
|
Amortization of prior service cost
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
|
|
|
|
|
|
|||||||
|
Net periodic
benefit
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||
|
|
|
As of or for the
year ended March 31 |
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
Change in projected benefit obligation:
|
|
|
|
|
|
|
|
|
|
Projected benefit obligation at beginning of year
|
¥ |
|
¥ |
|
||||
|
Service cost
|
|
|
||||||
|
Interest cost
|
|
|
||||||
|
Actuarial gain
|
(
|
) |
(
|
)
|
||||
|
Benefits paid
|
(
|
) |
(
|
) | ||||
|
Acquisition, divestitures and other
|
(
|
) |
(
|
) | ||||
|
|
|
|
|
|||||
|
Projected benefit obligation at end of year
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
Change in plan assets:
|
||||||||
|
Fair value of plan assets at beginning of year
|
¥ |
|
¥ |
|
||||
|
Actual return on plan assets
|
(
|
) |
|
|||||
|
Employer contributions
|
|
|
||||||
|
Benefits paid
|
(
|
) |
(
|
) | ||||
|
|
|
|
|
|||||
|
Fair value of plan assets at end of year
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
Funded status at end of year
|
(
|
) |
(
|
) | ||||
|
|
|
|
|
|||||
|
Amounts recognized in the consolidated balance sheets
|
¥ |
(
|
) | ¥ |
(
|
) | ||
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||
|
|
|
March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
Plans with ABO in excess of plan assets:
|
|
|
|
|
|
|
|
|
|
PBO
|
¥ |
|
¥ |
|
||||
|
ABO
|
|
|
||||||
|
Fair value of plan assets
|
|
|
||||||
|
Plans with PBO in excess of plan assets:
|
||||||||
|
PBO
|
¥ |
|
¥ |
|
||||
|
ABO
|
|
|
||||||
|
Fair value of plan assets
|
|
|
||||||
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|
|
|
|
For the year ended
March 31, 2024
|
|
|
|
Net actuarial loss
|
¥ |
|
||
|
Net prior service cost
|
(
|
)
|
||
|
|
|
|||
|
Total
|
¥ |
|
||
|
|
|
|||
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|
|
|
|
For the year ending
March 31, 2025
|
|
|
|
Net actuarial loss
|
¥ |
|
||
|
Net prior service cost
|
(
|
)
|
||
|
|
|
|||
|
Total
|
¥ |
|
||
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
Discount rate
|
|
% |
|
% | ||||
|
Rate of increase in compensation levels
|
|
% |
|
% | ||||
|
Interest crediting rate
|
|
% |
|
% | ||||
|
Year ended March 31
|
||||||||||||
|
2022
|
2023
|
2024
|
||||||||||
|
Discount rate
|
|
% |
|
% |
|
% | ||||||
|
Rate of increase in compensation levels
|
|
% |
|
% |
|
% | ||||||
|
Expected long-term rate of return on plan assets
|
|
% |
|
% |
|
% | ||||||
|
Interest crediting rate
|
|
% |
|
% |
|
% | ||||||
|
Millions of yen
|
||||||||||||||||
|
March 31, 2023
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Balance as of
March 31,
2023 |
|||||||||||||
|
Pension plan assets:
|
||||||||||||||||
|
Private equity and pooled investments
(1)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
Japanese government securities
|
|
|
|
|
||||||||||||
|
Investment trust funds and other
(2)(3)
|
|
|
|
|
||||||||||||
|
Life insurance company general accounts
|
|
|
|
|
||||||||||||
|
Other assets
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Millions of yen
|
||||||||||||||||
|
March 31, 2024
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Balance as of
March 31,
2024 |
|||||||||||||
|
Pension plan assets:
|
||||||||||||||||
|
Private equity and pooled investments
(1)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
Japanese government securities
|
|
|
|
|
||||||||||||
|
Investment trust funds and other
(2)(3)
|
|
|
|
|
||||||||||||
|
Life insurance company general accounts
|
|
|
|
|
||||||||||||
|
Other assets
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| (1) |
Includes corporate type equity investments.
|
| (2) |
Includes primarily debt investment funds. Hedge funds and real estate funds are also included.
|
| (3) |
Certain assets that are measured at fair value using net asset value per share as a practical expedient have not been classified in the fair value hierarchy. As of March 31, 2023 and 2024, the fair values of these assets were ¥
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||||||
|
|
|
Year ended March 31, 2023
|
|
|
|
|
||||||||||
|
|
|
Balance
as of
April 1,
2022
|
|
|
Unrealized
and realized
gains / (loss)
|
|
|
Purchases /
sales and
other
settlement
|
|
|
Balance
as of
March 31,
2023
|
|
||||
|
Private equity and pooled investments
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
||||||
|
Investment trust funds and other
|
|
|
(
|
) |
|
|||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Millions of yen
|
||||||||||||||||
|
Year ended March 31, 2024
|
||||||||||||||||
|
Balance
as of
April 1,
2023
|
Unrealized
and realized
gains / (loss)
|
Purchases /
sales and
other
settlement
|
Balance
as of
March 31,
2024
|
|||||||||||||
|
Private equity and pooled investments
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
||||||
|
Investment trust funds and other
|
|
|
(
|
) |
|
|||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Year ending March 31
|
Millions of yen
|
|||
|
2025
|
¥ |
|
||
|
2026
|
|
|||
|
2027
|
|
|||
|
2028
|
|
|||
|
2029
|
|
|||
|
2030-2034
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding
(number of Nomura
shares)
|
|
|
Weighted-average
grant date fair
value per share
|
|
|
Weighted-average
remaining life
until expiry
(years)
|
|
|||
|
Outstanding as of March 31, 2023
|
|
¥ |
|
|
||||||||
|
Granted
|
|
|
||||||||||
|
Forfeited
|
(
|
) |
|
|||||||||
|
Delivered
|
(
|
)
|
|
|||||||||
|
|
|
|
|
|||||||||
|
Outstanding as of March 31, 2024
|
|
¥ |
|
|
||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding
(number of Nomura
shares)
|
|
|
Weighted-average
grant date fair
value per share
|
|
|
Weighted-average
remaining life
until expiry
(years)
|
|
|||
|
Outstanding as of March 31, 2023
|
|
¥ |
|
|
||||||||
|
Granted
|
|
|
||||||||||
|
Exercised
|
(
|
)
|
|
|||||||||
|
Forfeited
|
(
|
) |
|
|||||||||
|
Expired
|
(
|
) |
|
|||||||||
|
|
|
|
|
|||||||||
|
Outstanding as of March 31, 2024
|
|
¥ |
|
|
||||||||
|
|
|
|
|
|||||||||
|
Exercisable as of March 31, 2024
|
|
¥ |
|
|
||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NSUs
|
|
|
CSUs
|
|
||||||||||
|
|
|
Outstanding
(number of units)
|
|
|
Stock
price
|
|
|
Outstanding
(number of units)
|
|
|
Stock
price
|
|
||||
|
Outstanding as of March 31, 2023
|
|
¥ |
|
|
¥ |
|
||||||||||
|
Granted
|
|
|
(1)
|
|
|
|||||||||||
|
Vested
|
(
|
)
|
|
(2)
|
(
|
)
|
|
(2)
|
||||||||
|
Forfeited
|
(
|
) |
(
|
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
Outstanding as of March 31, 2024
|
|
¥ |
|
(3)
|
|
¥ |
|
(3)
|
||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| (1) |
Weighted-average price of the Company’s common stock used to determine number of awards granted.
|
| (2) |
Weighted-average price of the Company’s common stock used to determine the final cash settlement amount of the awards.
|
| (3) |
The price of the Company’s common stock used to remeasure the fair value of the remaining outstanding unvested awards as of March 31, 2024.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Domestic
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Foreign
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Subtotal
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Deferred:
|
||||||||||||
|
Domestic
|
|
|
|
|||||||||
|
Foreign
|
|
(
|
) |
(
|
)
|
|||||||
|
|
|
|
|
|
|
|||||||
|
Subtotal
|
|
|
(
|
) | ||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Nomura’s effective statutory tax rate
|
|
% |
|
% |
|
% | ||||||
|
Impact of:
|
||||||||||||
|
Changes in deferred tax valuation allowances
(
1
)
|
|
|
|
|||||||||
|
Additional taxable income
|
|
|
|
|||||||||
|
Non-deductible
expenses
|
|
|
|
|||||||||
|
Non-taxable
income
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
Dividends from foreign subsidiaries
|
|
|
|
|||||||||
|
Tax effect of undistributed earnings of foreign subsidiaries
|
|
|
(
|
) | ||||||||
|
Different tax rate applicable to income (loss) of foreign subsidiaries
|
|
(
|
) |
(
|
) | |||||||
|
Effect of changes in foreign tax laws
(
1
)
|
(
|
) |
(
|
) |
|
|||||||
|
Tax benefit recognized on the outside basis differences for investment in subsidiaries and affiliates
|
|
(
|
) |
(
|
)
|
|||||||
|
Other
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
|
|
|
|
|
|
|||||||
|
Effective tax rate
|
|
% |
|
% |
|
% | ||||||
|
|
|
|
|
|
|
|||||||
| (1) |
The U.K. Finance Act 2021, enacted on June 10, 2021, increases the headline U.K. corporation tax rate from
Effect of
changes in foreign tax laws
of ¥
Changes in deferred tax valuation allowances
of ¥
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||
|
|
|
March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
Deferred tax assets
|
|
|
|
|
|
|
|
|
|
Depreciation, amortization and valuation of fixed assets
|
¥ |
|
¥ |
|
||||
|
Investments in subsidiaries and affiliates
|
|
|
||||||
|
Valuation of financial instruments
|
|
|
||||||
|
Accrued pension and severance costs
|
|
|
||||||
|
Other accrued expenses and provisions
|
|
|
||||||
|
Operating losses
|
|
|
||||||
|
Lease liabilities
|
|
|
||||||
|
Other
|
|
|
||||||
|
|
|
|
|
|||||
|
Gross deferred tax assets
|
|
|
||||||
|
Less
—
|
(
|
) |
(
|
)
|
||||
|
|
|
|
|
|||||
|
Total deferred tax assets
|
|
|
||||||
|
|
|
|
|
|||||
|
Deferred tax liabilities
|
||||||||
|
Investments in subsidiaries and affiliates
|
|
|
||||||
|
Valuation of financial instruments
|
|
|
||||||
|
Undistributed earnings of foreign subsidiaries
|
|
|
||||||
|
Valuation of fixed assets
|
|
|
||||||
|
Right-of-use
|
|
|
||||||
|
Other
|
|
|
||||||
|
|
|
|
|
|||||
|
Total deferred tax liabilities
|
|
|
||||||
|
|
|
|
|
|||||
|
Net deferred tax assets (liabilities)
|
¥ |
(
|
) | ¥ |
(
|
) | ||
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Balance at beginning of year
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Net change during the year
|
|
(1)
|
|
(2)
|
|
(3)
|
||||||
|
|
|
|
|
|
|
|||||||
|
Balance at end of year
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
| (1) |
Primarily includes an increase of ¥
|
| (2) |
Primarily includes an increase of ¥
|
| (3) |
Primarily includes an increase of ¥
utilization
of
loss carryforwards
. In total, ¥
|
|
|
|
|
|
|
|
Jurisdiction
|
|
Fiscal year ended March 31,
|
|
|
|
Japan
|
|
(1)
|
||
|
United Kingdom
|
|
(2)
|
||
|
United States
|
|
|||
| (1) |
The earliest year in which Nomura remains subject to examination for transfer pricing issues is the fiscal year ended March 31, 2018.
|
|
(2)
|
The earliest year in which Nomura remains subject to examination for transfer pricing issues is the fiscal year ended March 31, 2016.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||||||||||
|
|
|
For the year ended March 31, 2022
|
|
|||||||||||||||||
|
|
|
Balance at
beginning
of year
|
|
|
Other
comprehensive
income (loss)
before
reclassifications
|
|
|
Reclassifications
out of
accumulated other
comprehensive
income (loss)
|
|
|
Net change
during the
year
|
|
|
Balance at
end of year
|
|
|||||
|
Cumulative translation adjustments
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
Pension liability adjustment
(1)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Own credit adjustments
(2)
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
||||||||||||||||||||
|
For the year ended March 31, 2023
|
||||||||||||||||||||
|
Balance at
beginning
of year
|
Other
comprehensive
income (loss)
before
reclassifications
|
Reclassifications
out of
accumulated other
comprehensive
income (loss)
|
Net change
during the
year
|
Balance at
end of year
|
||||||||||||||||
|
Cumulative translation adjustments
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||||||
|
Pension liability adjustment
(1)
|
(
|
) |
|
|
|
(
|
) | |||||||||||||
|
Own credit adjustments
(2)
|
|
|
(
|
) |
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Millions of yen
|
||||||||||||||||||||
|
For the year ended March 31, 2024
|
||||||||||||||||||||
|
Balance at
beginning
of year
|
Other
comprehensive
income (loss)
before
reclassifications
|
Reclassifications
out of
accumulated other
comprehensive
income (loss)
|
Net change
during the
year
|
Balance at
end of year
|
||||||||||||||||
|
Cumulative translation adjustments
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||||||
|
Pension liability adjustment
(1)
|
(
|
) |
|
|
|
(
|
) | |||||||||||||
|
Own credit adjustments
(2)
|
|
(
|
) |
(
|
) |
(
|
)
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| (1) |
See Note 12 “
Employee benefit plans
|
| (2) |
See Note 2 “
Fair value measurements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
||||||||||||
|
|
|
For the year ended March 31
|
||||||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|
Affected line items in consolidated
statements of income |
|||
|
|
|
Reclassifications
out of
accumulated other
comprehensive
income (loss) |
|
|
Reclassifications
out of
accumulated other
comprehensive
income (loss) |
|
|
Reclassifications
out of
accumulated other
comprehensive
income (loss) |
|
|||||
|
Cumulative translation adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
¥
|
|
|
|
Revenue—Other /
Non-interest
expenses—Other
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
Income tax expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to noncontrolling interests
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
¥
|
|
|
|
Net income (loss) attributable to NHI shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
||||||||||||
|
|
|
For the year ended March 31
|
||||||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|
Affected line items in consolidated
statements of income |
|||
|
|
|
Reclassifications
out of
accumulated other
comprehensive
income (loss) |
|
|
Reclassifications
out of
accumulated other
comprehensive
income (loss) |
|
|
Reclassifications
out of
accumulated other
comprehensive
income (loss) |
|
|||||
|
Pension liability adjustment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥
|
(
|
)
|
|
¥
|
(
|
)
|
|
¥
|
(
|
)
|
|
Non-interest expenses—Compensation and benefits /
Revenue—Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Net income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to noncontrolling interests
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥
|
(
|
)
|
|
¥
|
(
|
)
|
|
¥
|
(
|
)
|
|
Net income (loss) attributable to NHI shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
||||||||||||
|
|
|
For the year ended March 31
|
||||||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|
Affected line items in consolidated
statements of income |
|||
|
|
|
Reclassifications
out of
accumulated other
comprehensive
income (loss) |
|
|
Reclassifications
out of
accumulated other
comprehensive
income (loss) |
|
|
Reclassifications
out of
accumulated other
comprehensive
income (loss) |
|
|||||
|
Own credit adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
¥
|
|
|
|
Revenue—Net gain on trading
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Income tax expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to noncontrolling interests
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
¥
|
|
|
|
Net income (loss) attributable to NHI shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Common stock outstanding at beginning of year
|
|
|
|
|||||||||
|
Decrease of common stock by cancellation of treasury stock
|
|
|
(
|
) | ||||||||
|
Common stock held in treasury:
|
||||||||||||
|
Repurchases of common stock
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
Sales of common stock
|
|
|
|
|||||||||
|
Common stock issued to employees
|
|
|
|
|||||||||
|
Cancellation of treasury stock
|
|
|
|
|||||||||
|
Other net change in treasury stock
|
(
|
) |
(
|
) |
(
|
) | ||||||
|
|
|
|
|
|
|
|||||||
|
Common stock outstanding at end of year
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||
|
|
|
March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
Total assets
|
¥ |
|
¥ |
|
||||
|
Total liabilities
|
|
|
||||||
|
Millions of yen
|
||||||||||||
|
Year ended March 31
|
||||||||||||
|
2022
|
2023
|
2024
|
||||||||||
|
Net revenues
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Non-interest
expenses
|
|
|
|
|||||||||
|
Net income attributable to affiliated companies
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||
|
|
|
March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
Investments in affiliated companies
|
¥ |
|
¥ |
|
||||
|
Advances to affiliated companies
|
|
|
||||||
|
Other receivables from affiliated companies
(1)
|
|
|
||||||
|
Other payables to affiliated companies
(2)
|
|
|
||||||
| (1) |
Includes ROU assets of ¥
million and ¥
|
| (2) |
Includes operating lease liabilities of ¥
31,
2023 and 2024, respe
c
tively.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Revenues
|
¥ |
|
¥ |
|
¥
|
|
||||||
|
Non-interest
expenses
|
|
|
|
|||||||||
|
Purchase of software, securities and tangible assets
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||
|
|
|
March 31
|
|
|||||
|
|
|
2023
|
|
|
2024
|
|
||
|
Carrying amount
|
¥ |
|
¥ |
|
||||
|
Fair value
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Equity in earnings of equity-method investees
(1)
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Dividends from equity-method investees
|
|
|
|
|||||||||
| (1) |
Equity in earnings of equity-method investees is reported within
Revenue—Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||
|
|
|
March 31, 2023
|
|
|
March 31, 2024
|
|
||
|
Commitments to extend credit
|
|
|
|
|
|
|
|
|
|
Liquidity facilities to central clearing counterparties
|
¥ |
|
¥ |
|
||||
|
Other commitments to extend credit
|
|
|
||||||
|
|
|
|
|
|||||
|
Total
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|||||
|
Commitments to invest
|
¥ |
|
¥ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||||||||||
|
|
|
Total
contractual
amount
|
|
|
Years to maturity
|
|
||||||||||||||
|
|
|
Less than
1 year
|
|
|
1 to 3
years
|
|
|
3 to 5
years
|
|
|
More than
5 years
|
|
||||||||
|
Commitments to extend credit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liquidity facilities to central clearing counterparties
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Other commitments to extend credit
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitments to invest
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||||||||||||||||||
|
|
Total
|
|
|
Years of payment
|
|
|||||||||||||||||||||||
|
|
Less than
1 year
|
|
|
1 to 2
years
|
|
|
2 to 3
years
|
|
|
3 to 4
years
|
|
|
4 to 5
years
|
|
|
More than
5 years
|
|
|||||||||||
|
Purchase obligations
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||||||
|
|
|
March 31
|
|
|||||||||||||
|
|
|
2023
|
|
|
2024
|
|
||||||||||
|
|
|
Carrying
value
|
|
|
Maximum
potential
payout /
Notional total
|
|
|
Carrying
value
|
|
|
Maximum
potential
payout /
Notional total
|
|
||||
|
Derivative contracts
(1)(2)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
Standby letters of credit and other guarantees
(3)
|
|
|
|
|
||||||||||||
| (1) |
Credit derivatives are disclosed in Note 3 “
Derivative instruments and hedging activities
|
| (2) |
Derivative contracts primarily consist of equity, interest rate and foreign exchange contracts.
|
| (3) |
Primarily related to a certain sponsored repo program where Nomura guarantees to a third party clearing house in relation to its clients’ payment obligations. Our credit exposures under this guarantee is minimized by obtaining collateral from clients at amount approximately the maximum potential payout under the guarantee.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||||||||||||||
|
|
|
Carrying
value
|
|
|
Maximum potential payout/Notional
|
|
||||||||||||||||||
|
|
|
Total
|
|
|
Years to Maturity
|
|
||||||||||||||||||
|
|
|
Less than
1 year
|
|
|
1 to 3 years
|
|
|
3 to 5 years
|
|
|
More than
5 years
|
|
||||||||||||
|
Derivative contracts
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
Standby letters of credit and other guarantees
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||||||||||
|
|
|
Retail
|
|
|
Investment
Management |
|
|
Wholesale
(1)(2)
(3)
|
|
|
Other
(Incl. elimination)
|
|
|
Total
|
|
|||||
|
Year ended March 31, 2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-interest
revenue
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Net interest revenue
|
|
|
|
(
|
) |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Net revenue
|
|
|
|
|
|
|||||||||||||||
|
Non-interest
expenses
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Income before income taxes
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Year ended March 31, 2023
|
||||||||||||||||||||
|
Non-interest
revenue
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Net interest revenue
|
|
|
(
|
) |
(
|
) |
(
|
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Net revenue
|
|
|
|
|
|
|||||||||||||||
|
Non-interest
expenses
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Income before income taxes
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Year ended March 31, 2024
|
||||||||||||||||||||
|
Non-interest
revenue
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Net interest revenue
|
|
|
(
|
) |
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Net revenue
|
|
|
|
|
|
|||||||||||||||
|
Non-interest
expenses
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Income before income taxes
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| (1) |
Non-interest
revenue
Non-interest
expense
Net gain on
trading
Non-interest
expenses
—Other
|
| (2) |
Non-interest revenue
and
Non-interest expense
for the year ended March 31, 2022 include gains of ¥
Net gain on trading
Non-interest
expenses
—
Other
|
| (3) |
Non-interest revenue
and
Non-interest expense
for the year ended March 31, 2023 include gains of
million, as the recoverable amount for a part of the claim related to the loss arising from the U.S. Prime Brokerage Event was reasonably estimated and collected. The gains are reported within
Net gain on trading
in the amount of ¥
million and in
(
Non-interest expenses—Other
in the amount of ¥
) million in the consolidated statements of income.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Net gain (loss) related to economic hedging transactions
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
||||
|
Realized gain on investments in equity securities held for operating purposes
|
|
|
|
|||||||||
|
Equity in earnings of affiliates
|
|
|
|
|||||||||
|
Corporate items
(1)
|
(
|
) |
(
|
) |
(
|
)
|
||||||
|
Other
(2)(3)(4)
|
|
|
(
|
) | ||||||||
|
|
|
|
|
|
|
|||||||
|
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
(1)
|
Income before income taxes for the year ended March 31, 2022 includes a loss of approximately ¥
|
|
(2)
|
Income before income taxes for the year ended March 31, 2022 includes a gain of approximately ¥
|
|
(3)
|
Income before income taxes for the year ended March 31, 2023 includes a gain of approximately ¥
|
| (4) |
Includes the impact of Nomura’s own creditworthiness.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Net revenue
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Unrealized gain (loss) on investments in equity securities held for operating purposes
|
|
(
|
) |
(
|
) | |||||||
|
|
|
|
|
|
|
|||||||
|
Consolidated net revenue
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Non-interest
expenses
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Unrealized gain (loss) on investments in equity securities held for operating purposes
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Consolidated
non-interest
expenses
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Income before income taxes
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Unrealized gain (loss) on investments in equity securities held for operating purposes
|
|
(
|
) |
(
|
)
|
|||||||
|
|
|
|
|
|
|
|||||||
|
Consolidated income before income taxes
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
| (1) |
Includes a reversal of unrealized gain (loss) on investments in equity securities held for operating purposes that were sold in the years ended March 31, 2022, 2023 and 2024.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
(2)
|
|
|
2023
(3)
|
|
|
2024
|
|
|||
|
Net revenue
(1)(3)
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Americas
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Europe
|
|
|
|
|||||||||
|
Asia and Oceania
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Subtotal
|
|
|
|
|||||||||
|
Japan
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Consolidated
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Income (loss) before income taxes
(3)
:
|
||||||||||||
|
Americas
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
||||
|
Europe
|
(
|
) |
|
(
|
)
|
|||||||
|
Asia and Oceania
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Subtotal
|
(
|
) |
(
|
) |
|
|||||||
|
Japan
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Consolidated
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
| (1) |
There is no revenue derived from transactions with a single major external customer.
|
| (2) |
Includes losses arising from the U.S. Prime Brokerage Event.
|
| (3) |
Includes gains from the estimated recoverable amounts and collected amounts for a part of the claim related to the loss arising from the U.S. Prime Brokerage Event.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millions of yen
|
|
|||||||||
|
|
|
Year ended March 31
|
|
|||||||||
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|||
|
Long-lived assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Americas
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Europe
|
|
|
|
|||||||||
|
Asia and Oceania
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Subtotal
|
|
|
|
|||||||||
|
Japan
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|||||||
|
Consolidated
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
|
|
|
|
|||||||
|
Exhibit
Number
|
Description
|
|
| 1.1 | ||
| 1.2 | ||
| 1.3 | ||
| 1.4 | ||
| 1.5 | ||
| 1.6 | ||
| 2.1 | ||
| 2.2 | ||
| 4.1 | ||
| 8.1 | ||
| 11.1 | ||
| 11.2 | ||
| 11.3 | ||
| 11.4 | ||
| 12.1 | ||
| 12.2 | ||
| 13.1 | ||
| 13.2 | ||
| 15.1 | ||
| 17.1 | ||
| 97.1 | ||
| 101.INS |
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
|
| 101.SCH |
Inline XBRL Taxonomy Extension Schema Document
|
|
| 101.CAL |
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
|
| 101.DEF |
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
|
| 101.LAB |
Inline XBRL Taxonomy Extension Label Linkbase Document
|
|
| 101.PRE |
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
|
| 104 |
The cover page for the Company’s Annual Report on Form
20-F
for the year ended March 31, 2023, has been formatted in Inline XBRL
|
|
|
(1)
|
The Company has entered into Limitation of Liability Agreements substantially in the form of this exhibit with all of its outside directors and director Shoji Ogawa.
|
|
|
|
|
|
|
|
NOMURA HOLDINGS, INC.
|
||||
|
|
|
|||
|
By:
|
|
/s/ KENTARO OKUDA
|
||
|
|
|
Name:
|
|
Kentaro Okuda
|
|
|
|
Title:
|
|
Representative Executive Officer,
President and Group Chief Executive Officer
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| Expeditors International of Washington, Inc. | EXPD |
| Terex Corporation | TEX |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|